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ABSTRACT 
The aim of this project was the study of neutrophil recruitment and reverse transmigration 
using murine and human in vitro models of inflammation. Murine in vitro models of 
inflammation were developed using an immortalised microvascular cell line (MCEC-1) and 
primary murine vascular endothelial cells (mEC) isolated from heart and lung. We found that 
MCEC-1 could recruit murine neutrophils without the requirement of cytokine stimulation, 
although efficient transmigration did require such a stimulus. Primary cells required cytokine 
stimulation to recruit mEC. Interestingly, and in contrast to human EC, mEC were relatively 
insensitive to TNF-α stimulation, although IL-1β was a good stimulus for adhesion and 
migration. Using the IL-1β driven system we generated reverse migrated murine neutrophils 
and their phenotype and prolonged survival were assessed. The effect of shear stress and nitric 
oxide on the regulation of the process of reverse migration was examined. Using adoptive 
transfer strategies we investigated the fate of mRPMNs in vivo. A significant part of this work 
involved the study of human reverse migrated neutrophils at a proteomic level using two-
Dimensional Fluorescence Gel Electrophoresis methodology to identify changes in 
neutrophils associated with reverse migration process. We found that murine reverse migrated 
neutrophils had a very similar surface phenotype to human reverse migrated cells. They also 
showed prolonged survival. However, our preliminary data on trafficking in vivo did not give 
a clear indication about their fate upon adoptive transfer into recipient mice. In vitro studies 
showed that flow generated shear stress and nitric oxide delayed, but did not inhibit, the 
process of reverse migration. Finally, the proteomics study revealed a number of metabolic, 
cytoskeletal and regulatory proteins that were differentially expressed in human reverse 
migrated neutrophils although the functional significance of these changes is yet to be 
explored.  
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1.1 Inflammation 
The immune system is a highly organised system, which contains many different 
organs and cells. Its purpose is to protect the body against external invaders such as pathogens 
by successfully removing them. It also plays a significant role in tissue repair after infection 
or trauma. A major function of the immune system is to maintain homeostasis and to do this it 
has to deliver immune/inflammatory cells when and where they are needed (Gallin et al., 
1992). Generally, the physiological inflammation operates on an acute response model, where 
rapid resolution of the inflammatory process terminates potentially damaging cellular activity. 
However, chronic inflammatory diseases may demonstrate prolonged or inappropriate 
inflammatory activity and/or an impaired resolution phase, all of which contribute to 
pathological changes in the effected tissues. There may also be an element of systemic 
damage in organs and tissues distant from the original inflammatory insult. 
 
From ancient times, several symptoms of inflammation have been reported: heat, 
swelling, redness and pain. These symptoms are caused by vasodilation at the site of 
inflammation and endothelial cell damage induces the formation of plasma and enzyme 
mediators that increase vascular permeability and vasodilation. This causes heat and redness. 
The increase in vascular permeability causes the swelling leading to oedema and pain.  Upon 
initiation of inflammation, leukocytes, which circulate in large numbers in the blood, are 
rapidly recruited to the site of inflammation. This process appears to be driven by tissue-
resident macrophages receiving signals from tissue damage or invading organisms and 
initiating the recruitment of a subset of leukocytes; neutrophils. Tissue macrophages achieve 
this by secreting agents, such as  IL-1, IL-6 and TNF-α, which activate vascular endothelial 
cells responsible for neutrophil recruitment by the multiple-step process of extravasation 
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(Feldmann et al., 1996). Following neutrophils, circulating monocytes are recruited, and after 
entering the tissue these become tissue resident-macrophages or dendritic cells. After the 
recruitment of these professional phagocytes to the site of inflammation, they execute their 
immune functions by removing the external pathogen and facilitating the tissue repair.  
 
Under physiological conditions, inflammation is resolved. Whenever this does not 
happen, persistent chronic inflammation may follow. In this case, leukocytes continue to 
infiltrate the tissue and stay for prolonged periods in the tissue where they continue to exhibit 
their pro-inflammatory functions. In this case, aberrant tissue remodelling occurs, leading to 
the loss of normal tissue and/or organ function.  
 
 
1.2 Blood 
The blood consists of the plasma and the cells that circulate in it. Plasma accounts for 
60% of blood volume. It contains water, glucose, electrolytes, and many proteins, some of 
which are responsible for transport of other organic compounds such as insoluble lipids. 
Among the many proteins present in plasma are antibodies, complement and coagulation 
factors, all of which play an important role in the immune and inflammatory processes. The 
remaining 40% of blood volume constitutes the cellular elements; erythrocytes, platelets and 
leukocytes. The most abundant cell population in the blood is the erythrocytes, with a 
concentration of 5x1012 cells/L. Their function is to facilitate gas exchange, as they transfer 
O2 and CO2 between the lungs and other respiring tissues (Pallister, 1994). Their elliptic 
shape also contributes for this function, as they are flexible and small with a large surface 
area/volume ratio. Platelets, which account for 2.5x1011/L, are cellular fragments with no 
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nucleus that derive from megakaryocytes in the bone marrow. Their major role is 
haemostasis, forming clots to limit blood loss. They are also involved in wound repair 
(Pallister, 1994), thereby securing the integrity of the cardiovascular system upon trauma. 
There is also increasing evidence that platelets play a role in the inflammatory process by 
promoting the recruitment of leukocytes (Lindemann et al., 2007). Leukocytes are further 
divided into different sub-populations, each one playing a role in the innate or adaptive 
immune response as will be described further in this text. 
 
1.2.1 Cells of the innate immune response 
The innate immune response is the first line of defence against pathogens and can be 
initiated within minutes. The mechanism of action of the innate system is considered to be 
non-specific and responsible for rapid destruction and clearance of invading pathogens. There 
are three sub-sets of leukocytes involved in innate immunity: granulocytes (neutrophils, 
eosinophils, basophils), mononuclear cells (monocytes, macrophages) and mast cells (Figure 
1.1). All three have in common the ability to phagocytose pathogens. This happens due to the 
existence of various types of receptors such as toll-like receptors (TLRs) or pattern 
recognition receptors (PRRs). These receptors recognise common repeat motives present in 
carbohydrates or lipids on the surface of foreign but not in the host organism. Coating of the 
foreign organism with immunoglobulin or complement can increase the efficiency of 
receptor- mediated phagocytosis.  
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1.2.1.1 Granulocytes 
Granulocytes are cells that contain intracellular vesicles or granules. Depending on the 
affinity of the contents of the granules to several dyes, granulocytes are divided in three sub-
categories: the neutrophils, the eosinophils and the basophils.  
 
Neutrophils are named after granule staining patterns that appear neutral after the 
application of dyes. They are the most abundant circulating leukocyte population in the blood. 
They have a short cell life and can be recruited to the site of inflammation within minutes 
(Cheretakis et al., 2006). Their primary function is the phagocytosis of the microbe invaders. 
Neutrophils are able to recognise foreign antigen via their Fc receptors FcγRIIa (CD32), 
FcγRIIIb (CD16) and complement receptor CR1 (CD35), although the major receptor for 
phagocytic uptake is the C3Rb otherwise known as the β2 integrin Mac-1 (CD11b/CD18). 
The activation of the neutrophils results in the production of a respiratory burst which releases 
reactive oxygen species capable of killing pathogens. They have two different types of 
granules: the azurophilic and the specific (secondary granules). The first contain 
myeloperoxidase, acid hydrolases and neutral proteases that have an antimicrobial action. The 
second contain lactoferrin, collagenase, alkaline phosphatase and vitamin B12-binding 
proteins (Alberts et al., 2002). Granules in the cytoplasm fuse with the phagolysosome and 
release their cytotoxic contents. The pathogen is then destroyed within a controlled 
environment. Another way for pathogen destruction is through respiratory burst. Respiratory 
burst results in the production of cytotoxic oxygen metabolites such as singlet oxygen, 
superoxide, hydrogen peroxide and hydroxyl radicals by the enzyme NADPH oxidase, on the 
membrane of the phagosomes. NADPH oxidase releases oxygen metabolites into the 
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phagolysosomes during phagocytosis and facilitates the destruction of the pathogen  
(Edwards, 1994). 
 
Eosinophils are pro-inflammatory cells with a bilobed nucleus. They have a large 
number of IgE receptors on their membrane and play an important role in the allergic 
response. Eosinophils also have granules that contain peroxidase and toxic proteins, able to 
destroy parasites, such as roundworms. Recent data suggest that eosinophils could act as APC 
(antigen presenting cells) to promote expansion of Th2 cells in vitro and in vivo (Shi, 2004). 
Basophils are the least numerous group of granulocytes. These cells are non-phagocytic and 
participate in the allergic response, by releasing histamine. They also play a role in the host 
defence against parasites (Askenase, 1980).  
 
1.2.1.2 Monocytes 
Monocytes circulate in the blood for many hours before they migrate to the tissue and 
remain there as resident cells under non-inflammatory conditions. As resident cells, they 
differentiate into macrophages and dendritic cells. An example of a specialised tissue resident 
macrophage are the Kupffer cells in the liver which play important scavenger roles. 
Langerhan cells in the skin are an example of specialised dendritic cells important for 
maintaining the integrity of the dermal barrier. Macrophages play an important role, both in 
innate and adaptive immunity. In the former, their functions are the detection and destruction 
of pathogens, the secretion of pro-inflammatory cytokines and growth factors, agents that in 
their own right can activate other leukocyte subsets (Janeway et al., 2001). Their participation 
in tumour killing (Cameron and Churchill, 1975), wound repair (Leibovich and Ross, 1975) 
and antigen presentation is also reported. Importantly, abnormal macrophage activity is 
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associated with pathology in chronic inflammatory disease such as atherosclerosis and 
rheumatoid arthritis. Dendritic cells function mainly as antigen presenting cells and their 
function will be further explored in the section describing the adaptive immune response. 
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Figure 1.1 Cells of the innate immune system 
Each cell type has a morphologically distinct lobular nuclei and cytoplasmic granules. 
Pictures courtesy of Professor G.B. Nash, Department of Physiology, University of 
Birmingham. 
 
 
1.2.2 Cells of the adaptive immune response 
Contrary to the innate immune response, the adaptive immune response is 
characterised by specificity and memory. Upon the first encounter with an invading pathogen, 
the adaptive immune response starts to function after 4-7 days post-infection. However, 
subsequent exposure to the antigen requires only 1-2 days for an effective response to occur. 
The cells of the adaptive immune response are the B and T lymphocytes, the natural killer 
(NK) cells and the antigen presenting cells (mainly dendritic cells) or APCs. Dendritic cells 
become activated once they encounter a pathogen and migrate to the lymph nodes via the 
lymphatic system. In the lymph nodes, they mature and present antigen on their surface. 
When the antigen is viral, it is presented to CD8+ cells in major complex histocompatibility 
complex class I. Then CD8+ cells become activated and have the ability to lyse infected cells 
using perforin and subsequently induce apoptosis (Janeway et al., 2001). CD4+ cells once 
ligated on APCs presenting an antigen in conjunction with MHC class II molecules, become 
activated and secrete cytokine such interleukin 2 (IL-2) that triggers the proliferation of other  
CD4+ and CD8+ T cells. Upon ligation of specific antigen (via the T-cell receptor or TCR) on 
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an antigen presenting cell (often a dendritic cell), T cells become activated. Apart from the 
between T-cell TCR-CD3 complex and the APC antigen peptide interaction, an additional co-
stimulatory signal, provided by T-cell CD28 and APC B7 molecule ligation is required for T-
cell activation (Janeway et al., 2001). Activated Th2 cells release IL-4, which induces the 
antigen class switching of B cells. There are also the regulatory T cells (previously named 
suppressor T cells), which are CD4+ cells that co-express the receptor for IL-2, CD25.  
Research since the 90’s has shown that these cells play an important role in the control of 
autoreactive T cells in vivo (Sakaguchi et al., 1995).  
 
B and T cells are derived from common progenitor cells in foetal liver and later in 
adult life, from the bone marrow. B cells are generated and mature in the bone marrow. In 
contrast, T cells, after their generation in the bone marrow, migrate to the thymus where they 
mature and undergo selective deletion of self (auto-) reactive clones. T-cells then migrate to 
the lymph nodes where they are functional. B cells are responsible for the humoral response. 
Upon ligation of an antigen presented on a professional antigen presenting cell such as a 
dendritic cell, B cells undergo clonal expansion and differentiate into plasma cells which 
subsequently secrete antibodies specific to that antigen (DeFranco, 1987). T-cells are also 
essential for efficient humoral responses, as co-stimulatory factors derived from antigen 
stimulated T-cells are essential for B-cell maturation. 
 
There are 5 isotypes of immunoglobulins: the IgA, IgD, IgE, IgG and IgM. Each 
isotype performs a different function; IgA is in secretions (e.g. mucus), IgE is involved in the 
mast cell degranulation and allergic and anti-parasite responses, IgG is the major isotype in 
the blood involved in the opsonisation of pathogens and IgM is the first to be secreted in the 
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primary immune response via activation of the complement system. Upon activation, B-cells 
perform class switching, where B cells secrete different isoforms of the antibody specialised 
to the different phases of the immune response (Janeway et al., 2001). 
 
 
1.3 Vascular endothelium  
Endothelial cells (EC) form the inner lining of all the vessels of the vascular tree and, 
therefore, are in direct contact with blood.  This layer is an active barrier between blood and 
the tissue and regulates a number of important functions, such as the transfer of gases, 
metabolites and cells (leukocytes) from blood into tissue and vice versa. The integrity and the 
specificity of the barrier function of different vascular beds are regulated by the existence of a 
system of complex junctions, i.e. the tight junctions, adherens junctions and gap junctions 
(Rubin, 1992). The EC also secrete an extracellular matrix or basement membrane consisting 
mainly of laminins, type IV collagen and heparin proteoglycans which is an essential 
anchorage point for the ECs (Erickson and Couchman, 2000). 
 
Depending on their site in the vascular tree, EC exhibit distinct phenotypic and 
morphological characteristics. EC in the blood brain barrier have highly organised tight 
junctions securing the homeostasis of the cerebral environment. But in the sinusoid capillaries 
of the liver EC the lack of junctions and basement membrane, as well as a highly fenestrated 
surface, enables the direct movement of macromolecules from the blood to the liver 
parenchymal cells (Enomoto and Nishiwaka, 2004). Importantly, EC in post capillary venules 
are involved in the recruitment of leukocytes during inflammation. In response to 
inflammatory cytokines, they express specific adhesion molecules and chemoattractants 
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required for leukocyte recruitment (Springer, 1994). In contrast, EC in closely opposed 
arterioles do not support leukocyte recruitment, unless the endothelial cell function has been 
altered inappropriately as found in chronic inflammation (van der Wal et al., 1992). Research 
has demonstrated that the stromal environment is able to influence the EC responses during an 
inflammatory response and may regulate the progression of leukocyte recruitment as well as 
causing pathological modification to the leukocyte recruitment process in disease (Rainger 
and Nash, 2001; Rainger et al., 2001). 
 
 
1.4 Leukocyte adhesion cascade  
Upon inflammation, circulating leukocytes in the blood must enter the tissue to carry 
out their immune functions. This process is dependent upon on the activation of EC to enable 
the recruitment of leukocytes to the sites of inflammation. The recruitment of leukocytes 
usually takes place in post-capillary venules, but also can occur in larger vessels, such as 
arteries, in chronic inflammation associated with atherosclerosis. The leukocyte adhesion 
cascade is a multistep process (Springer, 1994), as depicted in Figure 1.1. 
Generally, four distinct phases are recognised:  
Step 1: Leukocytes are captured from flow and roll on specialised adhesion receptors. 
Step 2: Leukocytes become activated by chemoattractants and arrest on the EC surface. 
Step 3: Leukocytes migrate on the endothelial cells to points suitable for migration.  
Step 4: Leukocytes transmigrate through EC junctions/endothelial cells, then through the 
basement membrane and finally into the tissue. 
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Figure 1.2 The leukocyte adhesion cascade 
Leukocytes are captured from flow and roll on specialised adhesion receptors on the 
endothelium surface. Then they become activated by chemoattractants and arrest on the EC 
surface. Next, they migrate on the endothelial cells and finally transmigrate through EC 
junctions/endothelial cells. Following transmigration, they penetrate the basement membrane 
and finally enter the tissue.  
 
 
1.4.1 Capture and rolling 
The flow of red cells in the blood pushes the leukocytes close to the vessel wall. This 
rheological phenomenon is called margination and enables the leukocytes to be in contact 
with the EC of the post-capillary venule. This process is independent of any inflammatory 
activation of the vasculature. When inflammation does occur, leukocytes are captured from 
flow via receptors highly expressed on the EC and leukocytes. Selectins are a large family of 
receptors of which there are three members: endothelial (E)-selectin, leukocyte (L) - and 
platelet (P)-selectin. All selectins contain a -NH2 terminal C-type lectin domain, a conserved 
epidermal growth factor (EGF-like) motif, a number (2-9) of short complement regulatory 
(CR) repeats, a transmembrane domain and a short cytoplasmic tail. Selectin ligands are 
glycoproteins and glycolipids with sialyl Liews X (SleX) motifs in their structure and bonds 
formed between selectins and their ligands are calcium dependent. Selectins form strong yet 
Margination 
Capture  
and rolling 
Arrest and firm 
adhesion 
Transendothelial 
migration 
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short-lived bonds, and the continuous breaking of bonds and making of new bonds results in a 
dynamic form of adhesion resulting in the rolling of the cells in the direction of blood flow. 
 
 L-selectin 
 L-selectin expression is restricted to leukocytes, usually on their microvilli. It is 
important for leukocyte recruitment in post capillary venules as well as the homing of 
lymphocytes to the lymph nodes (von Andrian et al., 1993). L-selectins can bind to P-selectin 
glycoprotein ligand-1(PSGL-1) (Spertini et al., 1996), CD34 (Oxley and Sackstein, 1994) and 
glycosylated cell adhesion molecule-1(GlyCAM-1) (Lasky et al., 1992). Soon after they have 
been activated, leukocytes undergo proteolytic cleavage of their L-selectin. The physiological 
role of this phenomenon is not known. It has been shown that inhibition of this process in vivo 
results in increased leukocyte adhesion and transmigration (Hafezi-Moghadam et al., 2001). 
However, no change in adhesion and transmigration was observed when the shedding was 
inhibited in vitro, in flow and static adhesion assays using tumour necrosis factor-alpha (TNF-
α) stimulated EC (Allport et al., 1997a). 
 
P-selectin 
P- selectin is expressed in EC and platelets. In EC, P-selectin is stored in Weibel-
Palade bodies (Bonfanti et al., 1989) and it translocates to the membrane within minutes after 
stimulation with oxygen radicals (Patel et al., 1991), histamine (Asako et al., 1994) or 
thrombin (Theoret et al., 2006). P-selectin can also be mobilised by inflammatory cytokines 
such as TNF-α, so that, 2-4 hours after stimulation it is expressed and is detected on the EC 
surface (Springer, 1994). However, it is unclear whether this expression occurs due to the 
translocation of the molecules previously in Weibel-Palade bodies or by de novo synthesis of 
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the protein. P-selectin is suggested to play an important role in the early stages of 
inflammation. When P-selectin was blocked in vivo using a function-blocking antibody in the 
canine cremaster muscle, total leukocyte adhesion was reduced by a 60% (Dore et al., 1993). 
Additionally, in a model of peritoneal cavity inflammation in the P-selectin knockout mouse, 
there was a delay in neutrophil recruitment to the peritoneal cavity (Mayadas et al., 1993). 
Mice lacking the major P-selectin ligand, the PSGL-1, also exhibited dramatic reduction in 
neutrophil recruitment to the peritoneal cavity 2 hours after inflammation induction by 
thioglycollate (Yang et al., 1999). Some investigators have suggested that P-selectin ligation 
on the leukocytes can trigger signal transduction pathways in them which finally lead to 
integrin up-regulation and activation (Hidari et al., 1997). Nevertheless, there is strong in 
vitro evidence that suggest that leukocytes are able to roll indefinitely on P-selectin coated 
surfaces or P-selectin on platelets (Sheikh and Nash, 1996). 
 
P-selectin in platelets is present in α-granules (Stenberg et al., 1985). In activated 
platelets, granule release results in P-selectin expression on the surface of the platelets. It has 
been demonstrated that platelets are able to support leukocyte adhesion in vitro. Neutrophils 
could adhere on P-selectin lipid bilayers and activated platelets within physiological shear 
stresses in the absence of other selectins and IgSF members (Buttrum et al., 1993; Diacovo et 
al., 1996; Lalor and Nash, 1995; Lawrence and Springer, 1991; Rainger et al., 1998). In vivo 
studies have confirmed the importance of P-selectin as a capture receptor and more recently, it 
has been shown to have a synergistic role with E-selectin in increasing the capture of 
neutrophils in postcapillary venules (Smith et al., 2004; Springer, 1995; Zimmerman et al., 
1992). Thus, P-selectin not only plays a major role in thrombus formation but also the 
recruitment of leukocytes to sites of inflammation.  
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This platelet-mediated adhesion may play a role in physiological and pathological 
inflammatory conditions. There is evidence that this occurs for neutrophil recruitment in 
hypoxia and reperfusion injury (Kogaki et al., 1999). Moreover, it has been shown that 
platelets may contribute to the formation of atherosclerotic plaque in the apolipoprotein-E 
(apo-E) knockout mice (Manka et al., 2004). 
 
E-selectin 
E-selectin is expressed in EC after stimulation with interleukin-1 beta (IL-1β), TNF-α, 
lymphotoxin or bacterial endotoxin, reaching maximal expression 6 hours post-stimulation 
and returning to initial levels after 24 hours (Bevilacqua et al., 1987). E–selectin ligands on 
leukocytes are PSGL-1 (Moore et al., 1994), E-selectin ligand -1(ESL-1) (Steegmaler et al., 
1995) and CD44 (Dimitroff et al., 2001). It has been recently reported that each ligand has a 
specific function in the rolling process. Thus, using hairpin RNA to knock down ESL-1 in 
hematopoietic cells deficient in PSGL-1, CD44 or both ligands it was shown that ligation of 
PSGL-1 induces tethering, ESL-1 mediates steady rolling and CD44 slow rolling. It has been 
suggested that close collaboration between the three of these ligands might be necessary for 
efficient recruitment (Hidalgo et al., 2007). 
 
An additional mechanism for rolling is mediated by integrins. It has been reported that 
cell lines expressing α4β7-integrin roll on mucosal vascular addressin cell-adhesion molecule 
1 (MADCAM1). Lymphocytes can roll on immobilised VCAM-1 via VLA4 (α4β1 integrin). 
This mechanism has been described in monocytes and T-cells. In addition, LFA1 (αLβ2 
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integrin) can support the rolling of lymphocytes interacting with ICAM-1 (Reviewed by Ley 
et al., 2007). 
 
1.4.2 Activation and firm adhesion 
Leukocytes can be activated by a number of chemoattractant molecules such as 
chemokines, bacterial derived N-formyl peptide (fMLP), the complement fragments C5a and 
C3a, leukotriene B4 (LTB4) and platelet activating factor (PAF) (Gerard and Gerard, 1994; 
Goldman and Goetzl, 1982; Hanahan, 1986; Schiffmann et al., 2008). However, in the 
context of physiological inflammation, the role of endothelial derived and presented 
chemokines are thought to be essential for leukocyte activation during the recruitment 
process. 
 
Chemokines are a family of small, low molecular weight (8-16KDa) chemoattractant 
cytokines with the ability to recruit different leukocyte populations by signalling through 
specific G-coupled counter receptors. There are 4 sub-groups of chemokines depending on the 
position of two highly conserved cysteines in the amino acid sequence: CXC, CX3C, CC and 
C. CXC chemokines can be further divided into two groups depending on the presence or 
absence of an ELR motif next to the CXC motif. The ones containing ELR motif are the 
CXCL1, 2, 3, 5, 6, 7, 8 chemokines and have the ability to activate neutrophils and some 
other leukocyte subpopulations. In contrast chemokines lacking the ELR motif mainly 
activate  lymphocytes and monocytes (Laing and Secombes, 2004). The activity of CC 
chemokines is effectively restricted to monocytes. From the C group, two chemokines have 
been identified, the lymphotaxins-α and β (Gray et al., 1984). From the CX3C group 
fractakline is the only known member (Bazan et al., 1997). Chemokines are secreted by EC at 
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the sites of inflammation that have been activated by cytokines such TNF-α or IL-1. The 
binding of chemokines to their G-coupled protein receptors (CCR, CXCR, CX3CR) on 
leukocytes induces leukocyte integrin activation and, as a consequence, the leukocytes adhere 
firmly to the EC surface. Using in vitro models of inflammation it was shown that CXCL8 
chemokine activates the integrin CD18/CD11b and thus leads to the firm adhesion of 
neutrophils on ECM proteins or EC, and in flow, it can cause neutrophil activation in less than 
1 second of tethering via P-selectin (Peveri et al., 1988; Rainger et al., 1997; Yoshimura et 
al., 1987). Chemokines and their receptors show varying degrees of specificity. As an 
example there are two main chemokine receptors that play a part in neutrophil recruitment to 
sites of inflammation: CXCR1 and CXCR2. While CXCR1 can bind only CXCL8 with high 
affinity and CXCL6 with lesser affinity, CXCR2 interacts with all the ELR motif containing 
chemokines (Murdoch and Finn, 2000). 
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Table 1.1 Chemokines and their receptors  
Group Systematic name Common name Receptor 
CXC CXCL1 Gro-α CXCR2 
 CXCL2 Gro-β CXCR2 
 CXCL3 Gro-γ CXCR2 
 CXCL4 PF4 CXCR2 
 CXCL5 ENA-78 CXCR2 
 CXCL6 GCP-2 CXCR1,2 
 CXCL7 NAP-2 CXCR2 
 CXCL8 IL-8 CXCR1,2 
 CXCL9 Mig CXCR3 
 CXCL10 IP-10 CXCR3 
 CXCL11 I-TAC CXCR3 
 CXCL12 SDF-1 CXCR4 
 CXCL13 BCA-1 CXCR5 
 CXCL14 BRAK Unknown 
 CXCL16 CXCL16 CXCR6 
CC CCL1 I-309 CCR8 
 CCL2 MCP-1 CCR2 
 CCL3 MIP-1α CCR1,5 
 CCL4 MIP-1β CCR1,5 
 CCL5 RANTES CCR1,3,5 
 CCL7 MCP-3 CCR2 
 CCL8 MCP-2 CCR2 
 CCL11 Eotaxin CCR2 
 CCL13 MCP-4 CCR2,3 
 CCL14 HCC-1 CCR1 
 CCL15 HCC-2 CCR1,3 
 CCL16 HCC-4 CCR1 
 CCL17 TARC CCR4 
 CCL18 DC-CK1 Unknown 
 CCL19 ELC CCR7 
 CCL20 LARC CCR6 
 CCL21 SLC CCR7 
 CCL22 MDC CCR4 
 CCL23 MPIF-1 CCR1 
 CCL24 MPIF-2 CCR3 
 CCL25 TECK CCR9 
 CCL26 Eotaxin-3 CCR3 
 CCL27 C-TACK CCR10 
CX3C CX3CL1 Fractalkine CX3CR1 
C XCL1 Lymphotaxin
 
XCR1 
 XCL2 Lymphotaxin
 
XCR2 
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Integrins 
Integrins are receptors that mediate the attachment of the cell to one another or to the 
extracellular matrix (ECM) and play an important role in cell migration and signalling. They 
are formed by two linked heterodimers, α and β chain. Each chain contains a large 
extracellular domain forming loops, one transmembrane domain and a short cytoplasmic tail. 
There are 18 α and 8 β chains, with various dimmer combinations giving rise to 24 integrins. 
The most important integrins for leukocyte recruitment are the β2 integrins which are found 
on all leukocytes. αLβ2 (CD18/CD11a) is expressed on lymphocytes, NK cells, monocytes and 
macrophages, neutrophils, dendritic cells and eosinophils (Smith, 2008). Its ligands are 
ICAM-1,-2,-3 and junctional adhesion molecule–A (JAM-A) (Ostermann et al., 2002). αMβ2  
integrin (or Mac-1) contributes to neutrophil adhesion by binding to ICAM-1 or -2 on the EC 
surface (Smith et al., 1989). Blocking of β2 integrin results in the inhibition of neutrophil 
adhesion in a static, in vitro model of inflammation (Luscinskas et al., 1989). Under flow 
conditions, antibodies against β2 integrin specifically inhibited the firm adhesion stage but not 
rolling adhesion (Bahra et al., 1998), suggesting that β2 integrins are required for firm 
adhesion and transmigration not for rolling adhesion. Interestingly, blocking of CD11a 
inhibits the process of neutrophil transendothelial migration, even though cells can attach 
firmly to the endothelial surface.  
 
After firm adhesion, neutrophils migrate over the EC monolayer on their attempt to 
find the appropriate location to transmigrate in a CD18/CD11b and ICAM-1 dependent 
manner (Phillipson et al., 2006). At this stage a dramatic actin cytoskeleton rearrangement 
takes place in neutrophils, which enables the dynamic interaction between integrins and their 
ligands on EC surface. Lamellipodia formation at the front edge of the neutrophils, in parallel 
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with the detachment of integrin bonds at the rear of the cell, enables the neutrophils to move 
forward (Moissoglu and Schwartz, 2006). 
 
1.4.3 Transmigration 
The leukocyte adhesion cascade is completed by the transmigration of leukocytes 
through the EC monolayer. This occurs in two ways; either by paracellular (between 
endothelial cell junctions) or by transcellular transmigration (through endothelial cells). 
Although it is suggested that paracellular transmigration is the main type of transmigration for 
neutrophils, transcellular transmigration through EC has been reported to take place in vitro 
and in vivo (Carman and Springer, 2004; Feng et al., 1998). There is also evidence that 
transmigration can occur at tricellular junctions after IL-1β stimulation of EC in vitro (Burns 
et al., 1997). There are a number of molecules that have been reported to promote integrin 
mediated transmigration: CD31, CD99, JAM-A,-B,-C and VE-cadherin (reviewed by Ley, 
2007). 
 
CD31 (Platelet Endothelial Cell Adhesion Molecule-1 or PECAM-1) is a 130kDa 
protein, a member of the IgG superfamily, it is expressed on leukocytes and it is present on 
endothelial cells, being particularly highly expressed at cell-cell junctions. At the EC junction 
CD31 molecules interact in a homophillic way, i.e. CD31-CD31 interactions occur between 
same domains of molecules on opposing cellular surfaces. The role of CD31 in transmigration 
has been widely studied with contradictory results. Blocking of CD31 on neutrophils, 
monocytes or EC inhibited transmigration through cytokine stimulated EC in an in vitro static 
assay, suggesting that CD31 is required for transmigration (Muller et al., 1993). It should be 
noted that in our own laboratories the blockade of CD31 had no effect on neutrophil migration 
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(Luu et al., 2003). In addition, the recruitment of leukocytes to sites of inflammation in the 
CD31 knockout mouse show only minor differences from wild-type animals, i.e. a short delay 
in passage into tissue, suggesting that CD31 is not essential for transmigration (Duncan et al., 
1999). There is evidence that CD31 also plays a role in the later stage of leukocyte migration 
through the subendothelial basal laminin (Dangerfield et al., 2002). Work from our own 
laboratories has shown that although CD31 is not essential for transendothelial migration, it 
does regulate the direction and velocity of neutrophil migration on EC and their migration 
velocity in the sub-endothelial environment (Luu et al., 2003).  
 
CD99 is a 32 kD highly -O-glycosylated molecule which is expressed on the surfaces 
of most leukocytes and is concentrated at the borders between endothelial cells. Blocking of 
this molecule on either leukocytes or endothelial cells blocks transmigration of monocytes 
(Schenkel et al., 2002). For example, blockade of CD99 could block transmigration  more 
than 90% in an in vitro model (Schenkel et al., 2002). There is also evidence that CD99 
blockade inhibits neutrophil transmigration across cytokine treated EC, indicating a role of 
CD99 in neutrophil transmigration (Bixel et al., 2007; Lou et al., 2007). 
 
JAMs (Junctional Adhesion Molecules) belong to the IgG superfamily and the three 
main members, JAM-A,-B and –C, are expressed in different cell types. JAM-A is expressed 
on leukocytes, erythrocytes, platelets, endothelial and epithelial cells, whereas JAM-B 
expression is restricted to EC and activated T-cell subpopulations (Dejana, 2004; Williams et 
al., 1999). JAM-A is mainly located at cell junctions or concentrated in cell-cell contacts and 
there is evidence that JAM-A is involved in transmigration in vitro and in vivo (Dejana, 2004; 
Williams et al., 1999). Using a  function-blocking antibody against JAM-A,  monocyte 
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transmigration through cultured EC and infiltration of monocytes into an air pouch in mice 
was inhibited (Martin-Padura et al., 1998). 
 
JAM-B interacts homotypically and heterotypically with JAM-C. JAM-B can bind the 
integrin α4β1,  but this interaction is JAM-C  dependent  (Cunningham et al., 2002). JAM-C is 
expressed by leukocyte, EC and platelets. It binds JAM-B, but also the neutrophil αMβ2  
integrin (Santoso et al., 2002). JAM-C has been proposed to play a role in leukocyte 
transmigration. In in vivo models of peritonitis and lung inflammation, it has been 
demonstrated that soluble recombinant JAM-C administration resulted in a reduction in 
neutrophil recruitment (Chavakis et al., 2004). Similar findings were obtained when 
antibodies against JAM-C were injected into mice (Aurrand-Lions et al., 2005). However, 
blocking JAM-C could not inhibit neutrophil migration across cytokine-stimulated EC in a 
human flow model (Sircar et al., 2007). When monocytes or HUVEC were treated with 
blocking monoclonal antibodies against JAM-C, there was no effect on monocyte 
transmigration (Bradfield et al., 2007). Direct observation revealed that more monocytes had 
migrated back from the abluminal to the luminal side of the endothelium in the presence of 
the JAM-C antibody (Bradfield et al., 2007). 
 
 VE-cadherin is a member of the cadherin family and is concentrated at adherens 
junctions between endothelial cells. It is linked to the cytoskeleton via α- and β- catenins, 
plakoglobin and p120 (Lampugnani et al., 1993). Studies with monoclonal antibodies against 
VE cadherin demonstrated an increase in the permeability of endothelial cell monolayers, 
suggesting that VE-cadherin can function as a regulator of increase in endothelial cell 
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monolayer permeability (Allport et al., 1997b; Corada et al., 1999; Del Maschio et al., 1996). 
In addition, VE-cadherin is redistributed during neutrophil transmigration (Su et al., 2002). 
 
 
1.4 Migration across the basement membrane 
After transendothelial cell migration, neutrophils proceed to penetrate the basement 
membrane. This stage is reported to be supported by β1 integrins (Dangerfield et al., 2002). 
The basement membrane alters the velocity of neutrophil migration and they become slower 
than during their penetration of the EC monolayer. Using intravital microscopy methodology 
to visualise the microcirculation of the unstimulated cremaster muscle, it has been 
demonstrated that areas low in basement membrane constituents such as laminin, coincide 
with the areas neutrophils choose to cross the barrier. This suggests that leukocyte migration 
may be focussed to these areas and that the process of leukocyte migration is minimally 
disruptive to the basement membrane. Prolonged culture of HUVEC increased their 
sensitivity to cytokines, but the migration velocity of transmigrated neutrophils was lower 
(Butler et al., 2008; Butler et al., 2005). 
 
 
1.5 Retention of leukocytes at the site of inflammation 
Following extravasation, activated neutrophils at the inflamed site execute their 
immune functions by phagocytosing invading microorganisms and cell debris. Their 
phagosomes fuse with lysosomal granules containing hydrolytic enzymes and neutrophils 
produce reactive oxygen species (ROS) that have anti-microbial activity. They also release 
nuclear content as chromatin forming the extracellular traps (NETs) to trap bacteria free in the 
                                                                                              CHAPTER 1 
 
24 
 
extracellular space. In addition, activated neutrophils produce signals that promote the 
recruitment of additional phagocytes to the site of inflammation for the effective elimination 
of microbe invasion and cell debris. They release CXCL8 and CXCL1/2/3 to recruit 
circulating neutrophils (Cassatella, 1999; Scapini et al., 2000). Neutrophils also promote 
monocyte recruitment in a number of ways. Granule proteins released from recruited 
neutrophils, such as azurocidin, defensins and cathepsin G, activate the formyl-peptide 
receptors (FPRs) on circulating monocytes and induce their firm adhesion on the EC (Chertov 
et al., 1996; Chertov et al., 1997; Yang et al., 2000). Furthermore, an additional mechanism 
that involves IL-6Rα in a process known as IL-6 trans-signalling induces monocyte 
recruitment (Romano et al., 1997; Taga et al., 1989). Activation of neutrophils results in the 
IL-6Rα shedding. Soluble IL-6Rα, subsequently forms complexes with IL-6 released from 
macrophages and ECs and these act upon ECs (through gp130), resulting in the up-regulation 
of VCAM-1 and the release of CCL2, thus promoting monocyte recruitment (Hurst et al., 
2001). Neutrophils at the site of inflammation also produce a number of chemokines that act 
as chemoattractants to monocytes, such as CXCL8, CCL2 and CCL3/4 (Cassatella, 1999; 
Scapini et al., 2000). 
 
The cross-talk between neutrophils and macrophages is not limited to the co-ordinated 
recruitment of additional phagocytes to inflamed tissues. Neutrophils and macrophages co-
operate for the destruction of microbial pathogens by phagocytosis as previously described. 
There is evidence that the former enhance the antimicrobial functions of the latter (Silva, 
2010). For example, neutrophil granule molecules are taken from macrophages, thus 
enhancing their antimicrobial capacity (Byrd and Horwitz, 1991; Mathy-Hartert et al., 1996). 
Macrophages also phagocytose neutrophils and acquire their antimicrobial granule molecules 
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(Silva, 2010). Macrophages not only promote neutrophil influx, but they also produce signals 
that enable their retention at the site of inflammation. They release G-CSF and GM-CSF that  
prolong the survival of recruited neutrophils. Low concentrations of TNF-α, released 
from macrophages, also have an anti-apoptotic effect on neutrophils (Silva, 2010). 
 
 
1.6 Resolution of inflammation 
Under physiological conditions, inflammation has to be resolved. Resolution of 
inflammation appears to be an active and highly regulated process which results in the 
restoration of tissue homeostasis (Levy et al., 2001; Serhan, 2004; Serhan et al., 2008). In the 
early stages of resolution a gradual decrease in neutrophil recruitment is accompanied by 
enhanced clearance of apoptotic phagocytes. As with the early stages of inflammation, lipid 
mediators also play a key role in resolution. For example, pro-inflammatory cyclooxygenase 
products such as prostaglandin-E2 and -D2 promote the synthesis of anti-inflammatory and 
pro-resolving molecules, such as lipoxins, resolvins and protectins, via the 
lipoxygenase/cyclooxygenase pathways. This process is known as lipid mediator class 
switching and is a key event to the initiation of resolution stage (Levy et al., 2001).  
 
Lipoxins (LX) are a group of eicosanoids produced from arachidonic acid and they 
play a crucial role in the resolution of inflammation (Serhan et al., 2008). Activated 
neutrophils metabolize AA to LTA4 (via 5-LOX), which is released at the site of 
inflammation and further metabolised by platelet 12-LOX, producing the lipoxins LXA4 and 
LXB4 (Lindgren and Edenius, 1993). LXs are anti-inflammatory and pro-resolution 
mediators. LXA4 has a major impact in neutrophil recruitment as it stops chemotaxis, 
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adhesion and transmigration (Fierro et al., 2003). It also reduces neutrophil activity by 
downregulating CD11b/CD18 expression and reducing ROS production and pro-
inflammatory chemokines synthesis (Filep et al., 1997; Jozsef et al., 2002). In macrophages, 
it stimulates the phagocytosis of apoptotic neutrophils (Godson et al., 2000). LXA4 therefore 
appears to play a dual role in the resolution stage, by reducing neutrophil infiltration at 
inflamed sites, but also by promoting the monocyte chemotaxis and the phagocytosis of 
apoptotic neutrophils by them. 
 
Resolvins are lipid mediators synthesised from the omega-3 fatty acids 
eicosapentanoic acid (EPA) and docosahexanoic acid (DHA) and they are named E-resolvins 
and D-resolvins respectively. They were first described as products generated from EPA by 
COX-2 using a murine dorsal air pouch model of inflammation (Serhan et al., 2000). It has 
been demonstrated that E-resolvins inhibit neutrophil recruitment in a TNF-α-induced murine 
dorsal air pouch model and a zymozan- induced peritonitis model (Arita et al., 2005; Serhan 
et al., 2000). D-resolvins are generated from DHA by COX in the presence of aspirin and they 
also inhibit neutrophil transmigration (Serhan et al., 2002). Protectins are generated by LOX 
from DHA. They play an important role in the resolution of inflammation by inducing 
macrophage phagocytosis of apoptotic neutrophils (Schwab et al., 2007). Protectin D1 and 
resolvin E1 upregulate CCR5 expression on the surface of apoptotic neutrophils resulting in 
the removal of CCL3 and CCL5 pro-inflammatory chemokines from the inflamed tissue 
(Ariel et al., 2006). 
 
Macrophages regulate the survival of the recruited neutrophils at inflamed tissues, by 
releasing a number of mediators. At the initial stages of inflammation, macrophages extend 
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neutrophil survival. At later stages, after neutrophils have executed their immune functions, 
macrophages promote their apoptosis via high TNF-α concentrations (van den Berg et al., 
2001). Apoptosis (or programmed cell death) is thought to be the main route for neutrophil 
clearance from tissue and is characterised by nuclear chromatin condensation and 
fragmentation of the nucleus into membrane bound “apoptotic bodies”. 
  
Apoptotic signals are produced after the release of the content of neutrophil granules. 
Annexin A1 is considered to play a key role to the promotion of neutrophil apoptosis (Perretti 
and D'Acquisto, 2009; Solito et al., 2003). Annexin A1 is a 37 kDa protein, a member of 
annexin superfamily. Neutrophils, monocytes and macrophages in a resting state constituvely 
contain annexin A1 in their cytoplasm. Upon activation, annexin A1 is translocated to the 
membrane and secreted (Perretti and Flower, 2004). It has been demonstrated that this protein 
promotes neutrophil apoptosis, by dephosphorylating the pro-apoptotic protein BCL-2-
antagonist of cell death (BAD) (Solito et al., 2003). Annexin A1, released from apoptotic 
neutrophils, promotes their phagocytosis and clearance from macrophages (Perretti and 
D'Acquisto, 2009). Other anti-inflammatory function of annexin 1 is the inhibition of 
neutrophil influx. A number of in vivo studies have demonstrated this anti-inflammatory 
effect, after administration of exogenous annexin A1 (Lim et al., 1998; Perretti and 
D'Acquisto, 2009; Perretti and Flower, 2004). Interestingly, annexin A1 -deficient neutrophils 
exhibit enhanced transmigration in vivo (Chatterjee et al., 2005). It is proposed that annexin 
A1 is a glycocorticoid modulator that promotes the suppression of innate and adaptive 
immune response by two opposing mechanisms (Perretti and D'Acquisto, 2009). 
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Once apoptosis has been initiated, neutrophil functional activity is reduced and 
neutrophil apoptosis is controlled by a complex network of signalling pathways that regulate 
the up-regulation of molecules such as the anti-apoptotic protein myeloid cell leukemia 1 
(Mcl-1) and the pro-apoptotic Bcl-2 family member Bax, as well as activation of the caspase 
family of proteases (Luo and Loison, 2008). Annexin A1 and lactoferrin released from 
apoptotic neutrophils abrogate further the neutrophil influx (Bournazou et al., 2009; Perretti et 
al., 1996). Apoptotic cells are cleared by phagocytosis by macrophages so that they do not 
trigger a pro-inflammatory response (Savill, 1989). In addition, they induce the production 
of transforming growth factor-b (TGF-b) and interleukin 10 (IL-10) from macrophages, 
promoting resolution and wound repair (Byrne and Reen, 2002; McCartney-Francis and 
Wahl, 1994). However, if neutrophil apoptosis or phagocytic clearance of dead cells by 
macrophages is impaired, chronic inflammation may be initiated (Haslett et al., 1994) (Figure 
1.3). 
                                                                                              CHAPTER 1 
 
29 
 
 
Figure 1.3 Phagocyte interactions during the resolution of inflammation (from Soehnlein 
and Lindbom, 2010) 
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When the inflammatory response is completed, macrophages and lymphocytes migrate 
to the lymphoid organs via the afferent lymphatics. Lymphocytes subsequently recirculate 
through the blood and lymphatic system. This continuous recirculation via the blood, through 
tissue into draining lymph and via the thoracic duct, back into the blood, facilitates the 
immune surveillance and allows immune responses to antigen challenged tissues (Imhof and 
Dunon, 1995; Mackay, 1993). 
 
1.6.1 Reverse migration 
Though it has been reported that leukocyte subpopulations, such as dendritic cells and 
lymphocytes, have the ability to re-emerge from the tissue via the lymphatic vasculature in 
order to recirculate in the blood, little is known about the recirculation of other leukocyte 
subsets (e.g. neutrophils). Furthermore, the general mechanism proposed for neutrophil 
clearance during resolution of inflammation, suggests clearance of the neutrophils from the 
tissue by apoptosis (Savill et al., 2002). Until recently there was little evidence that 
neutrophils could exit the tissue (Mathias et al., 2006).  
 
 A recent report studying the interaction between neutrophils and endothelial cells in 
vitro using a 24h co-culture flow system, has shown that transmigrated neutrophils can 
reverse migrate back across the endothelial monolayer, suggesting that neutrophils could 
return back to the blood circulation via the vascular endothelium in vivo. In this report more 
than 90% of migrated neutrophils re-emerged back from the sub-endothelial environment 
(Buckley et al, 2006) and importantly, these cells had a distinctive surface phenotype of 
CXCR2low, CD54 (ICAM-1)high. Interestingly, a small subset (≈0.25%) of human neutrophils 
in the peripheral blood of healthy donors shared this profile of receptors and the incidence of 
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‘reverse migrated’ neutrophils rose to 1-2% in patients with chronic systemic inflammatory 
diseases such as atherosclerosis or rheumatoid arthritis, implying a connection between 
inflammation and reverse migration of neutrophils (Buckley et al., 2006). This phenomenon 
challenges the well established perception of neutrophils as short-lived, terminally 
differentiated, effector cells of the innate immune response that die by apoptosis after having 
prosecuted their immune functions (Buckley et al., 2006). There are various postulations as to 
why reverse migration occurs. It has been suggested that it is an additional mechanism for 
clearance of neutrophils from tissues that is constantly recruiting low numbers of neutrophils 
during immune surveillance (i.e. gut, lung, peritoneum and other mucosal tissues)  (Buckley 
et al., 2006). Indeed, it has been speculated that the increase in ICAM-1 expression on the 
surface of reverse migrated neutrophils may facilitate their recognition and destruction by the 
reticuloendothelial cell system after their return to the blood. Another interesting observation 
in this study was the prolonged longevity of the reverse migrated cells. This prompted 
speculation that they may be functionally viable and traffic to other tissues (for example the 
bone marrow). However, what they would do in such an environment remains completely 
mysterious.  
 
Much less is known about reverse migration in animal models. Quite recently, the 
work of Mathias et al., using a novel transgenic zebrafish model to study the neutrophil 
recruitment in vivo, also showed evidence of reverse migration of neutrophils. With in vivo 
time-lapse imaging they observed retrograde chemotaxis back toward the vasculature, 
suggesting this as an alternative mechanism of resolution of inflammation (Mathias et al., 
2006).  
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Reverse migration is not exclusive to neutrophils. Indeed both monocytes and 
lymphocytes have been shown to reverse migrate. Thus, blood monocytes co-cultured with 
endothelium for 2 days differentiated into dendritic cells and macrophages. The DC subset 
had the ability to migrate back across the endothelium out of the subendothelial environment, 
whereas macrophages remained in the subendothelial matrix (Randolph et al., 1998). 
Interestingly, blockade of JAM-B/-C interaction resulted in a decrease in the numbers of 
transmigrated monocytes, through increased reverse migration. In vivo studies, confirmed the 
previous findings. The use of an anti–JAM-C antibody reduced the number of monocytes in 
the inflammatory site and increased the number of those with a reverse-transmigratory 
phenotype in the peripheral blood (Bradfield et al., 2007). The reverse migration of 
lymphocytes was observed in vitro. Lymphocytes in static cultures with EC migrated back 
and forth continuously across endothelium (McGettrick et al., 2009). 
 
 
1.7 Murine models of inflammation 
Although a lot of research has studied various aspects of neutrophil recruitment in the 
human system in vitro, little has been done using murine models. One of the main reasons is 
the difficulties in the culture of primary mouse endothelial cells. In addition adequate 
numbers of isolated neutrophils from whole mouse blood are difficult to obtain due to the 
small volume of blood circulating in the mouse. This can be overcome by isolation from the 
bone marrow; however the maturity of these cells is variable. Although mouse endothelial cell 
lines have been established in order to overcome the difficulties in obtaining primary cells, 
these do not appear to respond well to inflammatory stimulation. As a consequence, 
researchers have used a different approach to examine leukocyte recruitment in murine 
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systems. A lot of research has been done using intravital microscopy in the murine cremaster 
muscle model, investigating neutrophil transmigration through endothelium and its 
perivascular basement membrane in vivo (Nourshargh and Marelli-Berg, 2005). 
 
Some years ago, researchers established conditionally immortalized growth factor-
responsive cardiac endothelial cells from H-2Kb-tsA58 mice, and they called this murine 
cardiac endothelial cell line MCEC-1. They also found that these cells show increased 
adhesion molecule expression such as CD31, ICAM-1 and E-selectin in response to 
inflammatory cytokines such as TNF-α and IL-1β (Lidington et al., 2002). These cells 
represent a more realistic opportunity to investigate the inflammatory process in vitro using 
murine tools. Indeed we have conducted a comparison of MCEC-1 and primary murine EC in 
in vitro cytokine driven models of neutrophil migration and reverse migration in this thesis. 
 
 
1.8 Aims and hypotheses of the project 
Overall, the major hypothesis of this project is that reverse migrated neutrophils have 
a distinct phenotype, are rescued from apoptosis and have a specific protein expression 
profile.  The aim of this project is to study neutrophil recruitment and reverse migration using 
murine and human in vitro models of inflammation.  
 
In Chapter 3, our hypothesis is that murine endothelial cells can respond to different 
cytokine treatment in a dose dependent manner. For this purpose, we are going to use the 
MCEC-1 cell line and primary endothelial cells from heart and lung in order to establish flow 
and static adhesion assays in our in vitro models of inflammation. 
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In Chapter 4, our hypothesis is that murine reverse migrated neutrophils exhibit a 
specific phenotype and have a prolonged lifespan. We aim to generate murine reverse 
migrated neutrophils in order to examine their phenotype and survival. Furthermore, we are 
interested in investigating their fate in vivo using an adoptive transfer methodology.  
 
In Chapter 5, our hypothesis is that shear stress inhibits the reverse migration of 
neutrophils and this mechanism is mediated by NO production.  We are going to investigate 
reverse migration in the presence and absence of continuous flow.  
 
Finally in Chapter 6, our hypothesis is that human reverse migrated neutrophils have a 
distinct protein expression profile. A significant part of this work will involve the study of 
human neutrophils at the proteomic level to identify changes in neutrophils that are associated 
with the process of reverse migration. We are going to use 2-D Fluorescence Difference Gel 
Electrophoresis methodology (DIGE) to examine the differences in protein expression 
between human reverse migrated neutrophils and their control groups.  
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1 Reagents 
All reagents were from Sigma-Aldrich (Poole, Dorset, UK), unless otherwise stated. 
Reagents included: Collagenase (type 1A), gelatin (2% solution type B from bovine skin), 
EDTA (Ethylenediaminetetraacetic acid), culture-tested trypsin solution, Histopaque 1119 
and Histopaque 1077, phosphate buffered saline (PBS) with/without Ca2+/Mg2+, 10X PBS 
solution, dimethylsulfoxide hybrid-max (DMSO), albumin bovine fraction (BSA) V solution 
(7.5%), percoll, fibronectin from human plasma, Hanks’ Balanced Salt solution (HBSS) 
with/without Ca2+/Mg2+, Dulbecco’s modified eagle’s medium (DMEM), HEPES solution 
1M, sodium pyruvate solution 100mM, MEM non-essential amino acid solution (100X), 
trypan blue, JC-1, dimethylformamide, Tris, glycerol, sodium dodecyl sulfate (SDS), 
mercaptoethanol, glycine, Tween-20, Triton X-100, N,N,N′,N′-Tetramethylethylenediamine 
(TEMED), ammonium persulfate (APS), acetic acid, Nω-Nitro-L-arginine methyl ester 
hydrochloride (L-NAME), diethylamine NONOate (DEANO). 
 
Recombinant human TNF-α, and IL-1β, recombinant murine TNF-α and IL-1β were 
from R&D Systems, Abingdon, UK. Murine epidermal growth factor (mEGF) was from 
Peprotech, Inc. (London, UK). Collagenase type 1 was from Worthington Biochemical 
Corporation (Lakewood, US). Dynabeads® Goat anti-Mouse IgG and ACK lysing buffer 
were from Invitrogen (Paisley, UK).  May Grunwald Giemsa (Diff Quik) was from Dade 
Behring (Milton Keynes, UK). Depex mounting fluid was from Raymond A Lamb, 
Laboratory Suppliers (Eastbourne, East Sussex, UK). DiOC6 (3’3’-dihexyloxacarbocyanine 
iodide) was from Molecular Probes (Cambridge, UK). CD19 Microbeads and MACS columns 
were from Miltenyi Biotech. (Surrey, UK). Ficoll-Paque, CyDyes, 24cm polyacrylamide gel 
strips, paraffin oil (Dry strip cover fluid), acrylamide, bis-acrylamide and bindsilane were 
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obtained from GE Healthcare (Uppsala, Sweden). Complete EDTA-free protease inhibitor 
cocktail tablets were from Roche (Indianapolis, US). Flamingo fluorescent stain and 10X SDS 
running buffer were obtained from Biorad (Hercules, US). Human serum albumin (HAS) was 
obtained from Sanquin (Amsterdam, the Netherlands) and RPMI 1640 medium from 
Invitrogen (Carlsbad, US). Transwell filters were from BD Biosciences (Oxford, UK). ECL 
Western Blotting Substrate and Restore western blot stripping buffer were from Thermo 
Scientific Pierce (Loughborough, UK) and Hyperfilm ECL from GE Healthcare Life Sciences 
(Amersham, UK). Prestained protein marker, broad range (7-175 kDa) was from New 
England Biolabs Ltd. (Hitchin, Hertfordshire, UK). 
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Antibodies 
 
Table 2.1 Antibodies used in this thesis 
Antibodies were obtained from eBiosciences, San Diego, US; BD Pharmingen, Oxford, UK; 
Lifespan Biosciences, Seattle, US; Abnova, Taipei, Taiwan; Epitomics, California, US; 
Sigma, Poole, Dorset, UK; DAKO, Ely, Cambridgeshire, UK and R&D Systems, Abingdon, 
UK. 
 
 
  
 
Antibody Conj. Clone Origin Target Isotype  Company Conc. 
anti-CD16/32 N/A 93 Rat Mouse IgG2a,λ eBiosciences 10µg/ml 
anti-CD31 N/A YR-131-12 Rat Human IgG1 Gift from Prof. 
C. Buckley, UK 
10µg/ml 
anti-CD99 N/A YG32 Rat Human not specified DiNonA, Seoul, 
Korea 
10µg/ml 
anti-JAM-C N/A H33 Rat Human IgG1 Gift from Prof. 
B. Imhof, 
Geneva 
10µg/ml 
anti-ICAM-2 N/A 3C4(mIC2/4) Rat Mouse IgG2a,κ BD Pharmingen 10μg/ml 
anti-VE-cadherin N/A 11D4.1 Rat Mouse IgG2a,κ BD Pharmingen 10μg/ml 
anti-alpha enolase N/A Polyclonal Rabbit Human IgG Lifespan 
Biosciences 
10μg/ml 
CAP1 N/A 4A2 Mouse  Human IgG1 Abnova 2 μg/ml 
PP1b N/A EP1804Y Rabbit Human IgG Epitomics 1:2000 
RNAse2 N/A Polyclonal Mouse Human IgG Abnova 1:2000 
Β-actin N/A AC-15 Mouse Human IgG1 Sigma 1μg/ml 
HRP anti-mouse IgG HRP Polyclonal Goat Mouse IgG DAKO 1:1000 
HRP anti-rabbit IgG HRP Polyclonal Goat Rabbit IgG DAKO 1:2000 
anti-ICAM-1 PE YN1/1.7.4 Rat Mouse IgG2b,κ eBiosciences 0.4μg/ml 
anti-CXCR2 APC 242216 Rat Mouse IgG2a R&D Systems 2.5μg/ml 
anti-CD31 APC MEC 13.3 Rat Mouse IgG2a,κ BD Pharmingen 4μg/ml 
anti-ICAM-2 FITC 3C4(mIC2/4) Rat Mouse IgG2a,κ BD Pharmingen 10μg/ml 
Rat IgG control PE not specified Rat Mouse IgG2b,κ eBiosciences 0.4μg/ml 
Rat IgG control APC not specified Rat Mouse IgG2a eBiosciences 2.5μg/ml 
Secondary IgG control  FITC Polyclonal Goat Rat IgG R&D Systems 2.5μg/ml 
Rat IgG control N/A A23-1 Rat Mouse IgG2a,κ BD Pharmingen 10μg/ml 
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2.2 Cell culture media and solutions 
MCEC-1 murine endothelial cell line was cultured in MCEC-1 complete medium: 
Dulbecco’s modified eagle’s medium (Sigma) supplemented with 10% heat inactivated fetal 
calf serum (FCS), 10ng/ml murine epidermal growth factor (mEGF), 2.5µg/ml amphotericin 
B, 100U/ml penicillin and 100µg/ml streptomycin , 2mM L-glutamin (Sigma,UK) and 
10U/ml heparin sodium (CP Pharmaceuticals Ltd, Wrexham,UK). 
 
Murine primary endothelial cells from lung (MLEC) and heart (MHEC) were cultured 
in mEC complete medium: 80ml base medium [(Dulbecco’s modified eagle’s medium 
supplemented with 20% heat inactivated fetal calf serum (FCS), 100U/100μg/ml 
penicillin/streptomycin, 2.5µg/ml amphotericin B, 2mM L-glutamin and 25mM HEPES)] 
containing 10U/ml heparin sodium, (CP Pharmaceuticals Ltd, Wrexham,UK), 100ng/ml 
murine epidermal growth factor (mEGF), 1X nonessential amino acid and 1mM sodium 
pyruvate. 
 
Human umbilical endothelial cells (HUVEC) were cultured in medium: Medium 199 
(M199- Gibco Invitrogen Compounds, Paisley, UK), 20% heat inactivated fetal calf serum 
(FCS), 10ng/ml epidermal growth factor (EGF), 35µg/ml gentamycin, 100U/100mg/ml 
penicillin/streptomycin, 1µg/ml hydrocortisone (all from Sigma) and 2.5µg/ml amphotericin 
B (Gibco Invitrogen Compounds, Paisley, UK ). 
 
PBSA: phosphate buffered saline (PBS) containing 1mM Ca2+, 0.5mM Mg2+ and 
0.15% culture-tested bovine serum albumin. 
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M199/BSA: Medium 199 containing 0.15% bovine serum albumin. 
 
2D-DIGE and Western blot solutions 
Tables 2.2 and 2.3 describe the solutions used for 2D-DIGE electrophoresis and Western Blot. 
2D-DIGE solutions 
Sucrose buffer 0.34M sucrose,  
1mM EDTA 
10mM Tris pH 7.4 
Neutrophil lysis buffer 10mM Tris pH 7.4,  
10% glycerol,  
1% NP40,  
50mM NaF,  
20mM tetra-Na-pyrophosphate,  
1mM DTT, 
 2mM vanadate,  
1mM PMSF  
2mM DFP and  
1x complete EDTA-free protease 
inhibitor cocktail tablet 
Labelling buffer (10ml) 8M urea, 
2M thiourea, 
4% CHAPS, 
100mM Tris-HCl pH 8.5  
IEF buffer     (10ml) 8M urea, 
2M thiourea, 
4% CHAPS, 
150mM DTT, 
1% Biolyte, 
0.002% BFB  
12% SDS gel (90ml per gel) 26.4ml H2O, 
22.5ml 1.5M Tris pH 8.8, 
26.3 ml 40% acrylamide, 
14ml 2% bis-acrylamide, 
450µl 20% SDS, 
297µl 30% APS, 
54µl TEMED 
Equilibration buffer (200ml) 6M urea, 
2% SDS, 
30% glycerol 87%, 
75mM Tris-HCL pH 8.8, 
0.002% BFB 1% 
 
Table 2.2 Solutions for 2D-DIGE electrophoresis 
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Western Blotting solutions 
Sample buffer 10 % SDS, 
50% glycerol, 
10% β-mercaptoethanol, 
300 mM TRIS-HCl pH6.8, 
0.002% BFB  
12% SDS gel 10% (Resolving gel) 5.7ml H2O, 
2.5ml 1.5M Tris pH 8.8, 
1.7ml 30% acrylamide/bis-
acrylamide, 
100µl 10% SDS, 
20µl 10% APS, 
20µl TEMED 
5% SDS gel 5% (Stacking gel) 3.4ml H2O, 
2.5ml 0.5M Tris pH 6.8, 
4ml 30% acrylamide/ bis-acrylamide, 
100µl 10% SDS, 
20µl 10% APS, 
20µl TEMED 
10XRunning buffer per L 60g Tris 
288g Glycine 
10g SDS 
Transfer buffer (per 2L) 28.8g glycine,  
6g Tris, 
400ml MeOH 
Blocking buffer 5% BSA   
TBS/0.05% TWEEN-20 
            Wash buffer per L TBS/0.05% TWEEN-20 
 
Table 2.3 Solutions for Western Blotting 
 
2.3 Isolation of neutrophils 
2.3.1 Isolation of murine bone marrow neutrophils 
Wild type C57BL6 mice (20-30g), killed by schedule 1 procedure, were obtained from 
the Biomedical Services Unit (University of Birmingham, UK). Usually neutrophils isolated 
from one mouse were used for each experiment. 
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All legs were immobilized using 21G needles and all the body was sprayed with 70% 
ethanol. The skin, muscles, and connective tissue were removed and femur, tibia and humerus 
were isolated from the limbs and kept on ice. The bone marrow was flushed with 10ml of 
EDTA/HEPES solution (0.01% and 30mM respectively) using a 10ml syringe and a 23G 
needle, and collected in a 15ml tube. All clumps were gently re-suspended using a 5ml 
syringe and a 21G needle and the cell suspension was left for 5 minutes, enough time for large 
pieces of tissue to sediment to the bottom of the tube. The supernatant was then collected and 
centrifuged at 400g for 5 minutes. The cell pellet was re-suspended in 1ml of flush media. In 
order to remove red blood cells, a hypertonic lysis step was utilized. Briefly, 4ml of H2O was 
added to the cells, and mixed for 30 seconds. Then, 2ml of 4x PBS was added to restore the 
osmolarity and the cell suspension was centrifuged at 400g for 5 minutes. The pellet was re-
suspended in 2ml of flush media and was layered on the top of a 3-step density gradient, made 
from dilutions of different concentrations of stock solution of Percoll (Sigma) (52, 64 and 
72%) and centrifuged at 1500g for 30 minutes at 20oC with no brake (Figure 2.1). 
 
Mature neutrophils were isolated from the layer formed in the interface of the two 
gradients of highest concentration and washed twice in PBSA, by centrifugation at 400g for 
10 minutes (time sufficient to obtain a cell pellet). Neutrophils were counted using a Coulter 
Multisizer II (Coulter, Leicester, UK) and re-suspended in PBSA at the desired concentration 
(2x106 cells/ml), unless otherwise stated. 
 
In order to determine the percentage of mature neutrophils in this heterogenous cell 
population, 100μl of neutrophil suspension was centrifuged onto a glass slide at 10g for 3 
minutes in a Shandon Cytospin II and stained with Diff Quick. They were then air-dried for at 
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least 5 minutes before mounting a coverslip with Depex mounting fluid. In this way it was 
possible to calculate the percentage of mature neutrophils, identifying them by their hallo 
nucleus shape, counting them under a Leitz microscope at x40 magnification. 
 
In some experiments mouse CD19 Microbeads were used for the depletion of 
contaminating B cells from the bone marrow. The CD19+ cells were magnetically labelled 
with CD19 Microbeads. Then the cell suspension was loaded onto a MACS column which 
was placed in the magnetic field of a MACS separator. The magnetically labelled CD19+ cells 
were retained on the column, whereas the unlabeled cells (PMN) ran through and were 
collected as CD19+ depleted cells. 
 
2.3.2 Isolation of human neutrophils 
Venous blood from healthy donors was collected and immediately transferred into 
tubes containing K2EDTA (1.6mg/ml, Sarstedt). Blood was maintained at room temperature 
and used within 2 hours of venipuncture. 
 
Neutrophils were isolated using a 2-step density gradient method. First, 2.5ml of 
Histopaque 1119 was placed in the bottom of a 10ml tube and 2.5ml of Histopaque 1077 was 
layered on the top. Then, 5ml of whole blood was gently layered on the top of the gradient 
and the tube was centrifuged at 800g for 30 minutes. The neutrophil layer, formed in the 
interface between the two density gradient media, was collected in a 10ml tube and washed 
twice by centrifugation in PBSA at 400g for 5 minutes. Neutrophils were then counted using a 
Counter Multisizer II (Coulter, Leicester, UK) and re-suspended in PBSA at the preferred 
concentration. 
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Figure 2.1 Isolation of neutrophils 
(A) Mature murine neutrophils are isolated from bone marrow using a 3-step Percoll density 
gradient. The lower layers contains mainly mature neutrophils. (B) Human neutrophils are 
isolated from whole blood using a 2-step Histopaque density gradient. The neutrophil cell 
fraction is above red cells. 
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2.4. Cell culture 
2.4.1 Culture of murine endothelial cell line (MCEC-1) 
Cryopreserved vials (Nalgene), each containing a 1ml aliquot of MCEC-1 cell line, 
were removed from liquid nitrogen, and left for 2-3 minutes at room temperature before being 
transferred into 15ml tubes with 9ml of MCEC-1 medium. They were centrifuged at 400g for 
5 minutes. The supernatant was aspirated and the cell pellet was re-suspended in 4ml MCEC-
1 medium and transferred into 25cm2 culture tissue flask previously treated with 1% gelatin.  
 
Cultures in each flask became confluent after 1-2 days. Upon reaching confluence, 
MCEC-1 cultures were dissociated and passaged onto microslides at a concentration that 
yielded confluent monolayers after 24 hours. Briefly the monolayers were bathed with 3ml of 
EDTA (0.02%) for 60 sec. EDTA was removed by aspiration and tryspin (2.5mg/ml)/EDTA 
was added at a 2:1 ratio for 3-5 minutes. Using phase contrast microscopy, the time point 
when the cells started to detach from the plastic surface was determined and 6ml of MCEC-1 
medium was added to neutralise the trypsin. The cell suspension was transferred into a 15ml 
tube and centrifuged at 400g for 5 minutes. The pellet was re-suspended in MCEC-1 medium 
and was transferred either at equal quantities in two 25cm2 flasks or into one 75cm2 flask. The 
cultures were maintained in MCEC-1 medium and, upon reaching confluence, were used in 
experiments, passaged between 2-4 times (for experiments) or cryopreserved in 
Dimethylsulfoxide (DMSO).  
 
 In order to freeze cells, a cryopreservant medium was used containing: 90% FCS and 
10% DMSO. The freezing medium was maintained at all times in ice. Confluent cultures were 
tryspinized with trypsin/EDTA as previously described. The cell pellet was re-suspended with 
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the appropriate quantity of freezing medium (for a 75cm2 flask, 3ml of freezing medium is 
used) and transferred in 1ml aliquots into ice-cold sterile cryopreservant vials. The cryovials 
were immediately placed at -80oC for 24 hours and later stored in liquid nitrogen.  
 
2.4.1.1 Culture of MCEC-1 in glass capillaries (microslides) 
In order to conduct a flow based adhesion assay, MCEC-1 cells were cultured in glass 
capillary tubes with a rectangular cross section of 0.3x 3mm and a length of 5 cm 
(Camlab,Cambridge,UK), previously treated with 3-aminopropyl triethoxysilane (Sigma) 
(Figure 2.2).  
 
One 25cm2 flask of MCEC-1 cells was trypsinised as previously described. The pellet 
after dissociation was re-suspended in 400μl MCEC-1 medium, a quantity sufficient to load 
up to 6 microslides. Microslides, previously autoclaved and treated with 1% gelatine for 30 
minutes, were seeded with endothelial cells incubated for 1 hour at 37oC, 5%, CO2. The 
microslides were then double seeded and an additional confluent 25 cm2 flask was used for 
this purpose. After 1 hour incubation each slide was loaded with an additional 45μl cell 
suspension of approximately the same concentration. Then the seeded microslides were 
placed into a specially constructed glass dish filled with sterile MCEC-1 medium and were 
connected to the glass ports in the wall of the dish. The glass dish was transferred into an 
incubator. The other ends of these glass attachments were connected via silicon tubing to an 8 
channel intermittent flow pump which allowed perfusion of medium for 60 seconds each hour 
at a wall shear stress of 0.05 Pa. The microslides formed confluent monolayers after 24 hours. 
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Figure 2.2 Glass microslides 
Glass microslides were used as a vessel model. Microslide dimensions were 5 cm X 0.3mm X 
3 mm. 
 
 
2.4.2 Isolation of murine primary endothelial cells from lung (MLEC) and heart 
(MHEC) 
Murine primary endothelial cells (mEC) were isolated from the hearts (MHEC) and 
lungs (MLEC) of wild type C57BL6 mice, as previously described, with minor modifications 
(Lim and Luscinskas, 2006). For each isolation, three 7-9 day old mice were used, and 
obtained from Biomedical Services Unit. 
 
The mice were sacrificed by schedule 1 procedure and their carcasses were immersed 
in 70% ethanol. They were placed on a polystyrene foam board and their legs were 
immobilised with 21G needles. The skin in the chest area was removed and the anterior 
abdomen was cut open. Then the rib cage was removed in order to expose the thoracic cavity. 
Spraying with 70% ethanol limited bacterial contamination to the minimum. 
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 The hearts and the lungs from all three mice were removed from the thoracic cavity 
and placed into separate petri dishes. Every lung lobe was cut in two parts and was minced 
using a scalpel, whereas the hearts, after the removal of any arteries or other large vessels, 
were minced with a pair of fine forceps. Each minced tissue was transferred into a 50ml tube 
containing 15ml of pre-warmed type I collagenase solution (200μg/ml). The tubes were 
subsequently placed in a rotator inside a hybridization oven set at 37oC. The incubation time 
for heart and lung tissue was 30 and 45 minutes respectively.  
 
After that step, each cellular suspension was forced gently 10 times using a 6 inches 
long 14G metal needle (Harvard apparatus, Kent, UK) attached to a 20ml syringe and filtered 
through a 70μm pore strainer (BD Falcon, Oxford, UK). To minimize cell loss, the strainers 
were further washed with 15ml of base medium, making the final volume of cell suspension 
up to 30ml. Following a centrifugation at 400g at 4oC for 8 minutes, each cell pellet was re-
suspended in the appropriate amount of base medium (1ml for heart and 2ml for lung cells) 
and transferred to a 5ml tube. Then, 15μl of anti-ICAM-2 coated magnetic beads was added 
for every millilitre of suspension and the tubes were placed on an end to end rotator for 10 
minutes at room temperature. Subsequently, each tube was attached to a vertical magnetic 
plate for 2 minutes, in order to get unbound and cell bound magnetic beads stuck to the 
magnet. The supernatant was removed by aspiration and the magnetic beads were re-
suspended into 3ml of base medium. This step was repeated twice, thus minimising the 
selection of contaminating cells. Finally, the anti-ICAM-2 bead coated cells were resuspended 
in 5ml of complete mEC medium and transferred to a precoated 25cm2 culture flask with 
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10μg/ml fibronectin and 0.1% gelatin. The number of isolated cells and growth rates varied 
from culture to culture. 
 
2.4.2.1 Culture of MLECs and MHECs 
The medium in the flasks was changed every 3 days. Usually the cultures reached 
confluence after 7-10 days, with the cells showing the classical cobblestone appearance. Upon 
confluence, the cells were trypsinized and an additional positive selection procedure was 
performed using anti-ICAM2 beads, as previously described, to ensure the culture’s high 
purity of endothelial cells. After the second positive selection the cells were again transferred 
to a 25cm2 flask previously treated with fibronectin and gelatine and cultured to reach 
confluence. Cells up to fourth passage were used for the following experiments. 
 
2.4.2.2 Culture of primary murine endothelial cells in glass capillaries (microslides) 
Third passage murine primary endothelial cells (mECs) were trypsinized and passaged 
into microslides, as previously described.  After dissociation, the cell pellet from 2 confluent 
flasks was resuspended in 700μl in order to seed 12 microslides, previously autoclaved and 
treated with fibronectin (10μg/ml) for 30 minutes. Following 1 hour incubation at 37oC, the 
microslides with MLEC or MHEC were incorporated to a flow culture system. Generally, 
MLEC monolayers reached confluence after 24 hours, while MHEC monolayers required 2-3 
days. 
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2.4.3 Culture of Human Umbilical Vein Endothelial Cells (HUVEC) 
2.4.3.1 Isolation of HUVEC 
Primary endothelial cultures were isolated from the veins of human umbilical cords, as 
previously described(Cooke et al., 1993). The cords were obtained from Birmingham 
Women’s Hospital from fully consented donors. 
 
Each cord was cut from the placenta, placed in a steel instrument tray covered in blue 
roll and sprayed with 70% ethanol. Damaged parts of the cord, such as clamp marks and 
needle holes were removed. A glass cannula was inserted in one end of the vein and was tied 
off. The vein was washed with 10-20ml of PBS until clear of blood and finally air was 
perfused through to remove residual fluid. Another cannula was then placed in the other end 
of the vein and also tied off. 
 
10ml of collagenase 1A (1mg/ml) was flushed into the vein until the cannuli reservoirs 
were full (this quantity is sufficient for 4-6 inches of cord). Then, both ends were clipped off 
and the cord was transferred, in a bag, for a 15-minute incubation at 37oC. At the end of this 
period, the cord was taken out of the bag, massaged to enable dissociation of the endothelial 
cells from the wall of the vein and finally flushed with 30ml of PBS followed by air. The cell 
suspension was collected in a 50 ml tube and centrifuged at 400g for 5 minutes. The pellet 
was resuspended in 4ml of HUVEC medium and was transferred into a 25cm2 culture flask, 
previously treated with 1% gelatine for 15 minutes. The culture medium was changed after 2 
and 24 hours and then every second day. The cultures became confluent after 4-7 days. 
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2.4.3.2 Culture of HUVEC in glass capillaries (microslides) 
First passage HUVEC cultures were trypsinised and passaged into microslides, as 
previously described. The pellet after dissociation was resuspended in 400μl HUVEC 
medium, a quantity sufficient to load up to 6 microslides. Microslides, previously autoclaved 
and treated with 1% gelatine for 30 minutes were seeded once with endothelial cells. After 1 
hour incubation at 37oC, 5% CO2, the seeded microslides were incorporated in a flow culture 
system for 24 hours until becoming confluent. 
 
 
2.5 Adhesion assays 
2.5.1 Flow-based adhesion assays 
2.5.1.1 Neutrophil adhesion assays on MCEC-1 
Microslides containing confluent MCEC-1 monolayers were detached from the flow 
culture system and were stimulated with various cytokines (TNF-α:  100U/ml and/ or IL-1β: 
0.5ng/ml) for 4 hours. The medium in each microslide was changed using a pipetor every 
hour. 
 
After the 4-hour incubation, the microslides were glued onto microscope slides, 
mounted onto a microscope stage and observed by phase contrast videomicroscopy. The 
microscope was enclosed in a perpex heating box in order to maintain a temperature of 37oC. 
One end of each microslide was attached via silicon rubber tubing to a Harvard syringe pump, 
allowing wall shear stress to be set by applying the appropriate flow rate. The other end was 
attached to an electronical valve (Lee products, Gerards Cross, UK), which could switch 
between the neutrophil suspension and the wash buffer (Figure 2.3). All flow adhesion assays 
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were performed at a wall shear stress of 0.05 Pa. Flow rate of the medium was calculated 
using the following equation assuming a parabolic flow distribution with a Newtonian fluid: 
 
Q = wh2 T = 0.27 x 0.05 = 0.0135 =  3.21 µl/s-1 
                     6η           0.042         0.042 
 
 
T = Wall shear stress (Pa) 
η = Viscosity of the medium (assumed to be 0.7x10-3 Pa.s for aqueous buffers) 
Q = Flow rate of the medium (µl/s-1) 
w = Width of the flow channel (mm) 
h = Height of the flow channel (mm) 
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Figure 2.3 The flow based adhesion assay 
(A) Microslides (1) containing EC were mounted on the stage of a video-microscope (2) and 
attached via silicone tubing to a 50ml glass syringe (3) and an electronic switching valve (4). 
Neutrophil suspension (5) or PBSA (6) were perfused through the microslides at a wall shear 
stress of 0.05 Pa. Experiments were conducted in a 37 ˚C Perspex cabinet (7) and video 
recordings made (8,9). (B) The video-microscope and recording equipment in situ.  
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MCEC-1 were initially perfused with PBSA for washing and then with neutrophil 
suspension for 4 minutes, followed by a washout with PBSA. Video recordings were made 
after 1, 5 and 11 minutes of washout from a series of fields as selected at random along the 
centre line of each microslide.  
 
In some experiments, the perfusion of wash buffer was prolonged up to 1 hour to 
allow neutrophil behaviour to be assessed over this longer period. For these experiments the 
shear stress was set at 0.05Pa, unless otherwise stated and the concentration of neutrophil 
suspension was 2x106 cells/ml. MCEC-1 monolayers were initially perfused with PBSA and 
soon after with neutrophil suspension for 4 minutes, followed by a washout with PBSA. In 
some experiments flow was turned off after 20 minutes, simulating conditions from that time 
point onwards. Recordings of 8-10 random fields were made every 5 minutes in all 
microslides and the total number of adherent and transmigrated neutrophils was assessed as 
detailed below.  
 
2.5.1.1.1 Video analysis of flow adhesion experiments 
Video records were analysed off-line. Neutrophils adherent to the endothelial 
monolayer were categorized, depending on their behaviour, as rolling, arrested or 
transmigrated. The rolling adherent cells were phase-bright, spherical and rotated slowly over 
the surface. Arrested cells were considered the ones that were phase-bright, either stationary 
or transmigrating on top the endothelium, changing shape and spreading. On the other hand, 
transmigrated cells were phase-dark, migrating underneath the endothelium. These three 
categories of neutrophil behaviour were quantified and expressed as percentages of the total 
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number of adherent cells at every chosen time point after neutrophil perfusion. The recordings 
were analysed using the Image-Pro Plus software (Image-Pro Plus, USA). 
 
2.5.1.2 Neutrophil adhesion assays on murine endothelial cells from lung (MLEC) and 
heart (MHEC)  
Microslides with confluent MLEC or MHEC monolayers were removed from the flow 
culture system and were stimulated with TNF-α, and/or IL-1β at various concentrations for 4 
hours at 37oC and flow based adhesion assays up to 20 minute duration were performed, as 
previously described. The shear stress was set at 0.05Pa, and the concentration of murine 
neutrophil suspension was 2x106 cells/ml. 
 
2.5.2 Static adhesion assays 
2.5.2.1 Co-culture of MCEC-1 and murine neutrophils in static cultures - Generating 
RPMNs from co-cultures of murine neutrophils and EC 
MCEC-1 cultures derived from two 25 cm2 flasks were trypsinised and passaged into a 
previously gelatinised 6-well plate (from two 25 cm2 flask, 3 wells were coated). Monolayer 
was formed in each well after 24 hours. Upon reaching confluence, the monolayer in each 
well was treated with TNF- α (100U/ml) and IL-1β (0.5ng/ml) for 4 hours. After the 4-hour 
incubation, each well was washed with M199/BSA. Murine neutrophil preparations (~2x106 
cells/well) were then added. After 1 hour incubation, non-adherent neutrophils were washed 
out and MCEC-1 medium was added to each well. The plate was then mounted on a 
microscope stage and 10-20 random fields from each well were recorded. The 6-well plate 
was placed in the incubator at 37oC for 1, 2, 4, and 24 hours and again random fields were 
recorded after this period of culture. All recordings were analysed off-line. The total number 
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of adherent cells and the number of transmigrated cells were determined and expressed as 
cells/mm2. 
 
2.5.2.2 Assaying the effects of constant flow on the rate of reverse migration  
HUVEC were passaged into microslides, incorporated into a flow culture system for 
24 hours to become confluent and then stimulated with cytokines (100U/ml TNF-α and 
0.5ng/ml IL-1β) for 4 hours, as previously described. After the 4-hour incubation, all the 
microslides were rinsed with PBSA to remove the excess cytokines. At this time point 45μl of 
neutrophil suspension (7x106 cells/ml in HUVEC medium) was added in each microslide and 
incubated at 37oC for 25 minutes, sufficient time for neutrophils to complete transmigration. 
This neutrophil concentration was chosen to yield a neutrophil/EC ratio of 6:1, in accordance 
with concentrations used in static cultures (Butler et al., 2005). The microslides were rinsed 
with PBSA to remove non-adherent neutrophils. As a control, one microslide was fixed with 
2% formaldehyde straight after the washout. One microslide was placed in the incubator at 
37oC for 1 hour and another was attached to a glass dish in a continuous flow system (0.05 
Pa) at 37oC for 1 hour. The continuous flow system has been described by Sheikh et al. 
(2003). At the end of that time slides were washed again and fixed with 4% formaldehyde. 
The microslides were glued onto microscope slides, mounted onto a microscope stage and 
observed by phase contrast videomicroscopy. Ten random fields along the centre line of each 
microslide were recorded and analysed off-line. The total number of adherent cells and the 
number of transmigrated cells were determined and expressed as cells/mm2. In some 
experiments the incubation time under flow conditions was extended to 2 or 4 hours. To 
identify the molecular mechanism(s) supporting reverse migration in other experiments, 
monoclonal blocking antibodies against adhesion molecules were introduced to the 
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microslides for 15 minutes after the first washout and prior to incorporation into a flow 
system. 
 
 
2.6. Flow cytometry 
2.6.1 Characterisation of MLEC and MHEC by flow cytometry 
Murine primary endothelial cells (mECs) cultured on six-well plates were washed 
twice with Ca2+/Mg2+ free HBSS and then were dissociated after a brief exposure to 0.5% 
trypsin in 0.02% EDTA. Following centrifugation at 400g for 5 minutes, the cells were re-
suspended at 1x106 cells/ml in ice-cold PBS2A (PBS/BSA 2%) and 100μl were transferred to 
each eppendorf tube. All antibodies were used at a 1 in 50 dilution, made up in ice-cold 
PBS2A, with the exception of the secondary antibody where the dilution was 1 in 10. After 
being washed twice in PBS2A the endothelial cells were incubated with 50µl of anti-ICAM-2, 
anti-CD31, anti-VE-Cadherin or rat anti-mouse IgG antibody (as negative control) for 30 
minutes on ice. Following a double wash in cold PBS2A, all cells in the samples were 
incubated with 50μl of the secondary antibody for 30 minutes on ice. The samples were 
washed twice in cold PBS2A, re-suspended in 100μl of PBS2A and finally transferred in 
FACS tubes containing 300μl PBS2A. Samples were analysed using the Cyan flow cytometer 
(DAKO) and Summit version 4.3 software package (DAKO) and data were expressed as 
median fluorescence intensities (MFI). 
 
2.6.2 Characterization of RPMNs-surface expression of adhesion molecules 
In some experiments, after the 24-hour co-culture all the neutrophils on the apical 
surface were collected and centrifuged at 400g for 5 minutes. Then they were washed in ice 
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cold PBS2A and re-suspended at a final concentration of 1x106 cells. Then 100μl were 
transferred into epperdorf tubes and centrifuged at 800g for 5 minutes. Each sample was 
incubated with 50μl of anti-CD16/32 (10μg/ml) for 20 minutes at 4oC. After a wash step, the 
samples were incubated with anti-CXCR2 (1 in 10 dilution in PBS2A), anti-CD54 (1 in 500 
dilution) or their IgG controls for 30 minutes on ice. The samples were washed twice, 
resuspended in 100μl of cold PBS2A and finally transferred into FACS tubes containing 
300μl PBS2A. All samples were analysed using the Cyan flow cytometer (DAKO) and 
Summit version 4.3 software package (DAKO) and data were expressed as median 
fluorescence intensities (MFI). 
 
 
2.7 Assessment of neutrophil viability and apoptosis  
Neutrophil viability was estimated by Trypan blue exclusion, as this dye can only 
penetrate the membrane of dead cells and subsequently it stains them blue. 10μl of neutrophil 
suspension from each group were stained with an equal amount of Trypan blue dye for 5 
minutes. Then, 10μl of the formed suspension were loaded on to a haemocytometer which 
was mounted on the microscope stage. The blue stained dead cells were counted and were 
expressed as a percentage of the total number of neutrophils. 
 
One way to determine neutrophil apoptosis is by nuclear morphology observation. In 
order to determine the percentage of apoptotic neutrophils, 100μl of neutrophil suspension 
from each group was centrifuged onto glass slides at 10g for 3 minutes in a Shandon Cytospin 
II and stained with Diff Quick. They were then air-dried for at least 5 minutes before 
mounting a coverslip with Depex mounting fluid. Usually a condensed nuclei was an 
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indication of apoptosis. Those cells were counted and their numbers were expressed as a 
percentage of total number of neutrophils.  
 
An alternative way to assess neutrophil apoptosis is by measuring the mitochondrial 
transmembrane potential. A reduction in the mitochondrial transmembrane potential is 
associated to apoptosis. The fluorochrome DiOC6 was used as its reduced uptake by 
mitochondria indicates apoptosis. In detail, 50μl of neutrophils (1x106 cells/ml) were 
incubated with 150µl of DiOC6 (40nM) for 30 minutes at 37oC. Ice-cold PBS was then added 
to stop the reaction. The cell suspension was centrifuged at 800g at 4oC for 4 minutes, 
resuspended in 100µl of cold PBS and finally transferred to FACS tubes containing 200µl 
PBS2A. Each sample was analysed using the Cyan flow cytometer and Summit version 4.3 
software package (DAKO). Data was presented as a percentage in reduction in Median 
Fluorescence Intensity (MFI) Data were presented as a percentage of neutrophils expressing 
low levels of DiOC6. 
 
For the assessement of neutrophil apoptosis, the mitochondrial dye JC-1 was also 
used. The JC-1 dye accumulates in the mitochondria of healthy cells as aggregates, which are 
fluorescent red in colour, but at the early stages of apoptosis, the mitochondrial potential is 
significantly reduced and the dye can not accumulate in the mitochondria. In this case JC-1 
remains in the cytoplasm in a monomeric form which fluoresces green. These differences can 
be analysed with flow cytometry. Neutrophils from all groups were incubated with JC-1 in 
RPMI (0.01mg/ml) for 15 minutes at 37oC. Each sample was transferred into a FACS tube, 
centrifuged at 400g for 5 minutes and washed once with ice cold PBS. Finally the samples 
were resuspended in 400μl of cold PBS and analysed using Cyan flow cytometry (DAKO), as 
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previously described. Data was presented as the percentage of cells whose red fluorescent 
aggregates decreased, compared to the fresh. 
 
 
2.8 2-D DIGE electrophoresis 
Sample preparation 
Neutrophils from each group were collected (maximum 10x106 cells) and washed 
twice with ice cold sucrose buffer. 200μl of lysis buffer was then added to each cell pellet. 
The lysis took place at 4oC for 30 minutes with gentle agitation every 5 minutes. After a 
centrifugation at maximum speed at 4oC for 20 minutes, the supernatant, which contained the 
protein fraction, was transferred to an eppendorf filled with 1.8ml 80% acetone and kept at -
20oC overnight. The following day after a wash with 80% acetone, protein pellets were gently 
dissolved in 50μl of labeling buffer and kept at -20oC for at least 2 hours prior to any further 
use. The protein concentration was later determined by Bradford assay.  
 
Labelling 
All three vials of CyDye are transferred from -20oC and allowed to warm in room 
temperature. Each vial contained 5nmol of Cy2, Cy3 or Cy5 dye. After CyDyes had been 
reconstituted in 5µl of anhydrous dimethylformamide (DMF) at a final concentration of 1mM, 
they were diluted 1:2 with DMF. Finally, 0.9μl of each dye was added to 30μg of protein 
lysate in 25μl of labelling buffer. Each sample was mixed, briefly centrifuged, and incubated 
for 30 minutes on ice in the dark. The reaction was finally terminated by the addition of 1 µl 
of lysine (10mM) and an equal amount of 2xIEF buffer was added, followed by a 10-minute 
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incubation on ice in the dark. Finally, each internal control and two samples were pooled at a 
final volume of 450μl in 1xIEF. 
 
Isoelectric focusing (IEF) 
Dry 24 cm polyacrylamide gel strips with an immobilized non-linear pH gradient 3-10 
were used for first dimension separation. First, the protein samples were loaded into separate 
grooves of a reswelling tray and then the strips were carefully placed with the gel surface 
down to prevent any air being traped in the interface. At the end all strips were covered in 
paraffin oil (Drystrip cover fluid) and left to rehydrate for at least 10 hours. After that, they 
were transferred to a manifold in the IPGphor chamber (GE Healthcare, Uppsala, Sweden), 
with the gel side facing up and the acidic end towards the anode. Then damp electrode pads 
were applied at each end of the strips and the electrode assemblies were placed on them. 
Again, the strips were covered in paraffin oil before the IEF initiation of first dimension 
electrophoresis. The running conditions were 1) 100V for 2 hours, 2) gradient up to 1000V 
for 5 hours, 3) gradient up to 8000V for 3 hours and 4) 8000V for 2 hours. After IEF 
completion, the gel strips were transferred to a manifold for storage at -20oC. 
 
Gel formation and second dimension electrophoresis 
Low fluorescent glass plates were assembled and placed in a vertical position inside 
the Ettan Dalt twelve separation unit (GE Healthcare, Uppsala, Sweden). Then 12% SDS 
solution was prepared and poured into the cassettes. Gels were left overnight, covered in wet 
tissue and cling film to keep them wet. The following day, strips were left at room 
temperature for 15 minutes. Firstly, 5ml of equilibration buffer containing 1% DTT was 
added to each strip for 15 minutes in gentle agitation, followed by a 15-minute incubation in 
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equilibration buffer with 2.5% iodoacetamide. Finally, strips were washed with 1x running 
buffer before being  carefully placed to the gels.  
 
The gel cassettes were placed inside the separation unit, previously filled with running 
buffer, were added and the lid was closed. The running conditions were 0.1W/gel for 1h, 
0.2W/gel for 1h and 1W/gel overnight. The following day, after the completion of the 
electrophoresis, the gel cassettes were carefully rinsed with water and scanned with Typhoon 
9400 Variable Mode Imager (GE Healthcare, Uppsala, Sweden). Each gel was scanned 3 
times with different lasers. The acquired images were uploaded to DeCyder software (GE 
Healthcare, Uppsala, Sweden) for analysis. 
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Figure 2.4 Equipment for 2D-DIGE experiments 
The IPG phor chamber (A) was used to perform the isoelectric focusing, the Ettan Dalt twelve 
separation unit (B) for the second dimension electrophoresis and Ettan spot picker (C) for gel 
spot picking. All the equipment was from GE Healthcare, Uppsala, Sweden. 
 
 
Spot picking 
After the spots of interest were identified preparative gels were made. This time 200-
250μg of total protein, without any previous staining, were dissolved in 450μl of 1xIEF buffer 
and loaded to gel strips exactly as before. The gel was immobilised on the surface of the small 
plate, using bindsilane. After the second dimension electrophoresis, gel cassettes were opened 
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and washed. The plate side with the gel was fixed with methanol/acetic acid for 1.5 hour with 
gentle agitation, followed by staining with Flamingo stain (1:20 dilution) for the same time. 
Finally, gels were scanned and the images were matched to the analysed DIGE images in the 
BVA analysis software. The gels were immersed in a tray filled with water and the spots of 
interest were picked using the automated Ettan spot picker (GE Healthcare, Uppsala, 
Sweden).The gel plugs were placed in 96-well plate in H2O, until being analysed. 
 
 
2.9 In-gel digestion and mass spectrometry analysis (I) 
In-gel digestion and mass spectrometry analysis was outsourced to ServiceXS 
(Leiden, The Netherlands). The gel plugs were washed twice with water, twice with 50mM 
ammonium bicarbonate in 50% acetonitrile and dehydrated using 100% acetonitrile. The 
proteins were reduced with 10mM DTT and subsequently alkylated with 55mM 
iodoacetamide. The gel plugs were washed with 50mM ammonium bicarbonate, 50mM 
ammonium bicarbonate/50% acetonitrile and 100% acetonitrile and rehydrated with 10μl 
50mM ammonium bicarbonate containing 50ng of trypsin. Gels plugs were incubated on ice 
for 30 minutes. When necessary, 50mM ammonium bicarbonate was added to completely 
cover them. Protein digestion by trypsin was allowed to proceed overnight at 37°C. Finally, 
the supernatant was acidified using TFA to a final concentration of 0.1%, desalted over a Zip-
Tip (Millipore) and spotted directly on a MALDI target plate using 1ml α-cyano-4-
hydroxycinnamic acid (HCCA, 0.3mg/ml in ethanol:acetone 2:1) as the Zip-Tip eluent. MS 
and MS/MS spectra were acquired on an Ultraflex™ II TOF/TOF instrument (Bruker 
Daltonics, Bremen, Germany). The MS and MS/MS spectra were searched against the 
IPI_Human database using the MASCOT search algorithm (version 2.1) using mass 
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tolerances of 0.1 Da for MS and 0.5 Da for MS/MS. Carbamidomethylcysteine was taken as a 
fixed modification and oxidation of methionines as a variable modification. Furthermore, the 
search parameters allowed for 1 missed cleavage. 
 
In- gel digestion and mass spectrometry analysis (II) 
The gel plugs were washed twice with water, twice with 50mM ammonium 
bicarbonate in 50% acetonitrile for 45 minutes at 37oC and finally dried. The proteins were 
reduced with 50mM DTT at 56oC for 1 hour and subsequently alkylated with 100mM 
iodoacetamide at room temperature for 30 minutes. The gel plugs were washed with 40mM 
ammonium bicarbonate/10% acetonitrile for 15 minutes and then completely dehydrated. 
After that, these were incubated with 20µl of trypsin (12.5μg/ml) in 10% acetonitrile/40mM 
ammonium bicarbonate for 1hour at room temperature. 20µl of 10% Acetonitrile/40mM 
Ammonium Bicarbonate was added to each plug and these incubated at 37°C overnight. The 
following day, supernatant was collected and incubated with formic acid in water at 37°C for 
1hour. Supernatant was collected and added to the previous one. 30µl of 3% formic acid in 
water was added again, followed by incubation at 37°C for 30 minutes. Supernatant was 
collected (final volume: 70-90µl) and stored at -20ºC or -80ºC. 
 
The peptides were separated on a 75μm i.d. 15cm long C18 PepMap reverse phase 
column (3μm particle size) (Dionex) using a 3% - 35%  solvent B gradient over 40 minutes 
(solvent A=2% acetonitrile/0.1% formic acid and solvent B= 99% acetonitrile/0.1% formic 
acid) at 350nl/minute using a Dionex U3000 nanobore HPLC system.  The separated peptides 
were sprayed, using electrospray ionization, directly into a Bruker Amazon ion-trap mass 
spectrometer via a nanospray source equipped with a stainless steel Proxeon emmiter tip 
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(Bruker Daltonics, Bremen, Germany). A charge of 1.5kV was applied and the mass of the 
peptide was determined in the initial MS analysis. This data was used to select ions for 
MS/MS analysis where these were subjected to collision induced disassociation using He. The 
mass of the fragments determined and used to perform a database search. The most abundant 
5 ions for each full scan were fragmented sequentially before another full scan was 
performed. This data dependent process selected ions for analysis twice, after which they 
were placed on an exclusion list for 1 minute to increase the number of low abundance 
fragmented ions. The spectra generated were analysed using the Mascot database search 
engine and the results processed by the ProteinScape software provided by Bruker (Bruker 
Daltonics, Bremen, Germany). Conditional carbamidomethylation of cysteine residues and 
oxidation of methionine residues were included and a minimum peptide score of 30 was 
employed. 
 
2.10 Western blotting 
Fresh and reverse migrated neutrophils were washed twice with ice cold PBS and 
lysed in sample buffer and boiled at 95oC for 5 minutes. Protein samples were separated on 
10-15% SDS-polyacrilamide gels, that were previously cast using mini gel apparatus (Mini-
PROTEAN, Bio-Rad, UK). Gels were run for 1-2 hours at 150V. PVDF membranes were cut 
to gel dimensions, activated with 100% methanol and soaked in transfer buffer. After 
electrophoresis completion, the proteins on the gels were transferred to PVDF membrane, via 
wet transfer, according to manufacturer’s protocol. After transfer, the membrane was washed 
in transfer buffer, and blocked for 2 hours at room temperature in blocking buffer. The 
membrane was then incubated with primary antibody diluted in blocking buffer overnight at 
4°C, followed by 5 washes with wash buffer for 5 minutes. The blot was incubated in 
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secondary antibody (rabbit or mouse anti-human IgG-HRP, DAKO) for 1 hour in blocking 
buffer at room temperature. The membrane was washed 5 times for 5 minutes and then was 
incubated for 1 minute with ECL Western Blotting Substrate (Thermo Scientific Pierce, 
USA). After that, the membrane was exposed to Hyperfilm ECL (Amersham, UK). After the 
exposure, blots were stripped and re-probed with a primary antibody by using the Restore 
western blot stripping buffer (Thermo Scientific Pierce), followed by blocking for 1 hour with 
blocking buffer.  
 
 
2.11 Statistical analysis 
Data are presented graphically as the mean ± SEM for n independent experiments 
where n > 3. Variations between multiple treatments were evaluated using one-way analysis 
of variance (ANOVA), followed by Bonferroni multiple comparison post-test when 
appropriate. Comparisons between specific treatment conditions were made by paired t test.
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3.1 Introduction 
The process of leukocyte recruitment to inflamed endothelium has been extensively 
studied over previous years using well-established human in vitro models of inflammation 
(Cooke et al., 1993; Luu et al., 1999; Sheikh et al., 2005). However, the availability of human 
tissue is limited and/or expensive, especially since the introduction of the Human Tissue Act. 
These problems have been addressed to some extent by the use of animal models of 
inflammation, in which genetically homogenous strains of mice are commonly utilised. 
Moreover, the generation of transgenic and knockout mice provides a powerful tool for the 
investigation of mechanisms that underlie this process. Antibodies that block the function of 
adhesion molecules or chemokine receptors have been used extensively in vitro and in vivo. 
There is large literature on in vivo models of inflammation. These often use intravital 
microscopy techniques to enable the direct visualization of leukocyte recruitment at the site of 
inflammation (Baez, 1973). For example, post-capillary venules in the cremaster muscle can 
be stimulated with inflammatory cytokines such as TNF-α οr IL-1β administered by 
intrascrotal injection. The muscle is subsequently exposed some hours post-stimulation with 
the circulation intact and leukocyte (typically neutrophil) adhesion is visualized under phase 
contrast or fluorescent microscopy (Dunne et al., 2002; Kunkel and Ley, 1996; Thompson et 
al., 2001).  
 
Despite the valuable information that has arisen from the use of the in vivo models of 
inflammation there are some limitations. The in vivo system is too complex to ascribe effects 
to specific activating stimuli. For example, cytokines directly released in the circulation may 
change the phenotype of leukocytes over the period of stimulation, changing the nature of 
their interactions with vascular endothelial cells (Cotter et al., 2001; Itou et al., 2006). In 
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addition, stimulation of a tissue with a single cytokine such as TNF-α not only results in the 
activation of vascular endothelium by this agent, but also results in the activation of stromal 
cells, such as fibroblasts and macrophages, resulting in the release of a complex combination 
of inflammatory mediators that may act in addition or opposition to TNF-α. Another issue is 
the concordance between the regulation of inflammation in humans and mice. For example, in 
vitro studies have shown that L-selectin on murine neutrophils does not act as a ligand for E-
selectin as it does on human neutrophils (Zollner et al., 1997). In addition, not all human 
genes have homologues in the murine genome (Chinwalla et al., 2002; Emes et al., 2003). 
Thus, findings from in vivo animal models cannot necessarily be directly applied to leukocyte 
adhesion paradigms in human systems. 
 
For all the above reasons, the establishment of murine in vitro models of inflammation 
is necessary. This allows the responses of endothelial cells from different species to be 
directly compared, because the same regimens of stimulation can be applied to them.  
Moreover, these are a more reliable tool to examine the role of individual molecules in the 
interactions between leukocytes and EC. However, there are only a very small number of 
studies using in vitro murine models of inflammation, and one major reason for this is the 
practical difficulties of isolating and culturing primary murine ECs (mECs) (Lidington et al., 
2002). An additional problem lies in the small volume of blood and therefore low numbers of 
leukocytes that can be isolated from this source. Indeed, an isolation protocol which yields a 
very pure neutrophil suspension (>95%)  from murine blood has been reported, but the total 
number of isolated cells is less than a 1x106 per mouse at most (Cotter et al., 2001), 
insufficient for the requirements of most  in vitro adhesion assays, in particular those using 
flow methodology. It is possible to use neutrophils from bone marrow, where they are 
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abundant (Boxio et al., 2004; Chervenick et al., 1968). However, this raises issues about the 
maturity of the isolated cells. It has been demonstrated that morphologically mature, but 
functionally immature neutrophils are present in the human bone marrow (Berkow and 
Dodson, 1986). The obvious question is whether this also applies to murine neutrophils. 
Boxio et al. (2004) have shown that a large number of functionally competent neutrophils 
reside in the murine bone marrow. Performing functional studies they compared murine 
neutrophils from blood and bone marrow and found minor differences in degranulation and 
superoxide production between the two populations when stimulated with formylmethionyl-
leucyl-phenylalanine (fMLF) (Boxio et al., 2004). Moreover, mature bone marrow 
neutrophils are in a resting state straight after isolation and have the ability to be primed when 
treated with TNF-α (Itou et al., 2006). 
 
Murine ECs have been isolated from various organs including  heart (Lidington et al., 
2002; Marelli-Berg et al., 2000), lung (Dong et al., 1997; Lim et al., 2003; Marelli-Berg et 
al., 2000), fat (Kajimoto et al., 2010), lymph nodes (Toyama-Sorimachi, 1993) and brain 
(Song and Pachter, 2003). However, successful mEC isolation and propagation has proved a 
difficult task for a long time. The cost, time and effort in isolation procedure, the limited 
number of passages that mEC are capable of sustaining and poor levels of purity are some of 
the obstacles to overcome in order to use mECs in in vitro models of inflammation (Lidington 
et al., 2002; Lim and Luscinskas, 2006). An alternative strategy is the use of conditionally 
immortalised EC lines from murine tissues. For example, immortalised cardiac EC (MCEC-1) 
have been used by others, as well as ourselves. MCEC-1 cells are positive for typical EC 
markers (CD31, ICAM-2, E-selectin and endoglin) and sensitive to TNF-α and IL-1β 
treatment (Lidington et al., 2002). 
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Our purpose in this chapter was to establish murine in vitro models of inflammation 
using the MCEC-1 cell line or primary mECs and bone marrow neutrophils. The first step was 
to examine the sensitivity of murine EC monolayers to cytokine treatment in the presence of 
flow using flow-based adhesion assays. We have compared MCEC-1 with primary mECs 
from heart and lung, isolated following the protocol by Lim et al. (2006). 
 
 
3.2 Methods 
3.2.1 Flow-based adhesion assays with MCEC-1 cell line 
In order to examine the recruitment of murine neutrophils to cytokine stimulated EC 
monolayers in murine in vitro models of inflammation under flow, experiments were 
performed using the flow-based adhesion assay methodology, as previously described in 
sections 2.4.1.1 and 2.5.1.1. 
 
For the flow-based adhesion assays, microslides previously coated with gelatin were 
double seeded with MCEC-1 cells and cultured for 24 hours, at 37oC, 5% CO2 until they 
reached confluence. The monolayers were stimulated with TNF-α (100U/ml), IL-1β 
(0.5ng/ml) or a combination of these agents for 4 hours. Medium was changed every hour. 
Murine neutrophils were isolated from bone marrow using a 3-step Percoll density gradient. 
The lower cell fraction (70-80% mature neutrophils) was collected and resuspended at a final 
concentration of 2x106 cells/ml. After 4-hour cytokine stimulation, the microslides were 
mounted on a phase-contrast microscope stage inside a heated box at 37oC and connected to a 
pump and an electronic valve via silicon rubber tubing. The wall shear stress was set at 0.05 
Pa by selecting a flow rate of 3.21 μl/s-1. 
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Initially, a 4-minute neutrophil bolus was perfused over the MCEC-1 monolayers, 
followed by a washout with PBSA. Video recordings of 10 fields were taken at 5, 9 and 15 
minutes from the beginning of the experiment. The adherent neutrophils were counted and 
classified as rolling (phase bright spherical cells, rotating over the surface), arrested (phase 
bright, firmly adherent cells) and transmigrated (phase dark, migrating cells underneath the 
monolayer). The total number of adherent neutrophils was expressed as the number of 
adherent neutrophils/mm2/106 cells perfused and transmigration was expressed as the 
percentage of the adherent cells that transmigrated. Figure 3.1 shows the time line of the 
experimental procedure. 
 
In some experiments, B-cell depletion of the neutrophil suspension was performed. 
The neutrophil suspension was incubated with anti-CD19 magnetic beads. CD19+ cells, such 
as B-cells, were labelled with the beads and when the cell suspension was loaded onto a 
column placed in the magnetic field of a MACS separator; these were retained on the column, 
while the unlabeled cells ran through. As a result, this neutrophil fraction was depleted of B- 
cells. 
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Figure 3.1 The time line of the flow based adhesion assay 
After 4 minutes of neutrophil perfusion, PBSA washout was established and video recordings 
of 10 fields were taken at 5, 9 and 15 minutes after the beginning of neutrophil perfusion. 
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3.2.2 Characterization of MLEC and MHEC by flow cytometry 
Following the protocol of Lim and Luscinskas (2006), we obtained EC that had a 
‘classical’ EC cobblestone appearance. To verify that these cells constituted a pure population 
of endothelial cells, they were stained with antibodies against endothelial markers such as 
CD31, ICAM-2 and VE-cadherin. Table 3.1 shows the antibodies and dilutions used for mEC 
characterization. 
 
     Table 3.1 Antibodies and dilutions used for mEC characterization 
ANTIBODY ISOTYPE DILUTION 
APC anti-mouse CD31 Rat IgG 1:50 
FITC anti-mouse ICAM-2 Rat IgG 1:50 
Anti-mouse VE-cadherin Rat IgG 1:50 
FITC anti-rat IgG 
 (as secondary against VE-cadherin) 
Mouse IgG 1:10 
 
 
 
3.2.3 Flow-based adhesion assays with mECs 
After successfully establishing primary mEC cultures from heart and lung, we 
examined the ability of mECs to respond to cytokine treatment and recruit neutrophils from 
flow using titrations of activating stimuli. MLEC or MHEC were seeded on microslides 
precoated with 0.1% gelatin and 10μg/ml fibronectin and cultured for 24 or 48 hours, 
respectively.  Confluent monolayers were stimulated with mTNF-α (at 2, 10, 100 and 500 
U/ml), mIL-1β (at 0.01, 0.05, 0.5 and 2.5ng/ml) or a combination of agents (100U/ml and 
0.5ng/ml, respectively). The flow-based adhesion assays were conducted, as previously 
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described, with the exception that an extra time point at 20 minutes from the beginning of 
neutrophil perfusion was introduced for collection of data by video microscopy. Video 
recordings were analysed off-line and the results were expressed as previously described. 
 
 
3.3. Results 
3.3.1 The effect of different cytokine treatments on neutrophil adhesion to MCEC-1 
monolayers 
Flow based adhesion assays were conducted on MCEC-1 cells after stimulation with 
cytokines. Neutrophil behaviour on cytokine stimulated EC could be categorised as rolling, 
arrested or transmigrated (Figure 3.2). Total adhesion levels and the percentage of 
transmigrated neutrophils, under different MCEC-1 cytokine treatment at the final time point 
of the experiment (15 minutes) are presented in Figure 3.3A. A surprising finding was the 
considerable levels of adhesion in the absence of inflammatory stimulus (198±42 
cells/mm2/106 perfused). Treatment with TNF-α, IL-1β or the combination of agents did not 
significantly increase levels of adhesion. 
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Figure 3.2 Images of MCEC-1 cultures (A) and cytokine stimulated (B) MCEC-1 
monolayers after neutrophil perfusion  
In (B), adherent neutrophils were categorized as rolling (blue arrows), arrested (red arrows) 
and transmigrated (black arrows). 
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Figure 3.3 Effect of cytokine treatment on murine neutrophil adhesion (A) and 
transmigration (B) on MCEC-1 monolayers 
MCEC- 1 monolayers in microslides were stimulated with TNF-α (100U/ml), IL-1β (0.5 
ng/ml) or their combination for 4 hours and were incorporated in flow based-adhesion assays. 
After 4-minute neutrophil perfusion, non-adherent neutrophils were washed out and adherent 
(A) and transmigrated (B) neutrophils were counted at 15 minutes. Highest levels of adhesion 
and transmigration were obtained when the combination was used. In both cases, the 
differences were not statistically significant, as shown by one-way ANOVA. All data are the 
mean+SEM of three experiments. 
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Transmigration, expressed as a percentage of total adherent cells, followed the same 
trend. In the absence of inflammatory stimulus, 3.5±0.9% of the total number of adherent 
neutrophils had transmigrated at the final time point of the experiment. This percentage was 
7.8±3.7%, with TNF-α treatment, and this was tripled with IL-1β. Transmigration was even 
higher when MCEC-1 monolayers were stimulated with TNF-α and IL-1β (31 ±13%, Figure 
3.3B). However, ANOVA showed no significant differences between the responses to 
different cytokine stimulation regimens. 
 
 Figure 3.4 shows the effect of cytokine treatment of MCEC-1 monolayers on 
neutrophil behaviour. Adherent neutrophils were classified as rolling, arrested or 
transmigrated, based on their behaviour. The percentage of rolling neutrophils decreased over 
time in all treatments (Figure 3.4A). The majority of neutrophils at any time point were 
arrested. In the absence of treatment or stimulation with TNF-α, the percentage of arrested 
neutrophils remained stable over time. In other treatments, the number of arrested cells was 
reduced with time as the cells transmigrated (Figure 3.4B). The percentage of transmigration 
in unstimulated conditions and with TNF-α was low and stable, while treatment with IL-1β 
and the combination markedly increased transmigration over time, reaching a maximum at 
~30% (Figure 3.4C). The different behaviour patterns show that an increasing number of 
rolling cells firmly arrested and the ones already stationary transmigrated over time. 
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Figure 3.4 Effect of cytokine treatment of MCEC-1 monolayers on neutrophil behaviour 
Adherent neutrophils were categorized as rolling (A), arrested (B), and transmigrated (C). All 
data are the mean+SEM of three experiments. 
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3.3.2 The effect of B-cell depletion on total adhesion   
 Following the bone marrow isolation protocol for neutrophils we isolated the lower 
cell fraction from the 3-step Percoll gradient density. This fraction constitutes 70-80% mature 
neutrophils, 15-25% immature neutrophils and around 5% B-cells. We examined whether B-
cell contamination is able to affect the numbers of adherent and transmigrated neutrophils. 
For this purpose, B-cell depletion was performed and the B-cell depleted neutrophils were 
used in flow-based adhesion assays.  
 
As shown in Figure 3.5A adhesion levels were slightly higher when B-cell depleted 
neutrophils were used compared with those with the non-depleted. However, the difference 
between the two cell populations was not significant. Percentages of transmigration were 
almost the same over time reaching a maximum of 40% at 15 minutes (Figure 3.5B). These 
results from 4 experiments suggest that B-cell contamination does not affect the overall 
adhesion and transmigration.  
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Figure 3.5 Effect of B-cell depletion in adhesion and transmigration 
B-cell depleted and non-B-cell depleted neutrophils were perfused over TNF-α and IL-1β 
stimulated monolayers. B-cell depletion did not have an effect on adhesion (A) and 
transmigration (B). All data are the mean+SEM of four experiments. 
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3.3.3 Surface expression of ICAM-2, CD31 and VE-cadherin on MLECs and MHECs 
Murine primary ECs from heart and lung showed the classical cobblestone appearance 
(Figure 3.6A and B). In order to characterize the cells, surface expression of ICAM-2, CD31 
and VE-cadherin was measured (Figure 3.6C-H). Table 3.2 presents data from two 
experiments with MHECs and five from MLECs. 
 
Table 3.2 Surface expression of ICAM-2, CD31 and VE-cadherin on MLECs and 
MHECs expressed as Median Fluorescence Intensity (MFI) and % of positive cells 
 
 MLEC  (n=2) MHEC (n=5) 
 MFI % Histogram MFI % Histogram 
ICAM-2 17.5 ±7.4 77.1±9.5 34±9.6 89.8 ±5.8 
CD31 84±23.2 94.5±2 16.5±11.2 32±24 
VE-cadherin 38±27.2 87.6±11.6 12.5±1.6 34.5±7 
 
 
Approximately 77, 94.5 and 87.6% of the MLEC population expressed ICAM-2, 
CD31 and VE-cadherin, respectively. However, mEC marker surface expression was different 
in MHEC from 2 experiments. Here, 89% of the cells expressed ICAM-2, but only 31.9% and 
34% of cell population were positive for CD31 and VE-cadherin, respectively (Figure 3.6C, D 
and E). 
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Figure 3.6 Morphological appearance and surface expression of ICAM-2, CD31 and VE-
cadherin on MHECs and MLECs 
MHECs (A) and MLECs (B) show the classical EC cobblestone appearance. MHECs and 
MLECs were positive for ICAM-2 (C and F), CD31 (D and G), and VE-cadherin (E and H), 
respectively. Data are representative from two (MHEC) and five experiments (MLEC). 
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3.3.4 The effect of different cytokine treatment of MHEC monolayers on neutrophil 
recruitment and behaviour under flow.  
In order to investigate the effect of different concentrations of various cytokines on the 
ability of MHEC monolayers to recruit neutrophils, 20-minute flow-based adhesion assays 
were conducted. MHEC monolayers in microslides were stimulated with different 
concentrations of IL-1β (0.01, 0.05, 0.5 and 2.5ng/ml), TNF-α (2, 5, 10 and 100U/ml) or a 
combination of agents (0.5ng/ml and 100U/ml respectively), for 4 hours. Adhesion and 
transmigration was analysed and neutrophils were categorised as rolling, arrested and 
transmigrated, based on their behaviour. 
 
MHEC responded to IL-1β treatment in a dose dependent manner. The two lower 
doses resulted in similar adhesion levels, but as IL-1β concentration increased, so did the 
neutrophil adhesion. There was a significant dose dependent effect on adhesion (p<0.001, by 
ANOVA). Adhesion levels in each treatment remained relatively stable after 10 minutes 
(Figure 3.7A). The dose dependent effect of IL-1β treatment on neutrophil adhesion on 
MHEC monolayers can be seen more clearly at the final time point of the experiment (p<0.01, 
by ANOVA). The highest level of adhesion (661±72 adherent cells/mm2/106 perfused) was 
reached in the highest IL-1β concentration (2.5ng/ml) (Figure 3.7B). IL-1β treatment also had 
an effect on transmigration in a concentration dependent manner (p<0.001, by ANOVA). 
However, treatment with a dose higher than 0.5ng/ml did not result in an increase in 
transmigration efficiency, which reached a peak at ≈50% (Figure 3.7C). 
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Figure 3.7 Effect of ΜΗΕC treatment with different concentrations of IL-1β on 
neutrophil adhesion (A and B) and transmigration (C) 
MHEC monolayers in microslides were stimulated with different concentrations of IL-1β 
(0.01, 0.05, 0.5 and 2.5ng/ml) for 4 hours. (A) ANOVA showed a significant effect (P<0.001) 
of IL-1β dose treatment on adhesion at all time points, P<0.001. (B) Dose of IL-1β had a 
significant effect on adhesion levels at 20 minutes, P<0.01, by ANOVA, *, P<0.05, **, 
P<0.01 by Bonferroni's Multiple Comparison Test.  (C) ANOVA showed a significant effect 
(P<0.001) of IL-1β dose on % of transmigration at 20 minutes. *, P<0.05, **, P<0.01 and 
***, P<0.001, by Bonferroni's Multiple Comparison Test. 
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The behaviour of adherent neutrophils in all IL-1β concentrations over time is 
illustrated in Figure 3.8. The percentage of rolling cells decreased over time at all 
concentrations (Figure 3.8A). At 5 minutes, around 50% of adherent neutrophils were firmly 
arrested and this percentage decreased over time in all concentrations apart from the lowest 
(Figure 3.8B). The opposite pattern was observed in the percentages of transmigrated 
neutrophils as these behaviours are reciprocal, i.e. arrested cells go on to migrate over time.  
 
Findings were different when TNF-α was used to activate MHEC. Again, MHEC 
responded to TNF-α treatment in a dose dependent manner (p<0.001, by ANOVA). This time 
though, adhesion levels slightly decreased over time. This finding suggests that adherent cells 
detached from EC monolayer (Figure 3.9A). Overall adhesion at 20 minutes increased with 
higher TNF-α concentrations, reaching a maximum at 500U/ml (Figure 3.9B). But by far the 
most striking result was the very low transmigration observed even at high concentrations of 
TNF-α. MHEC treatment with TNF-α concentration higher than 10U/ml could induce 
transmigration that only reached ≈5% (Figure 3.9C). The majority of adherent cells (50-75%) 
were rolling at 5 minutes and this percentage remained stable over time with minor changes 
between the different concentrations (Figure, 3.10A). The same pattern was true for the 
percentage of firmly arrested cells (25-50% of adherent neutrophils) (Figure, 3.10B). 
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Figure 3.8 Effect of different doses of IL-1β stimulated MHECs on neutrophil behaviour  
Adherent neutrophils were categorized as rolling (A), arrested (B) and transmigrated (C). All 
data are the mean+SEM of three experiments. 
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Figure 3.9 Effect of ΜΗΕC treatment with different concentrations of TNF-α on 
neutrophil adhesion (A and B) and transmigration (C) 
MHEC monolayers in microslides were stimulated with different concentrations of ΤΝF-α (2, 
5, 10 and 100U/ml) for 4 hours. (A) ANOVA showed a statistically significant effect of TNF-
α dose treatment on adhesion at all time points,P<0.001. (B) Despite the gradual increase of 
adhesion with higher concentrations, the TNF-α. dose treatment did not have a statistically 
significant effect on adhesion at 20 minutes. (C) Very low transmigration (5%) was observed 
in the highest TNF-α concentration at the final time point. All data are the mean+SEM of 
three experiments. 
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Figure 3.10 Effect of different doses of TNF-α stimulated MHECs on neutrophil 
behaviour 
Adherent neutrophils were categorized as rolling (A) arrested (B) and transmigrated (C). All 
data are the mean+SEM of three experiments. 
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We also compared the highest dose of TNF-α and IL-1β stimulation with treatment 
using a combination of cytokines. Treatment with cytokines always induced increased levels 
of adhesion compared to unstimulated EC. However, there was no significant difference 
between the levels of adhesion using single or combined cytokines for EC stimulation  
(Figure 3.11A). Τhere was still, a significant effect of cytokine treatment on transmigration 
(p<0.01, by ANOVA). Very few neutrophils transmigrated when TNF-α alone was used as 
inflammatory stimulus. More than 50% of cells transmigrated, when MHEC were stimulated 
with IL-1β or the combination of agents and the difference in levels of migration between the 
two activation regimens was not significant (Figure 3.11B). Data are the mean of 3 
experiments. 
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Figure 3.11 Effect of cytokine treatment on neutrophil adhesion (A) and transmigration 
(B) on MHEC monolayers 
MHEC monolayers in microslides were stimulated with TNF-α (100 µg), IL-1β (0.5ng/ml) or 
their combination for 4 hours and were incorporated in flow based-adhesion assays. After 4-
minute neutrophil perfusion, non-adherent neutrophils were washed out and adherent (A) and 
transmigrated (B) neutrophils were counted at 20 minutes. (A) ANOVA showed no 
statistically significant effect of different cytokine treatment on adhesion at 20 minutes. (B) 
There was a significant effect of cytokine treatment on transmigration (P<0.01, by ANOVA). 
*, P<0.05, **, P<0.01, by Bonferroni's Multiple Comparison Test. All data are the 
mean+SEM of three experiments. 
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3.3.5 The effect of cytokine treatment of MLEC on neutrophil recruitment and 
behaviour under flow  
Three cytokine titration experiments were conducted on MLECs. MLECs responded 
to IL-1β treatment in a dose dependent manner. As IL-1β concentration increased, so did the 
levels of neutrophil adhesion, although the two higher doses resulted in similar adhesion 
levels. Overall, there was a significant dose dependent effect on adhesion (p<0.001, by 
ANOVA). Adhesion levels in the unstimulated condition and the lowest dose slightly 
decreased over time indicating unstable binding of neutrophils to the monolayer. Higher doses 
were able to stabilise adhesion (Figure 3.12A). After 20 minutes, the highest levels of 
adhesion (720±171 cells/mm2/106 perfused) were observed at the maximum IL-1β 
concentration (Figure 3.12B). There was significant effect of IL-1β treatment in the 
percentage of transmigrated neutrophils at 20 minutes (p<0.001, by ANOVA). Treatment with 
the higher concentration resulted in maximum transmigration; around 75% of adherent 
neutrophils had transmigrated at 20 minutes (Figure 3.12C). 
 
The behaviour of adherent neutrophils in all IL-1β concentrations over time is 
illustrated in Figure 3.13. In contrast with MHEC, the dose and the percentage of rolling cells 
were inversely proportional at 5 minutes. The percentage of firmly arrested cells decreased 
over time in all concentrations, apart from the concentration of 0.01ng/ml (Figure 3.13B). The 
opposite pattern was observed in transmigration, which increased in all doses over time. There 
was a very significant effect of dose treatment on transmigration (p<0.001, by ANOVA). The 
two highest concentrations of IL-1β led to 75% transmigration at 20 minutes (Figure 3.13C). 
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Figure 3.12 Effect of ΜLΕC treatment with different concentrations of IL-1β on 
neutrophil adhesion (A and B) and transmigration (C) 
MLEC monolayers in microslides were stimulated with different concentrations of IL-1β 
(0.01, 0.05, 0.5 and 2.5ng/ml) for 4 hours. (A) ANOVA showed an extremely significant 
effect (P<0.001) of IL-1β dose treatment on adhesion at all time points, P<0.001. (B) IL-1β 
dose treatment had a significant effect on adhesion levels at 20 minutes, P<0.05, by ANOVA. 
(C) ANOVA showed an extremely significant effect (P<0.001) of IL-1β dose treatment on % 
transmigration at 20 minutes. *, P<0.05 and ***, P<0.001, by Bonferroni's Multiple 
Comparison Test. All data are the mean+SEM of three experiments. 
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Figure 3.13 Effect of different doses of IL-1β stimulated MLECs on neutrophil 
behaviour 
Adherent neutrophils were categorized as rolling (A) arrested (B) and transmigrated (C). All 
data are the mean+SEM of three experiments. 
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MLEC responded to TNF-α treatment in a concentration dependent manner (P<0.001, 
by ANOVA). Adhesion levels in all concentrations slightly decreased over time indicating 
that adhesion of neutrophils to the monolayer was not stable. The adhesion response saturated 
at 100U/ml TNF-α (Figure 3.14A and B). There was a significant effect of dose in adhesion 
(p<0.05, by ANOVA). Stimulation with TNF-α supported very low levels of transmigration 
(≈5%) even at the highest concentration (Figure 3.14C). The majority of adherent neutrophils 
(around 75%) were rolling unless 500U/ml of TNF-α was used, when the majority were 
firmly arrested (Figure 3.15A and B). 
 
We also compared the treatment with each cytokine at the highest concentration alone 
or in combination. EC stimulated with TNF-α or the combination of cytokines supported the 
same levels of adhesion, but the highest levels of adhesion were observed with IL-1β alone 
(Figure 3.16A). There was a significant effect of cytokine treatment to transmigration 
(p<0.01, by ANOVA). Very low levels of transmigration were observed with TNF-α 
stimulation. More than 50% of cells transmigrated when MLEC were stimulated with IL-1β 
and this was not significantly altered by use of the combination of cytokines (Figure 3.16B). 
Data are the mean of 3 experiments. 
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Figure 3.14 Effect of ΜLΕC treatment with different concentrations of TNF-α on 
neutrophil adhesion (A) and B) and transmigration (C) 
MLEC monolayers in microslides were stimulated with different concentrations of ΤΝF-α (2, 
5, 10 and 100U/ml) for 4 hours. (A) ANOVA showed an extremely significant effect 
(P<0.001) of TNF-α dose treatment on adhesion at all time points. (B) TNF-α dose treatment 
had a significant effect on adhesion levels at 20 minutes, P<0.01, by ANOVA, (C) ANOVA 
showed a significant effect (P<0.01) of ΤΝF-α dose treatment on % transmigration at 20 
minutes. *, P<0.05, **, P<0.01, by Bonferroni's Multiple Comparison Test. All data are the 
mean+SEM of three experiments. 
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Figure 3.15 Effect of different doses of TNF-α stimulated MLECs on neutrophil 
behaviour 
Adherent neutrophils were categorized as rolling (A), arrested (B) and transmigrated (C). All 
data are the mean+SEM of three experiments. 
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Figure 3.16 Effect of cytokine treatment on neutrophil adhesion (A) and transmigration 
(B) on MLEC monolayers 
MLEC monolayers in microslides were stimulated with TNF-α (100U/ml), IL-1β (0.5ng/ml) 
or their combination for 4 hours and were incorporated in flow based-adhesion assays. After 
4-minute neutrophil perfusion, non-adherent neutrophils were washed out and adherent (A) 
and transmigrated (B) neutrophils were counted at 20 minutes. (A) ANOVA showed an effect 
of different cytokine treatment on adhesion at 20 minutes, P<0.05. (B) There was an 
extremely significant effect of cytokine treatment on transmigration (P<0.001, by ANOVA). 
**, P<0.01, by Bonferroni's Multiple Comparison Test. All data are the mean+SEM of three 
experiments. 
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3.3.6 Direct comparison of neutrophil adhesion to MHEC and MLEC stimulated with 
different regimen of cytokines  
By presenting the data detailed above in a different format we here present a direct 
comparison of the levels of adhesion and transmigration to the different ECs after stimulation 
with TNF-α, IL-1β or the combination of agents. This analysis showed that the responses of 
the two endothelial cells were remarkably consistent to all stimulation regimens and there was 
no significant differences in adhesion or transmigration when comparing MHEC and MLEC 
for any given cytokine regimen (Figure 3.17). 
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Figure 3.17 Comparison on adhesion and transmigration levels between different 
cytokine treatment on MHECs and MLECs 
Αdhesion levels (A) and % transmigration (B) were higher in MLECs (black bars) than in 
MHECs (grey bars) when they were stimulated with IL-1β οr the combination,*, P<0.05, by 
Bonferroni's Multiple Comparison Test. Data are from 3 experiments in MHECs and MLECs 
respectively.  
 
 
 
                                                                                                                  CHAPTER 3 
 
102 
 
3.4 Discussion  
In this chapter we described the development of three murine in vitro models of 
inflammation which can be used to investigate the recruitment of murine neutrophils to 
cytokine stimulated murine EC monolayers.  
 
Initially we used the MCEC-1 cell line in our flow-based adhesion assays and we 
verified its responsiveness to cytokine treatment at a functional level in vitro. Treatment with 
IL-1β induced higher levels of adhesion and transmigration than treatment with TNF-α, and 
both readouts were further increased by the combination of cytokines. These findings are in 
accordance with those from the group who generated the MCEC-1 cell line (Lidington et al., 
2002). It has been demonstrated that MCEC-1 cells express endothelial markers such as 
CD31, ICAM-2 and endoglin and respond to cytokine treatment. Their surface expression of 
E-and P-selectin, VCAM-1 and ICAM-1 was significantly induced after 6 hours when a 
combination of IL-1β and TNF-α was used as inflammatory stimulus (Lidington et al., 2002). 
Another interesting finding was the fact that unstimulated MCEC-1 monolayers were able to 
support considerable levels of neutrophil adhesion. This could be associated with the high 
constitutive expression of VCAM-1 in MCEC-1 cells as murine neutrophils have been 
described to express α4β1, the counter ligand for this receptor (Bowden et al., 2002; 
Lidington et al., 2002).  
 
Bone marrow neutrophil isolation is accompanied with <5% contaminating B cells. 
The depletion of these cells does not modulate the behaviour of neutrophils in our assays. In 
fact, the smaller size of lymphocytes compared with neutrophils enables their discrimination 
with relative ease under phase contrast microscopy, and an experienced user is able to exclude 
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the very small number of lymphocytes from the analysis. Moreover, there was significant cell 
loss through the magnetic immuno-separating columns and an increased risk of inducing 
activation on the neutrophils finally isolated. For all the above reasons, we believed that B-
cell depletion was unnecessary and we did not perform it routinely. 
 
Here we have successfully isolated primary murine EC from heart and lung tissue. 
Both MLEC and MHEC cells were found positive for CD31, ICAM-2 and VE-cadherin. 
However, CD31 and VE-cadherin expression was higher in MLEC than MHEC cells. 
Relatively low CD31 expression on cardiac ECs was found in previous studies (Lidington et 
al., 2002; Marelli-Berg et al., 2000). This may be because MHEC cultures generally require 
more time to reach confluence than MLEC. After characterisation of mECs we tested the 
ability of these cells to recruit neutrophils from flow after cytokine stimulation. Both MHEC 
and MLEC responded to these cytokines in a dose dependent manner in most cases and 
showed the same patterns between cytokine treatment with TNF-α οr IL-1β. However, our 
previous observations and the direct data comparison between them have raised some 
differences. Overall, the adhesion levels and the percentage of transmigrated neutrophils were 
higher in MLECs than MHECs under the same cytokine treatment.  An explanation could lie 
in the differential induction of adhesion molecules upon TNF-α stimulation. Performing 
fluorescent immunoassay, Lim and Luscinskas (2006) have shown that CD31, ICAM-1 and 
ICAM-2 induction upon stimulation was higher in  MLECs, while VCAM-1 and P-and E-
selectin expression was higher in MHEC (Lim and Luscinskas, 2006). 
 
The differences between adhesion and transmigration levels within the two cell 
cultures could be attributed to the intrinsic properties of the cells derived from different 
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vascular beds. It has been demonstrated with cDNA arrays that different biomechanical and 
humoral conditions acting upon the vascular endothelium from various organs has an effect 
on functional phenotype (Garcia-Cardena et al., 2001). Furthermore, dual radiolabel 
methodology has demonstrated marked differences in the constitutive expression of VCAM-1 
and ICAM-1 within brain, heart and intestine (Henninger et al., 1997). Interestingly, using 
immunohistochemistry techniques, VCAM -1 was found expressed in individual ECs of small 
and medium size vessels in the lung in the absence of inflammation (Fries, 1993). 
  
Further evidence indicating different phenotypic characteristics between lung and 
heart EC comes from a study on T cell recruitment by these cells when stimulated with TNF-
α. T-helper cells where perfused over TNF-α stimulated MLECs and MHEC in an in vitro 
flow assays. More Th1 cells arrested to MHECs than MLEC (87% than 27%, respectively) 
and transmigrated through them after 15 minutes (35.7% than 23.5%). The Th1 adherent cells 
exhibited a rolling phenotype on MLECs (Lim et al., 2003). The same group found that 
MHECs but not MLECs produced RANTES after TNF-α stimulation. Finally, blocking 
studies revealed that the differences in T helper recruitment between MHECs and MLECs are 
attributed to the  differential  expression of VCAM-1 and RANTES  in these cells (Lim et al., 
2003). 
 
By far the most striking finding was the lack of response of MLEC and MHEC to 
TNF-α stimulation. Adhesion reached similar levels in both cytokine treatments but these 
decreased over time with TNF-α treatment, suggesting that a number of neutrophils initially 
captured from flow were able to detach from ECs over time. While more than half of adherent 
neutrophils had transmigrated at 20 minutes when the highest dose of IL-1β was used, hardly 
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any cells migrated in response to TNF-α. This was rather a surprising result, because the 
majority of adherent neutrophils (around 75%) were arrested on MCEC-1 monolayers treated 
with a lower dose of TNF-α (100U/ml) and TNF-α is an excellent stimulus for driving the 
adhesion and migration of human neutrophils to human EC (Luu et al., 1999). One possible 
explanation could be that a higher TNF-α dose is required to induce transmigration on 
stimulated mECs. A dose more than the double the highest used here has been reported to 
induce ≈30% of murine neutrophils to transmigrate on primary cardiac endothelial cells in in 
vitro parallel plate flow assays (Allport et al., 2002). A reason for the low sensitivity of these 
cells to TNF-α stimulation could be explained by low density of TNF-α receptors. For 
example, a dramatic reduction in neutrophil adhesion and transmigration occurs in TNF-α 
receptor II (TNFR-II) deficient mice (Chandrasekharan et al., 2007). Whether isolation and 
culture of mEC leads to loss of TNF-α receptors still needs to be ascertained.  
 
Our findings could also be interpreted to indicate that TNF-α and IL-1β induce very 
different responses in primary murine endothelial cells. For example, injection of the 
cytokines into rabbit skin elicits responses with distinct kinetics. Administration of TNF-α 
results in rapid neutrophil recruitment (30 minutes), a process that does not require protein 
synthesis. IL-1β however induces a slower response (3-4 hours) and protein synthesis is 
required for neutrophil recruitment (Rampart. et al., 1989). Additional evidence for disparity 
of response is available for intravital studies in the cremaster muscle of the mouse. Neutrophil 
recruitment is inhibitable using anti-CD31 when TNF-α is used to stimulate the vasculature, 
but this is not the case when IL-1β is used (Thompson et al., 2001). Similar observations were 
made after blocking α6β1 integrin (Dangerfield et al., 2005), ICAM-2 and JAM-A (Woodfin 
et al., 2009). Finally, it has been demonstrated using well-characterized pharmacological 
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interventions (e.g. use of antagonists) that IL-1β (but not TNF-α) induced adhesion and 
transmigration of neutrophils is LTB4 and PAF dependent (Young, 2002). 
 
In this chapter, we have examined the ability of a cell line and primary ECs to recruit 
neutrophils, under different stimuli, in order to establish a murine in vitro model of 
inflammation that would enable us to investigate this process and reverse migration. The 
MCEC-1 cell line was characterized by constitutive levels of neutrophil recruitment and low 
levels of transmigration. The use of primary cells is preferred because these require 
stimulation with cytokines for neutrophil recruitment. However, stimulation with TNF-α did 
not give satisfactory results, as it did not induce stable adhesion and there was very little 
transmigration. In contrast, stimulation with IL-1β was more promising, as it could induce 
high levels of adhesion with consistently high proportion of transmigrating cells. Therefore, 
we chose to use mECs, with IL-1β routinely used as an inflammatory stimulus of choice.  
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CHAPTER 4 
GENERATION OF MURINE REVERSE MIGRATED 
NEUTROPHILS IN VITRO AND INVESTIGATION OF 
THEIR FATE IN VIVO 
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4.1 Introduction  
Human neutrophils are released from bone marrow and enter the blood circulation 
where they have a half life of ≈6.5 hours (Mauer et al., 1960). Under physiological 
conditions, neutrophils die by apoptosis and are cleared by the macrophages of liver and 
spleen (Doerschuk et al., 1987; Ohgami et al., 1989; Saverymuttu et al., 1985; Savill, 1997; 
Skretting et al., 1988). Clearance of neutrophils is performed by the Kupffer cells in the liver 
and presumably, although they have not been identified experimentally, by the red pulp 
macrophages in the spleen (Rankin, 2010; Weiss, 1974). Interestingly, P-selectin, is up-
regulated on Kupffer cells in the liver under inflammatory conditions  and might play a role in 
neutrophil clearance by this tissue during inflammation (Shi et al., 1998).  
 
A number of studies have demonstrated that bone marrow might also play a role in 
neutrophil clearance under physiological conditions (Lovas et al., 1996). When mice were 
injected with 111In senescent neutrophils, these migrated to various organs, depending on their 
activation and maturation state. Infused blood neutrophils migrated in equal numbers between 
bone marrow and liver, peritoneal exudate neutrophils localised primarily to the liver, while 
bone marrow derived neutrophils migrated preferentially to their tissue of origin (the bone 
marrow) 4 hours post-injection (Suratt et al., 2001). Another study has suggested an equal 
contribution of liver, spleen and bone marrow to neutrophil clearance (Furze and Rankin, 
2008).  
 
Neutrophil survival in vitro has been extensively investigated. Human neutrophils 
undergo spontaneous apoptosis after 18-36 hours in vitro (Scheel-Toellner et al., 2004) , but 
there is strong evidence that these cells exhibit prolonged survival under inflammatory 
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conditions, probably to maintain their immune functions. Peripheral neutrophils from patients 
with systemic inflammation became apoptotic relatively slowly in vitro (Ertel et al., 1998; 
Jimenez et al., 1997; Ottonello et al., 2002). Similarly, neutrophils isolated from mice, 
previously injected with pro-inflammatory agents showed a delay in apoptosis ex vivo (Coxon 
et al., 1996). Moreover, neutrophils isolated from an inflammatory milieu appear to also have 
a prolonged survival. Human neutrophils isolated from inflammatory exudates were protected 
against the pro-apoptotic effect of the combination of TNF-α and cycloheximide (Hotta et al., 
2001). In addition, neutrophils isolated from the bronchoalveloar lavage fluid, peritoneal 
cavity and cerebrospinal fluid of experimental animals, exhibited a delay in apoptosis ex 
vivo compared to peripheral blood derived neutrophils (Coxon et al., 1996; Coxon et al., 
1999; Watson et al., 1997). Interestingly, there is evidence that soluble factors produced at the 
site of inflammation are able to delay apoptosis. TNF-α is capable of delaying apoptosis 
(Colotta et al., 1992; Hotta et al., 2001). GM-CSF, produced by endothelial cells, is able to 
prolong neutrophil survival (Colotta et al., 1992). In addition, an anti-apoptotic role for IL-8, 
LTB4, C5a and LPS has also been reported (Kettritz et al., 1998; Klein et al., 2001; Murray et 
al., 2003; Perianayagam et al., 2002). 
 
Subsequently, the process of neutrophil adhesion and transmigration was examined for 
a potential role in modulation of neutrophil survival. It was shown that apoptosis of resting or 
fMLP activated neutrophils in the presence of soluble fibrinogen was reduced through the 
binding of neutrophil β2-integrin (Rubel et al., 2003). Similarly, neutrophils adherent to IL-
1β-stimulated endothelial monolayers exhibited prolonged survival through neutrophil β2-
integrin binding to ICAM-1 (Ginis and Faller, 1997).  Additionally, the interaction of αM- or 
β2-integrin chains with ICAM-1 resulted in a delay in apoptosis (Whitlock et al., 2000).  
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Transmigration also plays a role in neutrophil survival. It has been demonstrated that 
neutrophils are rescued from apoptosis when transmigrated through TNF-α+IL-1β treated-
endothelial monolayer on filters and collected onto a non-adhesive surface. Neutrophils 
survived from six to eight hours in the presence of cytokines (Coxon et al., 1999). Recently, it 
was found that neutrophil transmigration across EC stimulated with increasing concentrations 
of TNF-α and the levels of apoptosis were inversely correlated, i.e. the greater the 
inflammatory stimulus the less prone to apoptosis migrated cells became (McGettrick et al., 
2006).  
 
Other evidence that interactions with EC delay apoptosis comes from a study on once 
transmigrated neutrophils that were able to reverse transmigrate back across an EC monolayer 
in vitro in 24 hours (Buckley et al., 2006). These cells were found to be non-apoptotic and 
functionally distinct compared to naïve circulating neutrophils. Reverse migration of 
neutrophils not only challenges the very well established perception of neutrophils being 
short-lived cells which die in the tissue after recruitment, but also provides evidence for the 
cells ability to transmigrate twice across an EC in a bi-directional manner. This phenomenon 
has also been demonstrated in vivo in transgenic Zebrafish models of inflammation. Thus, by 
performing wounding assays, neutrophils were observed to bi-directionally migrate between 
the site of inflammation and the vasculature (Mathias et al., 2006). It is suggested that this 
process might be an additional mechanism for clearance of neutrophils from tissues that are 
constantly recruiting these cells during immune surveillance (gut, lung, and peritoneum). 
There is also evidence suggesting this reverse migration increases in frequency in chronic 
inflammatory diseases (Buckley et al., 2006). Reverse migration has also been demonstrated 
for monocytes in vivo (Bradfield et al., 2007) and lymphocytes in vitro (McGettrick et al., 
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2009). 
 
Reverse migrated neutrophils (RPMNs) exhibit an altered phenotype compared to 
naïve circulating neutrophils. These cells could adhere to TNF-α stimulated HUVEC from 
flow with reduced efficiency compared to peripheral blood neutrophils, but only 1% of 
recruited cells could transmigrate, suggesting that in vivo they were unlikely to re-enter a site 
of inflammation. Buckley et al. (2006) have shown that RPMNs were rheologically more 
rigid than the naïve cells and might have a tendency for mechanical entrapment in small 
vessels. RPMNs were also able to produce greater levels of ROS after fMLP stimulation, 
indicating that they were functionally primed. RPMNs also had a distinct surface phenotype 
(CXCR1 low, ICAM-1 high) compared to peripheral blood cells before (CXCR1 high, 
ICAM-1 low) or after activation (CXCR1 low, ICAM-1 low). Interestingly, RPMNs were 
also readily distinguished from tissue resident neutrophils isolated from the synovial fluid of 
patients with rheumatoid arthritis or cells that had migrated once across EC (CXCR1 low, 
ICAM-1 low). A very interesting finding in this study was the presence of cells carrying this 
phenotype in the blood of healthy individuals (~0.25%). More importantly, the frequency of 
these cells was increased to 1-2% in the blood of patients with inflammatory disease, such as 
rheumatoid arthritis and atherosclerosis (Buckley et al., 2006). 
 
In this chapter, we aim to characterize murine RPMNs. For this reason, these were 
generated in 24-hour static co-cultures with mECs. Their viability and apoptosis levels were 
quantified. CXCR2 (as an antibody against mCXCR1 was not available) and ICAM-1 surface 
expression was measured. Previous studies have not been able to demonstrate the fate of these 
cells in vivo. Here, we attempt to investigate the fate of murine RPMNs using adoptive 
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transfer methodology. RPMNs from EYFP (Enhanced Yellow Fluorescent Protein) mice were 
injected into WT mice that were later sacrificed. Blood and single cell suspensions from bone 
marrow, spleen, liver and lung were analysed for the presence of any EYFP cells, by flow 
cytometry.  
 
 
4.2 Methods 
4.2.1 Generation of mRPMNs using MCEC-1 and primary mEC cultures. 
MCEC-1 cells from two 25 cm2 flasks were seeded in a 6-well plate pre-coated with 
gelatin (0.1%). The cultures were confluent after 24 hours. The monolayer in each well was 
stimulated with 100U/ml TNF-α and 0.5ng/ml IL-1β for 4 hours. Cultures were washed twice 
and 2x106 murine neutrophils in DMEM/BSA were added to each well. After 1 hour 
incubation at 37oC, 5%CO2, non-adherent neutrophils were removed by a wash with 
DMEM/BSA and 2ml of MCEC-1 medium supplemented with TNF-α and IL-1β (100U/ml 
and 0.5ng/ml, respectively) was added to each well. The plate was then mounted on a 
microscope stage and 10 random fields from each well were video-recorded. The 6-well plate 
was placed in the incubator at 37oC, 5%CO2 for 24 hours.  Random fields from each well 
were captured on video after 2, 4 and 24 hours. All recordings were analysed off-line and 
reverse transmigration was expressed as a percentage of the total number of neutrophils that 
had transmigrated at 1 hour.  
 
Static adhesion assays with MHECs and MLECs were performed, as previously 
described with minor alterations. This time, IL-1β (2.5ng/ml) was used to stimulate the 
MHEC and MLEC monolayers in 25 cm2 flasks. In addition, mEC complete medium without 
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any cytokines was introduced to the flasks after the removal of non-adherent neutrophils. As 
control, 3x105 neutrophils were added in a well and cultured at 37oC, 5%CO2 for 24 hours. 
Neutrophils were cultured in MCEC-1 medium with TNF-α and IL-1β in experiments with 
MCEC-1 cells and mEC complete medium without any cytokines in those with primary 
mECs. 
 
4.2.2 Culture of neutrophils in different media 
Freshly isolated bone marrow neutrophils (3x105 cells) were added in a well of a six-
well plate and cultured in PBSA or MCEC-1 medium supplemented with TNF-α, IL-1β or 
their combination for 24 hours. The following day, each culture was observed under phase 
contrast microscopy and intact phase bright cells were counted. Results were presented as a 
percentage of reduction in neutrophil numbers. Additionally, the cells from each culture 
condition were collected, centrifuged at 400g for 5 minutes and stained with Trypan Blue. 
 
4.2.3 Measurement of neutrophil viability   
Neutrophil viability was assessed by Trypan blue exclusion. Trypan blue is a dye that 
only penetrates the membrane of dead cells and stains them blue. Equal amounts (10μl) of 
each neutrophil sample and dye were mixed for 5 minutes. Then, 10μl of the formed 
suspension was loaded on a haemocytometer.  Intact alive and blue stained dead cells were 
counted under phase contrast microscopy and viability was expressed as a percentage of live 
cells from the total number of neutrophils. 
 
4.2.4 Measurement of neutrophil apoptosis   
Neutrophil apoptosis was assessed in three ways. First, it was measured by 
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observation of nuclear morphology. Cytospin samples were stained with Diff Quick and 
observed under a light microscope.  The presence of a condensed nucleus in a cell is a typical 
sign of apoptosis. Apoptotic neutrophils were counted and their numbers were expressed as a 
percentage of total number of neutrophils.  
 
An additional way to assess neutrophil apoptosis is the measurement of the cells’ 
mitochondrial transmembrane potential. The mitochondrial transmembrane potential is 
reduced in apoptotic cells.  The reduction of DiOC6 fluorochrome uptake by mitochondria in 
cells that are undergoing apoptosis can be measured by flow cytometry. In detail, 50μl of 
neutrophils (1x 106 cells/ml) were incubated with 150μl of DiOC6 (40nM) for 30 minutes at 
37oC.  The reaction was stopped by adding ice-cold PBS and the cell suspension was 
centrifuged at 800g at 4oC for 4 minutes. Each sample was analysed using the Cyan flow 
cytometer and Summit version 4.3 software package (DAKO). Data was presented as a 
percentage in reduction in Median Fluorescence Intensity (MFI).         
              
 The mitochondrial dye JC-1 was also used for neutrophil apoptosis assessment. JC-1 
accumulates in aggregates in the mitochondria of non-apoptotic cells. These aggregates are 
fluorescent red in colour. At the early stages of apoptosis, the mitochondrial potential is 
significantly reduced and the dye remains in the cytoplasm in a monomeric form which 
fluoresces green. The difference in red/green JC-1 fluorescence ratio can be analysed with 
flow cytometry. Each sample was incubated with JC-1 in RPMI (0.01mg/ml) for 15 minutes 
at 37oC, centrifuged at 400g for 5 minutes, washed once with ice cold PBS, resuspended in 
400μl of cold PBS and analysed by Cyan flow cytometry, as previously described. Data was 
presented as the percentage of cells whose red fluorescent aggregates decreased, compared to 
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the fresh. 
 
4.2.5 Characterization of mRPMNs - Surface expression of CXCR2 and ICAM-1  
Fresh neutrophils, mRPMNs and 24-hour control neutrophils were collected and 
centrifuged at 400g for 5 minutes. Around 105 cells per sample were resuspended in ice cold 
PBS2A and centrifuged at 800g for 5 minutes. Each sample was incubated with 50μl of anti-
mouse CD16/CD32 antibody for 20 minutes at 4oC, in order to block any Fc-mediated 
reactions. After a wash step, the samples were incubated with antibodies against CXCR2 and 
ICAM-1 or their IgG controls for 30 minutes on ice. Table 4.1 shows the antibodies and 
dilutions used for FACS staining. Each sample was washed twice and transferred into a FACS 
tube in cold PBS2A (400μl final volume). All samples were analysed using the Cyan flow 
cytometer (DAKO) and Summit version 4.3 software package (DAKO). Results were 
expressed as median fluorescence intensities (MFI) and percentage of cells positive for the 
specific surface marker. 
 
Table 4.1 Antibodies and dilutions used for mRPMN characterization 
Antibody 
 
ISOTYPE 
 
DILUTION 
 
Anti-mouse CD16/CD32 
 
Rat IgG2a, λ 
 
1:50 
 
APC anti-mouse CXCR2 
 
Rat IgG2a 
 
1:10 
 
PE anti-mouse ICAM-1 
 
Rat IgG2b,κ 
 
1:500 
 
 
 
4.2.6 Adoptive transfer experiments 
Adoptive transfer experiments were performed in order to investigate the fate of 
mRPMNs. Isolated bone marrow neutrophils from EYFP mice (C57/BL6 strain) were used in 
static assays for the generation of a fluorescent mRPMN population. Reverse migrated 
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neutrophils were collected, centrifuged at 400g for 5 minutes, and finally resuspended in 
200μl HBSS at different concentrations. Wild type (C57/BL6) mice were injected 
intravenously (IV) with different numbers of EYFP mRPMNs (up to 1 x 106 cells) and 
sacrificed by cardiac puncture, after 4 or 24 hours. The blood from these mice was collected 
(300-800μl) and centrifuged at 800g for 10 minutes. The cell pellet was resuspended in 1ml of 
PBS and then 3ml of red cell lysis buffer was added. After centrifugation at 400g, for 5 
minutes, the samples were washed and resuspended in PBS2A on ice. 
 
Prior to dissection, mice were perfused with PBS through right atrium in order to 
remove any remaining blood cells from the organs. The tissues of interest (bone marrow, 
spleen, lungs and liver) were dissected and processed in order to obtain single cell 
suspensions. Bone marrow cell suspension was prepared following the same protocol for 
neutrophil isolation, excluding percoll centrifugation step. Spleen was mechanically 
disrupted, filtered through a 70μm nylon mesh cell strainer and rinsed with 10ml 
RPMI/EDTA (15mM). The cell suspension was centrifuged at 400g for 5 minutes and 
resuspended in 1ml of PBS. Next, red cell lysis buffer was added and the cells were 
centrifuged at 400g for 5 minutes. After a wash with RPMI/EDTA solution, cells were 
resuspended in PBS2A. 
 
Lungs were minced with a scalpel and tissues were incubated in 15ml type 1 
collagenase solution at 37oC for 45 minutes. At the end of the incubation, 15ml of 
RPMI/EDTA was added and the preparation was filtered twice through a cell strainer. After 
centrifugation at 400g for 5 minutes, red cell lysis buffer was added, and after two washes, 
cells were resuspended in PBS2A.  
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Liver was immersed in a petri dish filled with collagenase. Approximately 10ml of 
collagenase solution was injected into different parts of the liver, using 1ml syringe and a 25G 
needle. Then, liver was cut into small pieces and these were incubated with collagenase at 
37oC for 30 minutes. After filtration through a cell strainer, red cells were lysed and the 
remaining cells were diluted in PBS2A, as previously described. All cell suspensions were at 
a final concentration of 1x106 cells/ml. In some experiments, fresh EYFP neutrophils (1 or 
3x106) were injected into WT mice that were sacrificed by cardiac puncture after 4 hours. In 
these experiments, single cell suspensions were fixed in 4% PFA and analysed on the 
following day. 
 
 At least 5x103 cells were analysed for EYFP expression in the gate for reverse 
migrated neutrophils (CXCR2 low/ ICAM-1 high) in fluorescence isothiocyanate (FL1) 
channel by flow cytometry. The samples were analysed, as previously described. As EYFP 
cells are highly fluorescent (their MFI is between 100 and 700), we can estimate the number 
of EYFP cells present in the total cell population from each organ. 
 
 
4.3 Results 
4.3.1 Generation of mRPMNs in cytokine stimulated MCEC-1 cultures under static 
conditions 
In order to generate mRPMNs, MCEC-1 monolayers were stimulated with TNF-α 
(100U/ml) and IL-1β (0.5ng/ml), for 4 hours. Around 2x106 neutrophils were added to each 
well. The co-cultures were placed inside an incubator for 1 hour, at 37oC, 5% CO2. Then, non 
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adherent neutrophils were washed, and 10 random fields were recorded at that time point and 
after 2, 4 and 24 hours. Transmigration occurred in the absence of wall shear stress. Around 
33.3±6.5 % of the neutrophils added to each well transmigrated after 1 hour (data not shown). 
The number of transmigrated neutrophils gradually decreased at later time points, as cells 
reverse migrated onto the apical side of the EC. Almost 80.9±5% of the total number of 
transmigrated neutrophils at time point 0 hours, were still found underneath the monolayer at 
2 hours. This percentage decreased to 65.2±3.7% at 4 hours and finally to 28.2±8.5% at 24 
hours (Figure 4.1). ANOVA showed a significant correlation between the number of 
transmigrated cells and time (P<0.001). Direct visual observation confirmed that 
transmigrated neutrophils started reverse transmigrating back across the EC monolayer and 
re-appearing on the apical surface as phase-bright cells after 2 hours. The number of cells re-
appearing over EC monolayers increased over time. Staining of collected RPMNs the 
following day revealed that around 90% of these cells were live, compared to 55% in the 24-
hour control cells cultured on plastic. 
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Figure 4.1 Decrease in transmigrated neutrophils in static cultures over a 24–hour 
period 
2x106 neutrophils were added to MCEC-1 monolayers stimulated with TNF-α (100U/ml) and 
IL-1β (0.5ng/ml) for 4 hours. After 1 hour co-culture, non-adherent neutrophils were removed 
and the number of transmigrated neutrophils at 0, 2, 4 and 24 hours was determined under 
phase contrast microscopy. Transmigration at 2, 4 and 24 hours was expressed as a percentage 
of the number of transmigrated neutrophils at 0 hours. The number of transmigrated 
neutrophils decreased over time. ANOVA showed a significant correlation between 
transmigration and time (P<0.001). *, P<0.05, **, P<0.01, by Bonferonni’s Multiple 
comparison test. All data are the mean±SEM of 3-4 experiments. 
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4.3.2 Assessment of murine neutrophil survival in 24-hour culture in different media 
Following the static assay protocol, we added MCEC-1 medium with TNF-α and IL-
1β into the co-cultures after the removal of non-adherent neutrophils. However, the low 
survival of neutrophils in 24-hour control group, led us to examine the survival of neutrophils 
in different media. Twenty four-hour cultures of neutrophils in various media were observed 
under phase contrast microscopy and intact phase bright cells were counted. After 24 hours, 
50% of neutrophils cultured in PBSA were alive. Culture with TNF-α alone resulted in the 
survival of just 30% of the cells, while this was doubled with IL-1β alone. The combination 
led to a slight increase in cell viability, compared with PBSA (Figure 4.2).  
 
All the cells from each co-culture were collected, centrifuged at 400g for 5 minutes 
and stained with Trypan Blue. Around 90% of RPMNs were alive, compared to 54% of 
PBSA. In the cultures with MCEC-1 medium, 55% of cells were alive with the cytokine 
combination, 72 % with IL-1β and only 31% with TNF-α (data not shown). 
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Figure 4.2 The effect of culture with different media on neutrophil viability 
Bone marrow neutrophils were cultured in PBSA or MCEC-1 medium supplemented with 
TNF-α and IL-1β or their combination for 24 hours. The following day, each culture was 
observed under phase contrast microscopy and intact phase bright cells were counted. Results 
were presented as a percentage of neutrophil number reduction. All data are the mean+SEM 
of three experiments. 
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4.3.3 Generation of mRPMNs in IL-1β stimulated MHEC and MLEC cultures under 
static conditions 
 Comparing transmigration on IL-1β stimulated MHECs and MLECs, 35±10% and 
42±2% of the neutrophils added to MHECs and MLECs respectively, had transmigrated after 
1 hour of co-culture (Figure 4.3A). The numbers of transmigrated neutrophils followed the 
same pattern as with MCEC-1 static co-cultures over time. Transmigration levels were very 
similar between MHEC and MLEC at each time point. In MHEC co-cultures, 63.1±2.4% of 
neutrophils remained transmigrated at 2 hours, then 42.1±3.2% at 4 hours and 30.9±7.5% at 
24 hours (Figure 4.3B). In MLEC co-cultures, 49.8±3.7% of neutrophils remained 
transmigrated at 2 hours, then 36.7±3.4% at 4 hours and 25.4±6.2% at 24 hours (Figure 4.3C). 
In both cases, ANOVA showed a significant effect of time on the number of transmigrated 
neutrophils (P<0.001). At 24 hours, all mRPMNs were collected, centrifuged and checked for 
their viability. With Trypan Blue exclusion, around 90% of mRPMNs were alive from both 
cultures. The same percentage of 24-hour control cells was viable.  
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Figure 4.3 Transmigration on IL-1β stimulated MHECs and MLECs 
2x106 neutrophils were added to MHEC or MLEC monolayers previously stimulated with 2.5 
ng/ml IL-1β for 4 hours. After 1 hour co-culture, the number of transmigrated neutrophils at 
0, 2, 4 and 24 hours was determined under phase contrast microscopy. Transmigration at 2, 4 
and 24 hours was expressed as a percentage of the number of transmigrated neutrophils at 0 
hours. (Α) Almost equal levels of transmigration across MHECs and MLECs were observed. 
The number of transmigrated neutrophils decreased over time in MHEC and MLEC 
monolayers (B and C respectively). ANOVA showed a very significant correlation between 
transmigration and time in both cases (P<0.001). **, P<0.01, ***, P<0.001, by Bonferonni’s 
Multiple comparison test. All data are the mean+SEM of four experiments. 
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4.3.4 Measurement of apoptosis in RPMNs and 24-hour control neutrophils 
After defining the percentage of dead cells, we examined whether the intact cells from 
each group were undergoing apoptosis. Apoptosis was assessed by nuclear morphology 
observation and staining with DiOC6 and JC-1. 
 
Cytospin samples from each group, stained with Diff Quick, were observed under 
light microscopy and cells were categorised in non-apoptotic and apoptotic, based on the 
presence of a condensed nucleus (Figure 4.4A and B).  Less than 1% of neutrophils were 
found apoptotic in fresh samples. This percentage was 3.5±0.6% in RPMNs and almost 
doubled in the 24-hour control population (Figure 4.4C). ANOVA showed an effect of 
different conditions (P<0.05) on the percentage of apoptosis between the three groups. Results 
are shown from 5 experiments. Interestingly, mRPMNs had a typical ‘human’ 
polymorphonuclear appearance rather than the murine ring shaped nucleus. 
 
Cells from each group were incubated with DiOC6 and the reduction in their 
mitochondrial potential was measured by flow cytometry. DiOC6 uptake expressed as median 
fluorescence intensity was reduced by 10.9±18.7% in RPMNs and  38.4±18.7% in the 24- 
hour control population, compared with fresh neutrophils (Figure 4.5A, B and C). Again, 
ANOVA showed an effect of different conditions (P<0.05) on DiOC6 uptake between the 
three groups. 
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Figure 4.4 Assessment of apoptosis by observation of nuclear morphology  
Cytospin samples from fresh (A) and RPMNs (B), were observed under light microscopy and 
cells were determined as non-apoptotic and apoptotic (with black arrows), based in the 
presence of a condensed nucleus. (C) Percentage of apoptotic neutrophils in fresh, RPMNs 
and 24h control neutrophils. RPMNs exhibited a slight increase in apoptotic cells numbers, 
compared to the 24-hour control population. ANOVA showed an effect of different conditions 
on neutrophil apoptosis (P<0.05). *, P<0.05, **, P<0.01, at control and RPMNs compared to 
fresh, respectively, by students’t-test.  All data are the mean+SEM of five experiments. 
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Figure 4.5 Apoptosis assessment by measurement of reduction in DiOC6 uptake 
Cells from each group were incubated with DiOC6 (40nM) for 30 minutes at 37oC and the 
reduction in their mitochondrial potential was measured by flow cytometry. (A and B) Each 
histogram represents the DiOC6 uptake reduction in RPMNs (A) and 24 h control neutrophils 
(B), compared with the fresh. RPMNs and control cells uptake in grey compared with that of 
fresh in white. (C) MFI decrease was higher in control cells than in RPMNs, compared to 
fresh neutrophils. ANOVA showed an effect of different conditions on DiOC6 uptake 
(P<0.05). All data are the mean±SEM of three experiments. 
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Finally, the cells were stained with JC-1 for 15 minutes at 37oC, 5% CO2. Fluorescent 
red aggregates started to decrease in numbers in RPMNs and control cells, compared to fresh 
(Figure 4.6A, B and C). Low fluorescent red aggregates were around 2.5% in fresh, 4.5% in 
RPMNs and 13% in the control population (Figure 4.7). Despite the trend, the results were not 
statistically significant. 
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Figure 4.6 Measurement of the reduction of red fluorescent JC-1 aggregates in 
neutrophils 
Red fluorescence/green fluorescence plots of fresh (A), RPMNs (B) and 24-hour control (C) 
neutrophils stained with JC-1 for 15 minutes at 37oC, 5% CO2. The decrease in FL2/FL1 ratio 
is indicative of early apoptosis. Results shown are representative of three experiments. 
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Figure 4.7 Assessment of neutrophil apoptosis by measurement of the reduction of red 
fluorescent JC-1 aggregates 
Fresh, RPMNs and 24-hour control neutrophils were stained with JC-1 for 15 minutes at 
37oC, 5% CO2. Low fluorescent red aggregates were around 2.5% in fresh, 4.5% in RPMNs 
and 13% in control population. No statistical significance was found between the different 
condition and red fluorescent JC-1 aggregates reduction. All data are the mean+SEM of three 
experiments. 
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4.3.5 Characterization of mRPMNs by flow cytometry 
As with human RPMNs we hypothesised that mRPMNs would have a different 
phenotype from fresh neutrophils or the 24-hour control population. As a first step, we 
assessed the surface expression of CXCR2 and ICAM-1 on mRPMNs and compared these to 
fresh and 24h plastic cultured control neutrophils. As shown in Table 4.2 and Figure 4.4, 
CXCR2 expression almost doubled in mRPMNs (13.9±3.7, compared to 7.7 ± 2.3 in fresh), 
while it slightly increased in the control population (7.9±1.5). Interestingly, ICAM-1 
expression significantly increased in mRPMNs (more than 20 fold), compared to fresh and 
control cells.  In addition, the percentage of cells expressing ICAM-1 markedly increased, 
from 50 ± 0.8% in fresh to 83.6±11.3% in reverse migrated neutrophils. ANOVA showed an 
effect of different conditions to ICAM-1 expression, both in MFI and percentage of positive 
cells (P<0.05). 
 
Table 4.2 Surface expression of CXCR2 and ICAM-1 in fresh, reverse migrated and 24- 
hour control neutrophils 
 FRESH 
 
REVERSE MIGRATED 
 
24 H CONTROL 
 
 MFI 
 
%Histogram 
 
MFI 
 
%Histogram 
 
MFI 
 
%Histogram 
 
CXCR2 
 
7.7 ± 2.3 
 
53.1 ±4.1 
 
13.9±3.7 
 
59.4±8.3 
 
7.9±1.5 
 
52.4±4.1 
 
ICAM-1 
 
3.5±0.003 
 
50   ± 0.8 
 
83.3±28.8 
 
83.6±11.3 
 
4.1±1.3 
 
48.9±7.3 
 
P<0.05, by ANOVA in ICAM-1 expression. All data are the mean+SEM of three 
experiments.  
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Figure 4.8 Surface expression of CXCR2 (A, C) and ICAM-1 on RPMNs and 24-hour 
control neutrophils compared to fresh 
The expression of CXCR2 of RPMNs (A) and control (C) was quantified by flow cytometry. 
Similarly for ICAM-1 in RPMNs (B) and control (D). Each histogram represents the 
expression of the specific marker (in grey) compared to fresh (in white). ICAM-1 expression 
was significantly increased in RPMNs. Results shown are representative of three experiments. 
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4.3.6 Adoptive transfer experiments 
In an attempt to examine the fate of reverse migrated neutrophils in vivo, EYFP 
RPMNs were injected into WT mice. These were sacrificed after 4 or 24 hours. Blood and 
single cell suspensions from bone marrow, spleen, liver and lungs were analysed for the 
presence of any EYFP cells, by flow cytometry. Table 4.3 shows the MFI and % positive cells 
in injected mice, compared to control WT mice. In most cases, less than 2% had an increased 
MFI compared to the control. But the MFI of these cells did not correspond to the EYFP 
fluorescent intensity (MFI: 100-700). However, a very small number of cells in the EYFP 
fluorescent intensity range borderline was detected in the bone marrow 4 hours post-injection 
(Figure 4.9).  
 
Table 4.3 Median fluorescence intensities and % of histogram in WT and injected mice 
4 and 24 hours post injection with EYFP RPMNs 
4 HOURS 24 HOURS 
 
WILD TYPE 
 
1x106 INJECTED 
 
WILD TYPE 
 
1x106 INJECTED 
 
MFI 
 
% 
 
MFI 
 
% 
 
MFI 
 
% 
 
MFI 
 
% 
 
BLOOD 
2.90±0.52 
 
1.07±1.03 
 
2.60±0.82 
 
0.70±0.67 
 
3.81 
 
2.2 
 
2.85 
 
0.08 
 
BONE MARROW 
2.96 
 
0.81±0.01 
 
3.18±0.12 
 
0.95±0.05 
 
4.09 
 
1.38 
 
3.95 
 
1.77 
 
SPLEEN 
3.15±0.40 
 
0.56±0.30 
 
3.02±0.27 
 
1.40±0.80 
 
4.24 
 
0.88 
 
4.24 
 
0.51 
 
LIVER 
 
5.77±2.40 
 
1.57±0.21 
 
5.13±3.00 
 
1.17±0.62 
 
7.84 
 
4.83 
 
6.54 
 
1.51 
 
LUNG 
 
2.96±0.58 
 
0.51±0.08 
 
2.99±0.43 
 
0.81±0.58 
 
3.29 
 
0.18 
 
4.09 
 
0.27 
 
Results are the means±SEM from two experiments in the 4hour post-injection group. One 24- 
hour post-injection experiment was performed.  
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Figure 4.9 Detection of EYFP RPMNs in blood, bone marrow, spleen, liver and lungs, 4 
hours post injection 
1x 106 EYFP RPMNs were injected into WT mice Histograms represent the presence of any 
EYFP RPMNs in blood, bone marrow, spleen, liver and lungs, 4 hours post injection. 
Contours in black and brown represent the single cell suspensions from WT control and 
injected mice organs respectively. Results shown are representative of two experiments. 
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Figure 4.10 Detection of EYFP RPMNs in blood, bone marrow, spleen, liver and lungs, 
24 hours post injection 
Histograms represent the presence of any EYFP RPMNs in blood, bone marrow, spleen, liver 
and lungs 24 hours post injection. Contours in black and brown represent the single cell 
suspensions from WT control and injected mice organs respectively. Results shown are from 
one experiment. 
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In order to examine whether those findings were due to the technical limitations of the 
methodology we used, WT mice were injected with freshly isolated EYFP neutrophils (at 1 
and 3x106 cells), sacrificed after 4 hours and analysed as previously described. Table 4.4 
shows the MFI and % cells with higher MFI than the WT control, from 1 experiment. In bone 
marrow and spleen there was an increase in positively staining cells (22.49 and 8.22% 
respectively). It is difficult to draw firm conclusions in regard of the identity of these cells as 
we found that fixation dramatically altered the fluorescent profile of EYFP cells. However, 
the distribution of the histograms is highly suggestive that at 4h post transfer, RPMN are 
localised in the liver, spleen and lung.  
 
Table 4.4 Median fluorescence intensities and % of histogram in WT and injected mice 
with 1 and 3x 106   fresh EYFP neutrophils 
 
WILD TYPE 
 
1x106 INJECTED 
 
3x106 INJECTED 
  
 
MFI 
 
% 
 
MFI 
 
% 
 
MFI 
 
% 
 
BLOOD 
3.41 
 
3.33 
 
 
3.41 
 
 
3.07 
 
 
3.41 
 
 
3.34 
 
 
BONE MARROW 
2.56 
 
5.84 
 
1.99 
 
2.53 
 
5.08 
 
22.49 
 
SPLEEN 
2.14 
 
2.46 
 
4.4 
 
11.44 
 
4.09 
 
8.22 
 
LIVER 
3.81 11.24 
 
2.21 
 
2.32 
 
  
LUNG 
2.14 
 
2.51 
 
2.21 
 
3.17 
 
1.72 
 
3.04 
 
Results are from one experiment. 
                                                                                                                  CHAPTER 4 
 
136 
 
 
4.11 Detection of fresh EYFP neutrophils in blood, bone marrow, spleen, liver and lungs, 
24 hours post injection 
Histograms represent the presence of any EYFP fresh neutrophils in blood, bone marrow, 
spleen, liver and lungs, 4 hours post injection. Contours in grey represent the single cell 
suspensions from WT control mouse, while contour in black and brown line represent the 
single cell suspensions from mice injected with 1x106 and 3x106 EYFP neutrophils 
respectively. Results shown are from one experiment. 
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4.4. Discussion 
In this chapter, we studied the reverse migration of murine bone marrow neutrophils in 
vitro. Murine RPMNs were generated in static co-cultures with murine ECs and characterized 
in vitro, based on CXCR2 and ICAM-1 surface expression. Their viability and apoptosis 
levels were also assessed. At a later stage, we performed a small number of preliminary 
adoptive transfer experiments, in an attempt to investigate their fate in vivo.  
 
 First, static assays on cytokine stimulated MCEC-1 or primary mECs were conducted. 
Around 33% and 40% of cells added in MCEC-1 or primary mEC monolayers respectively 
had transmigrated in the absence of any wall shear stress.  Compared with our flow-based 
studies, these data indicate that flow is not essential for transmigration of neutrophils in this 
system, but it does increase the efficiency of transmigration. Thus, as described in chapter 3 
(section 3.3.4 and 3.3.5), most neutrophils had transmigrated by 15-20 minutes, where as here 
less than 50% had migrated after 1h. This slower rate of neutrophil migration under static 
regimens has been previously reported in assays performed on TNF-α stimulated human ECs 
(Butler et al., 2005; Kitayama et al., 2000).  
 
 In all cases, the number of transmigrated neutrophils decreased over time in the 24-
hour co-cultures. Simultaneously, the number of phase bright neutrophils followed exactly the 
opposite trend. In other words, these had reverse migrated across a mEC monolayer in 24 
hours in vitro, a process very similar to that described for human neutrophils by Buckley et 
al.,(2006). We wanted to verify that these cells were rescued from apoptosis after being in 
contact with endothelial cells as other studies have suggested (Buckley et al., 2006; 
McGettrick et al., 2006). Therefore, viability and apoptosis levels were measured in 
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mRPMNs, compared with fresh and 24-hour culture control neutrophils. 90% of mRPMNs 
were alive, as determined by Trypan Blue exclusion. Assessment of nuclear morphology 
revealed that 3.5% of these cells were apoptotic. Incubation with DiOC6 showed that 11% of 
mRPMNs exhibited a reduction in their mitochondrial membrane potential. Interestingly, 
incubation with JC-1 demonstrated that 4.5% of the cells were apoptotic.  The levels of 
apoptosis vary between assays as they report on different stages of the process. For example, 
nuclear morphology reports on the late stages of apoptosis, while changes in the 
mitochondrial membrane potential report on early changes in the process of apoptosis. 
However, differences in the apoptosis levels were found between DiOC6 and JC-1 staining.  
DiOC6 uptake from the cells depends on the state of mitochondria. If mitochondria are 
depolarized, DiOC6 could be distributed to other intracellular membranes, such as 
endoplasmic reticulum, introducing small changes in the total fluorescence intensity of the 
cells. That could make DiOC6 a less reliable probe than JC-1 for ΔΨ changes assessment in 
intact cells (Salvioli et al., 1997). Overall, the above findings demonstrate that mRPMNs 
show a delay in apoptosis when compared to cells aged on plastic, as previously shown with 
human RPMNs (Buckley et al., 2006). 
 
Another interesting finding was the fact that neutrophil survival is affected by culture 
medium and more importantly by the presence of various cytokines in it. When murine 
neutrophils were cultured in MCEC-1 medium in the presence of TNF-α and IL-1β, slightly 
more than 50% were alive after 24 hours. In the presence of TNF-α alone 30% were alive. 
Interestingly, neutrophil viability was higher with IL-1β than the combination. These findings 
suggest that TNF-α induces apoptosis in murine neutrophils. The role of TNF-α in neutrophil 
apoptosis remains unclear. There are a number of studies indicating that TNF-α delays 
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apoptosis of human neutrophils (Kilpatrick et al., 2006; Lindemans et al., 2006; van den Berg 
et al., 2001;Walmsley et al., 2004). However, other studies have shown an opposite effect 
(Maianski et al., 2003; Murray et al., 1997; Salamone et al., 2001). It has been proposed that 
the effect of TNF-α on apoptosis depends on the culture conditions and cytokine 
concentration (Salamone et al., 2001; van den Berg et al., 2001). IL-1β is thought to delay 
apoptosis (Colotta et al., 1992). However, in later experiments, where neutrophils were 
cultured in complete mEC medium without any cytokines we found around 90% of 
neutrophils were viable after 24 hours. This strongly implies that in our assays, TNF-α is pro-
apoptotic to murine neutrophils, while IL-1β did not have the same effect. 
 
 Another important aspect of this work was the characterization of mRPMNs, as 
human neutrophils that have twice transmigrated across an EC monolayer in opposite 
directions are known to exhibit an altered phenotype compared to fresh or plastic cultured 
neutrophils. Here we examined the surface expression of cytokine receptor CXCR2 and the 
adhesion molecule ICAM-1, based on the markers used in previous studies on human RPMNs 
(Buckley et al., 2006). We could not verify the down-regulation of CXCR2 in mRPMNs 
which would have mirrored the process in human RPMNs, however, levels of CXCR2 were at 
the limit of detection in our system and it is thus difficult to draw firm conclusions in regard 
of this marker. In contrast, ICAM-1 expression was increased 20 fold in mRPMNs compared 
to fresh. ICAM-1 is a surface glycoprotein that is a member of the immunoglobulin 
superfamily (Springer, 1990). During the process of reverse migration, ICAM-1 production is 
induced, leading to this marked increase in their surface expression. The change in ICAM-1 
expression in murine RPMNs is dramatically greater than that seen in human equivalents. 
ICAM-1 up-regulation in these cells has been suggested to facilitate their engagement with 
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the macrophages of the liver and spleen, and therefore permit their removal from the 
circulation (Buckley et al., 2006).  ICAM-1 is involved in the firm adhesion of neutrophils on 
EC. Ligands for ICAM-1 are the β2 integrins (LFA-1, Mac-1) (Kishimoto et al., 1989; 
Springer, 1990). It is possible that ICAM-1 up-regulation on the surface of RPMNs may result 
in their removal from the circulation, especially from sites at various organs that express β2 
integrins. 
 
Finally, adoptive transfer experiments were performed in order to examine the fate of 
RPMNs in vivo. Our preliminary data did not give a clear indication about where RPMNs 
have migrated to. Cells in the lower MFI borderline of EYFP cells were detected in the bone 
marrow 4 hours post injection. This could be attributed to the high auto-fluorescence of the 
cells in that particular tissue. The signals were so low it was hard to draw firm conclusions. 
However, if we were measuring cells in the bone marrow it would agree with the theory that 
bone marrow is a site of neutrophil clearance (Rankin, 2010; Suratt et al., 2001). However, 
we suspected that the assay used here was not sensitive enough when using 1x106 adoptively 
transferred cells. When 3x106 cells were injected (in a single experiment), cell suspensions 
from spleen, liver and lung exhibited distinct peaks, indicating the presence of RPMNs. 
However, it would not be technically feasible to use concentrations of RPMNs above 1x106 
per mouse, as this would represent an unfeasible effort in the production of cells for transfer.  
 
 Still, our findings in a single experiment using higher numbers of transferred cells 
indicate that RPMNs are rapidly recognised and cleared from the circulation. Investigation of 
the fate of mRPMNs needs to be performed using more sensitive in vivo imaging techniques 
such as IVIS whole animal imaging facility, now available in Birmingham. This assay is not 
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invasive and allows the observation of neutrophil trafficking into all the organs of the mouse 
at different time points. Moreover, it is probable that the increased sensitivity of this system 
would allow lower numbers of mRPMNs to be used. For the above reasons, this adoptive 
transfer methodology will be pursued in the future using this alternative technology. 
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CHAPTER 5 
THE EFFECT OF SHEAR STRESS AND 
NITRIC OXIDE ON NEUTROPHIL 
RECRUITMENT AND REVERSE MIGRATION 
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5.1 Introduction 
There is a large variation in the phenotype and properties of endothelial cells 
throughout the vascular tree and in different organs. These differences are seen in EC 
morphology, permeability, secretory potential and gene expression patterns (Aird, 2003; Aird, 
2007; Chi et al., 2003). Variation can also be seen in the ability of ECs to recruit leukocytes. 
For example, under physiological conditions, ECs lining the high endothelial venules (HEV) 
of secondary lymphoid tissue have the ability to constantly recruit circulating lymphocytes. In 
contrast, ECs in the post-capillary venules near a site of inflammation only recruit leukocytes 
to sites of inflammation after being activated, by inflammatory mediators such as cytokines 
(Nash et al., 2004).  
 
There is increasing evidence that EC phenotype is conditioned by the haemodynamic 
environment, such that shear forces acting upon EC can convey important regulatory signals 
important for determining phenotype. The (bio)chemical and cellular environment also 
appears to play a critical role in this process (Nash et al., 2004). Thus, the physicochemical 
environment can affect the sensitivity of ECs to inflammatory cytokines and therefore their 
ability to recruit leukocytes (Nash et al., 2004). For example, it has been demonstrated that 
leukocyte recruitment by HUVEC in response to TNF-α, is inversely related to wall shear 
stress at which they had been conditioned for 24h (Sheikh et al., 2003; Sheikh et al., 2005) . 
Leukocyte recruitment occurs at sites with low wall shear stress (Atherton and Born, 1972). 
Leukocytes are recruited to ECs lining the post-capillary venules, but not to those in their 
adjacent arterioles, where the wall shear stress is higher. In addition, leukocyte recruitment 
may take place in sites through the vascular tree, where the flow has been disturbed (Caro et 
al., 1971). It appears that disturbance in flow may facilitate leukocyte recruitment or increase 
                                                                                                                  CHAPTER 5 
 
144 
 
ECs sensitivity to cytokines (Nash et al., 2004). Thus, ECs covering atheromatous plaques, 
which occur at areas of low average shear stress, express P-selectin and VCAM-1 in contrast 
to adjacent vessel segments exposed to high shear laminar flow (Davies et al., 1993; Johnson-
Tidey et al., 1994). In addition, signalling responses and activation induced by TNF-α are 
modified in ECs previously cultured under flow for short or prolonged periods (Surapisitchat 
et al., 2001). In our own group Sheikh et al showed a graded loss of response of EC to TNF-α 
when the cells were activated after conditioning for 24 hours at increasing wall shear stress 
(Sheikh et al., 2004; Sheikh et al., 2003). In contrast, under static conditions there was 
abundant adhesion and migration of flowing neutrophils. At intermediate shear stress (0.3Pa), 
levels of adhesion were unaffected but migration was significantly less efficient. At high 
shear stress (2.0 Pa) neutrophils were not even recruited from flow. These authors showed 
that loss of IL-8 and E-selectin gene expression was responsible for the reduction in 
neutrophil recruitment.  
 
It is also worthy to note that ECs also respond rapidly to changes in wall shear stress 
by regulating a series of genes (Chen et al., 2001; McCormick et al., 2001; Nagel et al., 1994; 
Passerini et al., 2003; Sampath et al., 1995; Walpola et al., 1995). It has been demonstrated 
that shear stress activates a variety of regulatory molecules, such as the membrane K+ channel 
(Olesen et al., 1988), G proteins (Gudi et al., 1996), intracellular Ca2+ (Ando et al., 1988), 
cGMP (Ohno et al., 1993), mitogen-activated protein kinases (MAPKs, such as ERKs and 
JNKs) (Li et al., 1996; Tseng et al., 1995), small GTPases (Ras) (Li et al., 1996) and focal 
adhesion proteins (FAKs) (Li et al., 1997; Li et al., 1996). After the trigger of MAPK and 
FAK signaling cascades, a number of transcription factors such as AP-1, NF-κB (Davis et al., 
2004; Lan et al., 1994), Sp-1, and Egr-1 (Khachigian et al., 1997) are activated. These factors 
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induce transcription genes involved in the growth, adhesion, vasoactivation and monocyte 
attraction in endothelial cells (Chien et al., 1998). Shear stress is also believed to be one of the 
most potent inducers of nitric oxide (NO) production (Li et al., 2004). 
 
NO is a biologically active compound with many functions, such as vasodilation 
through vascular smooth muscle relaxation, inhibition of platelet aggregation, 
neurotransmission and immune regulation (Ignarro et al., 1987). NO activates guanylate 
cyclase generating cyclic guanosine monophosphate (cGMP) that acts as an intracellular 
second messenger (Murad, 1999). Endogenous NO is produced during the generation of L-
citruline from L-arginine. This reaction is catalysed by nitric oxide synthases (NOS). There 
are three mammalian NOS isoforms: the neuronal (nNOS or NOS-I), inducible (iNOS or 
NOS-II) and the endothelial (eNOS or NOS-III). nNOS and eNOS are constitutively 
expressed in healthy tissue, Ca2+ dependent and produce relatively small amounts of NO. In 
contrast, iNOS is inducible in a variety of cell types (ΝΚ cells, DCs, mast cells, monocytes, 
macrophages, eosinophils and neutrophils) upon inflammation and Ca2+ independent 
(Alderton et al., 2001). Inducible NOS in activated macrophages produces relatively large 
amounts of NO that acts as a cytotoxic agent against microorganisms and tumor cells (Bogdan 
et al., 2000; Nathan and Shiloh, 2000; Pervin et al., 2001; Stuehr and Nathan, 1989; Xie et 
al., 1996). There is also a direct link between NOS impairment and endothelial dysfunction in 
cardiovascular diseases such as atherosclerosis. Under oxidative stress, eNOS enzymology 
changes by producing more peroxynitrite (ONOO-) and finally O2- contributing further to 
endothelial dysfunction (Beckman et al., 1990; Ischiropoulos and Al-Mehdi, 1995; Wever et 
al., 1998). 
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One of NO major functions is the regulation of interactions of circulating leukocytes 
and platelets with the vessel wall. There is evidence that NO may effect the leukocyte ability 
to adhere to microvascular endothelium (Kubes et al., 1991; Tsao et al., 1996). Endothelial 
NOS inhibitors, such as L-NAME, were able to increase neutrophil adhesion 15 times (Kubes 
et al., 1991). In mesenteric post-capillary venules of mice lacking eNOS or nNOS, the levels 
of rolling and overall adherent leukocytes significantly increased, even in the absence of any 
inflammatory stimulus. Interestingly, in an acetic acid induced model of acute colitis, iNOS 
deficient mice exhibited increased neutrophil infiltration and impaired ability to resolve 
inflammation (McCafferty et al., 1997). Similar observations were made after LPS 
administration in cremasteric postcapillary and liver post sinusoidal venules, as well in the 
lungs, of iNOS deficient mice. These data indicate that, in the mouse at least, iNOS–produced 
NO may play a homeostatic regulatory role in inflammation (Hickey et al., 2001). NO has 
been shown to inhibit platelet aggregation and secretion in vitro (Stamler et al., 1989). When 
platelets were treated with  L-NAME, platelet aggregation increased (Freedman et al., 1997) . 
It has also been shown that NO could inhibit platelet adhesion to endothelial monolayers 
(Radomski et al., 1987). In some experiments with L-NAME treated ECs, there was a marked 
increase in platelet adhesion on them. In contrast, when exogenous NO was added to the 
cultures under flow this was inhibited (de Graaf et al., 1992).  This NO-induced inhibition of 
platelet activation is a result of the subsequent increase of cyclic nucleotides cAMP levels 
(Radomski et al., 1987; Wang et al., 1998). 
 
The above effects of NO on leukocyte recruitment can be associated with shear stress, 
as the latter induces the synthesis of the former. The role of shear stress in NO production has 
been extensively investigated. In vitro studies, using flow channels and stretch apparatus have 
                                                                                                                  CHAPTER 5 
 
147 
 
demonstrated that ECs under shear stress or mechanical strain respond by increasing their 
eNOS mRNA levels and NO production (Kuchan et al., 1994; Ranjan et al., 1995; Uematsu et 
al., 1995). In another study it was found that laminar flow could induce NO synthesis by 
HUVECs, which was dependent on shear stress levels, yet turbulent flow did not have the 
same effect (Noris et al., 1995). It has been demonstrated that, at a molecular level, laminar 
shear stress increases NF-κΒ subunits p50/p65 binding to shear stress response element 
(SSRE) on eNOS promoter, and subsequently the transcription of the enzyme (Davis et al., 
2004). In the same study, it was shown that mutation of the SSRE dramatically impaired 
eNOS promoter activity, otherwise induced by shear stress.  
 
 The molecular mechanisms supporting the reverse migration of neutrophils are 
unknown. In this chapter, we examined the effect of shear stress on the ability of EC 
monolayers to retain transmigrated neutrophils. As shear stress induces the production of NO 
production (Kuchan et al., 1994; Ranjan et al., 1995; Uematsu et al., 1995) and NO has been 
shown to regulate neutrophil recruitment (Hickey et al., 2001; Kubes et al., 1991; Lefer et al., 
1999), we addressed the question whether this shear stress effect on reverse migration was 
mediated via NO production. We used a NO donor, diethylamine NONOate (DEANO) and a 
NOS inhibitor (L-NAME) to study the effect of NO in neutrophil recruitment and reverse 
migration under the absence of shear stress. 
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5.2 Methods 
5.2.1 Flow based adhesion assays 
Prolonged duration flow assays (up to 45 minutes) were performed. Three microslides 
were seeded with HUVEC. Upon confluence, monolayers in two of them were stimulated 
with TNF-α (100U/ml) and IL-1β (0.5ng/ml) for 4 hours, while the other was untreated to 
serve as control. In the meantime, human neutrophils were isolated from whole blood, as 
previously described in chapter 2 and resuspended at a final concentration of 2x106 cells/ml. 
After 4 hours, the microslides were incorporated in a flow assay system. The shear stress was 
set at 0.05 Pa. HUVEC monolayers were initially perfused with PBSA and next with 
neutrophil suspension for 4 minutes, followed by a washout with PBSA. In one of the two 
microslides with cytokine stimulated HUVEC, the flow was turned off after 8 minutes, 
simulating static conditions from that time point onwards. Recordings were made every 10 
minutes in all microslides and the total numbers of adherent and transmigrated neutrophils 
were determined.  
 
5.2.2 Assessment of the effect of continuous shear stress on reverse transmigration rate 
HUVEC monolayers in microslides were stimulated with 100U/ml TNF-α and 
0.5ng/ml IL-1β for 4 hours. After the 4-hour incubation, all the microslides were rinsed with 
PBSA to remove any excess cytokines. At this time point approximately 2x105 neutrophils in 
M199/BSA were added to each microslide. This neutrophil concentration was chosen to yield 
a neutrophil/EC ratio of 6:1, in accordance with concentrations used in other static assays 
(Butler et al., 2005). The microslides were then placed in an incubator at 37oC for 25 minutes, 
sufficient time to complete transmigration. The microslides were rinsed with PBSA to remove 
non-adherent neutrophils. As control, one microslide was fixed with 2% paraformaldehyde 
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(PFA) straight after the washout. One microslide was placed in the incubator for at 37oC for 1 
hour, while another was attached to a glass dish in a continuous flow system (0.05 Pa) at 37oC 
for the same time period. At the end of that time, these were washed and fixed with 2% PFA 
(Figure 5.1). The microslides were glued onto microscope slides, mounted onto a microscope 
stage and observed by phase contrast videomicroscopy. Ten random fields along the centre 
line of each microslide were recorded and analysed off-line. The total number of adherent 
cells was determined and expressed as cells/mm2. 
 
In some experiments the incubation time in static and under flow conditions was 2 or 4 
hours. In some other experiments, monoclonal blocking antibodies against CD31, CD99, 
JAM-C and VE-cadherin (10μg/ml) were introduced to the co-cultures in microslides for 15 
minutes prior their incorporation to a flow system (Figure 5.2).  
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a)
 
Figure 5.1 Diagram representing the different experimental conditions of the 
experiment 
Approximately 2x105 neutrophils in M199/BSA were added to each microslide, subsequently 
placed inside an incubator at 37oC for 25 minutes. (a) one microslide was fixed with 2% PFA, 
as control, (b) a second was placed in the incubator for 1 hour at 37oC and (c) a third was 
attached to a glass dish in a continuous flow system (0.05 Pa) at 37oC for the same time 
period. At the end of that time, the microslides were washed and fixed with 2% PFA and the 
number of transmigrated neutrophils was determined. 
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Figure 5.2 Diagram representing the experimental procedure using blocking antibodies 
Approximately 2x105 neutrophils in M199/BSA were added to each microslide, subsequently 
placed inside an incubator at 37oC for 25 minutes. After washout the co-cultures were treated 
with monoclonal blocking antibodies against CD31, CD99, JAM-C or VE-cadherin (10μg/ml) 
for 15 minutes and then they were connected to a flow system. 
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5.2.3 Assessment of the effect of NO donor/inhibitor on neutrophil recruitment and 
reverse migration in static conditions 
For neutrophil recruitment studies, HUVEC monolayers in a 12-well plate were 
stimulated with 100U/ml of TNF-α for 4 hours, except for one well which was used as 
unstimulated control. Neutrophils, after being isolated from whole blood, were resuspended in 
1.5ml of M199/BSA at a final concentration of 1x106 cells/ml. At the end of the 4-hour 
HUVEC stimulation with TNF-α, the monolayers in all wells were washed with M199/BSA 
to remove any residual cytokine. 
 
A HUVEC monolayer in one well was incubated with L-NAME (100 μM) at 370C, for 
30 minutes (neutrophils added to that well were also treated with L-NAME for the same 
time). Static assays were performed, adapted from Butler et al, 2005. Next, 1.5ml of the 
neutrophil suspension was added to each well. In one case, neutrophils added to one well were 
previously incubated with DEANO, at 37oC, for 30 minutes. 
 
Neutrophils in each well were allowed to settle for 5 minutes and then non-adherent 
neutrophils were removed by a gentle wash, with M199/BSA. Video recording of 10 random 
fields were taken between the 7th and 9th minute and between the 24th and 26th minute. The 
numbers of adherent and transmigrated neutrophils, at each time point, were determined by 
off-line analysis, and expressed as cells/mm2. 
 
For reverse migration studies, HUVEC monolayers in a 12-well plate were stimulated 
with 100U/ml of TNF-α for 4 hours, except for one used as untreated control. After that time, 
monolayers were washed with M199/BSA and 1.5ml of neutrophil suspension (1 x 106 cells 
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in M199/BSA) was added to each well for 30 minutes. After three washes, complete HUVEC 
medium was re-introduced to each well. In one well, medium was supplemented with 
DEANO, while another with L-NAME (both 100μM). Video recordings of 10 random fields 
were taken at that time point. The plate was placed inside an incubator, at 37oC, 5% CO2, for 
2 hours, with changes in the medium every hour. The numbers of transmigrated neutrophils at 
each time point were counted by off-line analysis. The reduction in the number of 
transmigrated neutrophils, at 2 hours, compared to 0 hours, was calculated, and this difference 
was expressed as the percentage of once transmigrated neutrophils that had reverse migrated 
by the end of the experiment. 
 
5.3 Results 
5.3.1 The effect of constant shear stress on human neutrophil transmigration and 
reverse transmigration  
Prolonged flow assays were performed on TNF-α and IL-1β stimulated HUVEC 
monolayers, as previously described, in order to directly compare transmigration after brief or 
continuous exposure to shear stress. Very few neutrophils adhered to unstimulated HUVEC 
monolayers. There was no marked difference in neutrophil adhesion after brief or continuous 
exposure to flow (Figure 5.3A). On EC stimulated with cytokines adhesion levels were above 
1000 cells/mm2/106 cells perfused and remained stable over time in both conditions. The 
number of adherent neutrophils was slightly higher in the short than in the continuous 
exposure to flow. However, this result could probably be attributed to the fact that rolling and 
non-firmly adherent neutrophils could no longer be washed away after the flow had been 
turned off. Therefore, the numbers of those cells (that otherwise would have been washed) 
were included in the total number of neutrophils adherent to HUVEC.  
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When comparing the patterns of transmigration between brief and continuous exposure 
to shear stress we saw significant differences (Figure 5.3B). Approximately 75% of adherent 
neutrophils had transmigrated by 25 minutes, in both conditions. However, while 
transmigration was stable over time in continuous flow, it gradually decreased to 50% in the 
absence of flow. The ‘disappearance’ of transmigrated neutrophils was a result of their 
reverse transmigration, as confirmed by direct observation under phase-contrast microscopy. 
The phase dark transmigrated neutrophils started reverse transmigrating back across the 
endothelial cell monolayer after 25 minutes and re-emerging on the top of HUVEC 
monolayer, as phase bright cells. 
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Figure 5.3 Effect of continuous shear stress on neutrophil adhesion and transmigration 
(A) ANOVA showed a significant effect of these three conditions (P<0.001) on adhesion 
levels. Bonferonni’s Multiple comparison test showed a significant difference between 45- 
minute flow on adhesion and the 8-minute flow condition (P<0.05). (B) The effect of flow on 
the percentage of transmigration. ANOVA showed a significant effect on transmigration 
between 45-minute flow and 8-minute flow (p<0.001). Bonferonni’s Multiple comparison test 
showed a significant difference between 45-minute flow on adhesion and the 8-minute flow 
condition (P<0.01). All data are the mean+SEM of three experiments. 
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The difference in the patterns of transmigration between brief and continuous exposure 
to flow led us to the question whether continuous flow was able to retain transmigrated 
neutrophils underneath the monolayer, not allowing them to reverse transmigrate. To address 
this we tracked migration and transmigration over 1, 2 and 4 hours of continuous flow 
(compared to static controls). The number of transmigrated neutrophils in the 25-minute static 
control was 1200-1500 cells/mm2.  
 
After 1 hour of continuous flow, we found no significant reduction in the number of 
transmigrated neutrophils, compared to 65% reduction, in the absence of flow (Figure 5.4).  
After 2 hours of continuous flow there was a significant drop of 25% in the number 
transmigrated neutrophils, however nearly twice this number were lost form beneath the 
monolayer, under static conditions. The same pattern was observed after 4 hours, but this time 
there was a more dramatic decrease in transmigration levels both in the presence or absence of 
flow (Figure 5.5). Ultimately, the presence of continuous flow could not inhibit the reverse 
migration of neutrophils, but it did significantly delay the process. 
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Figure 5.4 The effect of 1h incubation under flow or static conditions on adhesion and 
transmigration levels of neutrophils 
(A) The levels of neutrophil adhesion significantly decreased after 1 hour incubation in static 
condition. In contrast, there was a slight decrease in adhesion levels under flow after 1h. 
There was a significant effect of experimental conditions on adhesion (P<0.001, by 
ANOVA).*, P<0.05, by Students’t-test. (B) Similarly, the levels of transmigration 
significantly decreased after 1 h incubation in static condition. There was a significant effect 
of experimental conditions on adhesion (P<0.001, by ANOVA). There was significant 
difference between static control and 1 hour incubation condition (***, P<0.001, by 
Students’t-test). All data are the mean+SEM of four different experiments. 
 
                                                                                                                  CHAPTER 5 
 
158 
 
 
untreated static control static flow static flow
0
1000
2000
3000
2 hours 4 hours
*
***               ******A
dh
er
en
t
ne
ut
ro
ph
ils
/m
m
2
untreated static control static flow static flow
0
50
100
2 hours 4 hours
**
***
***
*
Conditions
No
rm
al
iz
ed
tra
ns
m
ig
ra
tio
n
(%
 o
f s
ta
tic
 c
on
tro
l)
A
B
 
Figure 5.5 The effect of presence and absence of flow on neutrophil adhesion and 
transmigration 
 (A) The effect of presence and absence of flow on neutrophil adhesion. There was a 
significant effect of experimental conditions on adhesion (P<0.001, by ANOVA). *, P<0.05, 
***, P<0.001, by Bonferroni's Multiple Comparison Test. (B) The effect of flow and static 
conditions in transmigration. Similarly, ANOVA showed that the effect of the presence of 
flow on transmigration is significant (P<0.001).*, P<0.05, **, P<0.01 and ***P< 0.001, by 
Bonferroni's Multiple Comparison Test. All data are the mean+SEM of four different 
experiments. 
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The previous findings showed that flow could retain the neutrophils underneath the 
endothelium for up to 1 hour, preventing them from reverse migration. The hypothesis we had 
to test here was whether blocking important molecules for transmigration could impair the 
inhibitory effect of continuous flow on reverse migration. A number of monoclonal antibodies 
that could block adhesion molecules, such as CD31, CD99, JAM-C and VE-cadherin, were 
used in order to study their role in reverse transmigration. Data was presented normalized 
transmigration compared to the 1 hour flow control. 
 
 Blocking of CD31 or JAM-C resulted only in a detectable decrease in transmigration, 
compared to their isotypes and 1 hour control. Blocking CD99 or VE-cadherin led to a greater 
reduction in transmigration, but it was not statistically significant. Overall, blocking of these 
molecules could not increase the numbers of reverse transmigrated neutrophils. 
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Figure 5.6 The effect of blocking antibodies on transmigration levels 
Blockade of important adhesion molecules did not have an effect on reverse transmigration. 
All data are the mean+SEM of three different experiments. 
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5.3.2 The effect of NO donor/inhibitor treatment on human neutrophil recruitment and 
reverse transmigration 
Static assays were performed in order to investigate the effect of NO on neutrophil 
recruitment. For this purpose, DEANO as NO donor and L-NAME as NO synthase (eNOS) 
inhibitor were used. Figure 5.7 shows adhesion levels and percentage of transmigrated 
neutrophils at 7 and 24 minutes. Neutrophils did not adhere to unstimulated HUVEC. In 
HUVEC stimulated with cytokines, treatment with L-NAME resulted in slightly lower 
adhesion levels at 7 minutes, compared to control, but ultimately it reached similar levels by 
24 minutes. In contrast, neutrophil incubation with DEANO led to significantly lower 
adhesion at 7 minutes, compared to control. Despite the fact adhesion increased over time, it 
did not reach control adhesion levels (Figure 5.7A). 
 
Transmigration patterns in various conditions were similar to the ones of adhesion. 
HUVEC treatment with L-NAME showed a slightly lower percentage of transmigrated 
neutrophils, at 7 and 24 minutes compared to control. Neutrophil incubation with DEANO 
showed that only 40.1±23% of adherent neutrophils had transmigrated by 7 minutes, 
compared to 75% of control. Transmigration did not further increase in all conditions (Figure 
5.7B). 
 
Static assays were also conducted in order to examine the effect of NO on reverse 
migration of neutrophils. After establishing a population of transmigrated neutrophils, the co-
cultures were incubated with DEANO or L-NAME, for 2 hours. Transmigrated neutrophils 
were counted at 0 and 2 hours, and results were presented as the % of reduction in their 
numbers at 2 hours. This reduction represents the reverse migration of neutrophils. Treatment 
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with L-NAME did not change the percentage of reverse migrated neutrophils. Interestingly, 
incubation with DEANO resulted in lower levels of reverse transmigration, compared to 
control (Figure 5.8).    
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Figure 5.7 Effect of DEANO and L-NAME treatment on neutrophil adhesion and 
transmigration at 7 and 24 minutes of static culture 
All data are the mean+SEM of three different experiments, except for L-NAME, where n=2. 
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Figure 5.8 Effect of DEANO and L-NAME on neutrophil reverse migration 
Treatment of co-cultures with DEANO decreased reverse migration. All data are the 
mean+SEM of two different experiments. 
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5.4 Discussion 
 There is increasing evidence that EC phenotype and the behaviour on leukocytes can 
be conditioned by the physicochemical environment, including wall shear stress (Nash et al., 
2004). For example, a number of studies have investigated the role of wall shear stress on the 
responses of endothelial cells to cytokine stimulation and subsequent leukocyte adhesion and 
transmigration (Sheikh et al., 2004; Sheikh et al., 2003). In this chapter, we examined 
whether wall shear stress could modulate the migration, but more importantly the reverse 
migration of neutrophils, a process that might be dependent upon shear sensing by endothelial 
cells, neutrophils or both cell types. Firstly, we showed that flow generated wall shear stress is 
not required for neutrophil transmigration in the HUVEC system when driven by TNF-α 
stimulation. These findings are in accordance with previous studies in static cultures using 
neutrophils (Butler et al., 2005). Moreover, in our assay, transmigration could take place 
minutes after the flow had been turned off in prolonged flow-based adhesion assays. Previous 
studies have shown that the presence of shear stress did not lead to any increase in adhesion or 
transmigration of neutrophils, but resulted in faster kinetics of transmigration compared to 
static conditions (Kitayama et al., 2000). Others claim that T cell transmigration requires 
shear flow (Cinamon et al., 2001). Studies from our own group using peripheral blood 
lymphocytes demonstrate no such dependence upon flow generated shear forces (McGettrick 
et al., 2009). Interestingly, shear stress has been found to direct the migration of activated 
neutrophils on the surface of platelet monolayers and on the surface of endothelial cells. 
Neutrophils used αvβ3 integrin and CD31 as mechanotransductors and moved preferentially in 
the direction of flow (Rainger et al., 1999). However, these signals did not translate into more 
effective transmigration on an EC monolayer.  
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Many studies have shown effects of acute or prolonged changes in wall shear stress on 
endothelial cell phenotype. Of particular relevance here, our own group has shown that 
conditioning endothelial cells at increasing wall shear stress reduces their ability to respond to 
TNF-α and recruit neutrophils (Sheikh et al., 2004; Sheikh et al., 2003). However, nothing is 
known about whether wall shear stress is able to modify the long-term fate of the recruited 
neutrophils. For this reason, we investigated the fate of transmigrated neutrophils under 
different regimens of static or constant flow. In the presence of continuous flow, 
transmigration remained stable over a short period of time (1h). This was in contrast to 
neutrophil behaviour under static conditions where as quickly as 15 minutes after 
transmigration the process of reverse migration was evident. This is in agreement with a 
previous study from our group which remains the only published description of neutrophil 
reverse migration in a human system (Buckley et al., 2006). When we extended the period of 
flow out to 4 hours we found that the process of reverse migration was retarded but not 
inhibited. One possible explanation for this finding is the fact that under static conditions IL-8 
(or other neutrophil chemotactic agents) generated by ECs accumulates in the medium and are 
able to attract neutrophils from beneath the endothelial cell monolayer (Huber et al., 1991). 
This hypothesis is readily tested in our assays by adding exogenous agents to the medium 
(Luu et al., 2000). These experiments have not been done, but would represent an obvious 
line of experimental progression. 
 
An alternative hypothesis is that continuous shear stress is able to tighten EC junctions. 
However, when assays were performed using antibodies that inhibit the function of junctional 
molecules, a process that should permit accelerated reverse migration in the context of the 
prevailing hypothesis, we found no consistent effects. We chose targets that have previously 
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been reported to regulate EC permeability (CD31, JAM-C ,CD99 and VE-cadherin) (Muller, 
2003), so to date it would appear that there is no evidence that changes in the integrity of EC 
junctions plays a major role in retaining neutrophils in the sub-endothelial cell environment. 
This is perhaps surprising considering that regulation of EC junctional integrity via 
modulation of VE-cadherin plays a role during neutrophil transmigration by forming transient 
gap in cell junctions (Alcaide et al., 2009).  
 
As one endothelial cell response to shear stress is increased formation of nitric oxide 
(Li et al., 2004), and as nitric oxide has been shown to regulate neutrophil recruitment 
(Hickey et al., 2001; Kubes et al., 1991; Lefer et al., 1999), we tested the hypothesis that flow 
generated NO could regulate reverse migration. In the presence of a NO donor (DEANO) we 
found reduced levels of neutrophil adhesion, transmigration and reverse transmigration. The 
reduction in neutrophil recruitment by NO is in accordance with previous studies that have 
shown that NO may effect neutrophils ability to adhere to microvascular endothelium. 
Interestingly, in our experiments an inhibitor of eNOS did not have an effect on neutrophil 
transmigration. Again this in accordance with the studies of Kubes et al., who showed that 
neutrophil recruitment in eNOS and iNOS knockout mice was predominantly regulated by the 
latter with little contribution from the former (Hickey et al., 2001).  
 
In conclusion, shear stress could retard the process of reverse migration. Testing our 
hypothesis we found that indeed NO partially impairs neutrophil transmigration and reverse 
migration. Therefore, we could attribute shear stress effect on neutrophil transmigration and 
reverse migration to NO production. Our findings indicate that NO contributes to the 
mechanism, which shear stress acts upon endothelium, but this should be further investigated. 
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INVESTIGATION OF THE DISTINCT 
PROTEIN PROFILE OF REVERSE MIGRATED 
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6.1. Introduction 
As examined in Chapter 4, human reverse migrated neutrophils (RPMNs) exhibit an 
altered phenotype, compared to naïve circulating neutrophils. According to Buckley et al., 
(2006) these cells are morphologically more rigid than the naïve, can be functionally primed 
and exhibit a distinct surface phenotype compared to naïve circulating cells, naïve activated 
neutrophils and tissue resident neutrophils. We were interested in examining the changes in 
the RPMNs phenotype at a proteomic level. 
 
Two-dimensional (2D) gel electrophoresis is a powerful tool for studying protein 
expression. In 2D electrophoresis, proteins are separated according to their charge in the first 
dimension, by isoelectric focusing (IEF) and their size in the second dimension by SDS-
PAGE. Traditional 2D gel electrophoresis is both time and effort-consuming (Alban and Olu, 
2003). Moreover, variation between the gels makes it difficult to attribute any changes in 
protein expression to induced biological change and not the system variation. To address this 
problem, 2D fluorescence difference gel (DIGE) analysis technology has been developed 
(Marouga et al., 2005). 
 
2D difference gel electrophoresis (DIGE) enables the separation of more than one 
sample in a single 2D polyacrylamide gel, enabling to run multiple samples on the same 2D 
gel. In this way, the sensitivity and accuracy of the method is improved. The protein samples 
are labelled with up to three CyDye DIGE fluorescent dyes prior to electrophoresis. The 
CyDye DIGE fluor minimal dyes (Cy2, Cy3, and Cy5) are charge and size matched and label 
only 3–5% of the total protein present in each sample. The properties of the dyes ensure the 
high linearity and sensitivity for accurate protein quantitation. Another major advantage of 
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this methodology is the presence of an internal standard which significantly reduces the 
system variation. The internal standard is prepared by pooling equal amounts of protein from 
each biological sample in the experiment and it is usually labelled with Cy2. In this way, each 
protein from all samples is represented in the internal standard (Marouga et al., 2005). The 
internal standard and all the other labelled samples are mixed and run on the same 2D gel. 
The different protein extracts labelled with different CyDye DIGE fluors can be visualized 
separately by different excitation profiles. Digital images of each sample in each dye are 
generated and analysed with DeCyder software (GE Healthcare, Uppsala, Sweden). The 
presence of a common internal standard as a reference sample in every gel enables the inter-
gel analysis. Each sample within a gel can be normalized to the internal standard present on 
that gel. This allows the abundance of each protein spot in a biological sample to be measured 
as a ratio to its corresponding spot present in the internal standard, ensuring the accurate 
quantitation and spot statistics between gels. Moreover, biological variation can be 
distinguished from experimental variation (Marouga et al., 2005). 
 
The DeCyder differential analysis software (GE Healthcare, Uppsala, Sweden) is fully 
automated image analysis software for spot detection and accurate measurement of protein 
differences with statistical confidence.  Images, after being loaded to the programme, are 
analysed with Differential in-gel analysis (DIA). The DeCyder DIA module processes the 
images from a single gel and performs background subtraction, detection, quantitation and in-
gel normalization. The spots are then detected, using a co-detection algorithm. Spot volumes 
in each image are quantified in the DIA module and these are expressed as a ratio, between 
the spot volumes on the sample image and the corresponding spot volumes from the internal 
standard image. With this ratio, inter-gel protein abundance comparisons can be done. When 
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spot detection and quantitation of a single gel has been performed, analysis continues in BVA 
(biological variation analysis) module, where multiple images from different gels are matched 
(gel-to-gel matching) on pooled internal standard images only, making it possible to generate 
statistical data and thus comparing the different protein abundance levels between multiple 
groups. The presence of the same pooled internal standard on every gel enables accurate 
normalization of the individual experimental samples and therefore it reduces gel-to-gel and 
software analysis variation (From GE Healthcare).  
 
Using DeCyder analysis software, the spots of interest are identified. The next step is 
the making of preparative gels where the correspondent gel plugs can be picked from to be 
further analysed for mass spectrometry. After protein identification is the verification of 
previous findings with Western blotting, as it represents an alternative method to measure 
protein abundance differences. 
 
In this chapter, the protein expression profile of RPMNs was compared with those of 
four other control groups which represent a different level of neutrophil interaction with the 
EC. These were: 1) fresh neutrophils, 2) adherent neutrophils, 3) transmigrated neutrophils 
(TPMNs) and 4) neutrophils in culture for the same period with the experiment (4h control). 
Our hypothesis was that RPMNs are a distinct group with a series of proteins specifically 
regulated. 
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6.2. Methods 
Experimental design 
The protein lysates were prepared from 4 different experiments. The protein 
concentration of the samples was determined and the samples were labeled with CyDyes. 
Then, first and second electrophoresis were performed and the gels were scanned. The gel 
images were analysed with DeCyder software and the proteins of interest were determined. 
Preparative gels were made and the excised gel plugs of the proteins of interest were analysed 
by mass spectrometry for protein identification. The whole workflow is shown in Figure 6.1. 
After the preparation of protein lysates, the methodology used is described in the general 
methodology chapter  (section 2.8-10). 
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Figure 6.1 Analytical workflow in 2D-DIGE methodology (adapted from GE 
Healthcare) 
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Neutrophil isolation 
Whole blood was isolated from healthy donors and transferred into 50ml tubes, each 
containing 10% of sodium citrate as anticoagulant. 10ml of PBS was added per 25ml of whole 
blood and was gently mixed. Then 15ml of Ficoll-paque was introduced with a T-needle to 
the bottom of the tube. The blood was centrifuged at 800g for 20 minutes. After plasma and 
the monocyte fraction being removed, 40ml of an isotonic ice-cold NH4Cl solution was added 
to lyse the red cells. The mixture was left on ice for 15 minutes, followed by a 7-minute 
centrifugation at 400g at 4o C. After two washes, neutrophils were incubated in a recovery 
buffer containing 5% human serum albumin in RPMI for 30 minutes at 37oC. 
 
Experimental groups 
We aimed to include in our study as many control groups as possible. However, for 
practical reasons we had to conduct two series of 2-D DIGE experiments. In the first, protein 
lysates from RPMNs were compared to three other control groups (fresh, adherent, 4-hour 
control). In the second, transmigrated neutrophils (TPMNs) were compared to fresh. 
Below the experimental groups are described, as shown in Figure 6.2: 
1) Fresh neutrophils: 10x106 neutrophils, resuspended in recovery medium, are 
centrifuged at 400g and washed once in PBS.  
2) Adherent: 20x106 neutrophils in M199/BSA were added into a 75 cm2 flask with 
HUVEC, previously stimulated with 100U/ml TNF-α for 4 hours. The co-culture was kept for 
1 hour at 37oC. Next, the flasks were shaken and washed with M199/BSA and all the phase 
bright non-transmigrated neutrophils were collected. These cells were washed once in PBS. 
3) RPMNs: This group represents transmigrated neutrophils that remained in co-
culture with HUVEC (in complete medium) for 4 hours. A proportion of these cells had 
                                                                                                                  CHAPTER 6 
 
175 
 
reverse migrated by the end of this period. RPMNs were collected after 4 hours and 
centrifuged at 400g for 5 minutes. 
4) 4-hour control: Neutrophils incubated in pre-conditioned medium for 4 hours in 
contact with extracellular matrix. In detail, HUVEC in a 75cm2 flask were stimulated with 
TNF-α for 4 hours. After a wash, complete medium was introduced to the flask. After 2 hours, 
the pre-conditioned medium was collected. At the same time, the HUVEC monolayer was 
lysed using pre-heated to 37oC PBS containing 0.5% Triton X-100 (v/v) and 20mM NH4OH. 
The cell lysis was observed under a phase contrast microscope and after 5 washes with 4ml of 
PBS the extracellular matrix was exposed. Fresh neutrophils were resuspended in the pre-
conditioned medium and transferred to that flash, where they remained for 4 hours in culture. 
5) TPMNs: HUVEC were cultured for 4 days on Transwell filters and subsequently 
stimulated with 100U/ml TNF-α for 4 hours. Νeutrophils in M199/BSA were added to the 
filters, allowed to settle, adhere to, and finally transmigrate through HUVEC monolayers for 4 
hours. After that time, neutrophils that have transmigrated though the filters were collected 
from the bottom of the well. 
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Figure 6.2 The experimental groups in this proteomic study 
RPMNs were compared with four other control groups. These were: 1) fresh neutrophils, 2) 
adherent neutrophils (non-transmigrated neutrophils), 3) neutrophils in culture for the same 
period with the experiment (4h control) and 4) transmigrated neutrophils (TPMNs). 
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6.3 Results 
6.3.1 Identification of differentially regulated protein spots by biological variance 
analysis 
Protein samples from the four groups were labelled with CyDyes and separated by 2D-
DIGE in four individual experiments. Gel images were acquired and analysed with DeCyder 
7.0. Differential in-gel analysis (DIA) identified 1000-1500 protein spots, using a volume 
filter exclusion of 10000. 
 
Performing statistical analysis in the BVA we identified the protein spots that were 
differentially expressed between the groups. In RPMNs, 13 protein spots were differentially 
expressed, compared to fresh neutrophils. Similarly, 10 spots were differentially expressed in 
RPMNs, compared to adherent and 4-hour control neutrophils. The differentially expressed 
proteins between these four groups were overlapped. Only two spots were differentially 
expressed only in a single group. Spot no.234 was found to be significantly differentially 
expressed between adherent neutrophils and RPMNs and spot no.838 between fresh and 
adherent neutrophils. 
 
Table 6.1 shows 12 proteins spots that have been differentially expressed in reverse 
migrated neutrophils compared to fresh. The spot graphs also demonstrate the biological 
variation between the 4 different conditions (Figures 6.3, 4 and 5). Among the 13 
differentially regulated proteins in RPMNs, 5 are down-regulated and 8 are up-regulated, 
compared to fresh neutrophils. The down-regulation of these proteins appears to be specific 
for reverse migration. In contrast, protein spot no 298 appears to be specifically up-regulated 
upon reverse migration, compared to the other conditions. 
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Table 6.1 Biological variation analysis (BVA) of differential regulated protein 
spots in reverse migrated neutrophils compared to fresh 
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Figure 6.3 Down-regulated protein spots in RPMNs 
DIGE spot maps were analysed with DeCyder 7.0. Significantly regulated spot graphs from 
BVA analysis are shown, supplemented by images of the spots on 2D gel and their 3D 
construction. Results in the spot graphs are presented as log standardized abundance. Spots no 
433, 737, 1214, 1235 and 1833 are down-regulated in RPMNs compared with fresh 
neutrophils. 
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Figure 6.4 Differentially expressed protein spots between the four groups 
DIGE spot maps were analysed with DeCyder 7.0. Significantly regulated spot graphs from 
BVA analysis are shown, supplemented by images of the spots on 2D gel and their 3D 
construction. Results in the spot graphs are presented as log standardized abundance. Spot 
no.234 was found to be significantly differentially expressed between adherent and RPMNs 
and spot no.838 between fresh and adherent neutrophils. 
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Figure 6.5 Up-regulated protein spots in RPMNs 
All the above spot graphs show that these protein spots were up-regulated in RPMNs 
neutrophils. However, it appears that only protein spot no 298 (red frame) is specifically up-
regulated in RPMNs neutrophils. 
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6.3.2 Identification of protein spots by mass spectrometry (I) 
Trypsinization and analysis by mass spectrometry resulted in the identification of less 
than half of protein of interest (Table 6.2). From the down-regulated protein group, the 
ALDH16A1 isoform of aldehyde dehydrogenase (spot no.433), transaldolase (spot no.1214) 
and non-secretory ribonuclease (spot no.1833) were identified. Non-secretary ribonuclease is 
also known as eosinophil-derived neurotoxin and is an abundant protein in eosinophils. Also, 
transaldolase and serine-threonine-protein phosphatase PP1 were detected on the same spot 
(spot no.1235). Alpha enolase (spot no.960) and CAP1 (spot no.826 and 838) were the only 
up-regulated proteins in RPMNs that have been identified.  
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6.3.3 Extended data analysis (EDA) of all the experimental groups combined 
For practical reasons, a series of 2D-DIGE experiment profiles between fresh and 
TPMNs was performed later on. Its analysis was linked to the one of the previous series of 
experiment via the Extended Data Analysis software. The combination of the two series of 
experiments introduced changes in the statistical data, as eight fresh samples were compared 
to four samples from each group (Table 6.3). Overall, the trends observed did not change 
(Figures 6.6 and 7). Also, a new protein spot that was significantly down-regulated was 
identified. This was spot no 1989 that was not included in the previous analysis, because it 
was located at the very bottom of the gel.  
 
 
Table 6.3 Extended Data Analysis (EDA) of differential regulated protein spots in 
RPMNs compared to fresh 
 
Extended data analysis combined the 5 groups together (fresh, adherent, TPMNs, RPMNs and 
4-hour control) and revealed differential regulated proteins in RPMNs neutrophils compared 
to fresh. The statistics are altered due to the fact that 8 fresh samples were compared to 4 
samples from each group. 
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Figure 6.6 Differentially expressed protein spots after all groups were combined in 
Extended Data Analysis (EDA) (i) 
Significantly down-regulated protein spots from EDA analysis are shown. Each group from 
left to right is represented by a colour. Red: fresh, purple: adherent, cyan: TPMNs, green: 
RPMNs, blue: 4h control. Results are presented as log standardized abundance. 
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Figure 6.7 Differentially expressed protein spots after all groups were combined in 
Extended Data Analysis (EDA) (ii) 
Significantly up-regulated protein spots from EDA analysis are shown. Each group from left 
to right is represented by a colour. Red: fresh, purple: adherent, cyan: TPMNs, green: 
RPMNs, blue: 4h control. Results are presented as log standardized abundance. 
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6.3.4 Identification of protein spots by mass spectrometry (II) 
In order to increase the number of identified proteins, we repeated the process and 
analysed the gel plugs with mass spectrometry in the CRUK Institute for Cancer studies at the 
University of Birmingham. This time, 7 down-regulated and 10 up-regulated protein spots 
were identified. Tables 6.4 and 6.5 show the results from mass spectrometry. Alpha-enolase, 
transaldolase, CAP1 and non-secretory ribonuclease were identified again at the same spots, 
as previously. In contrast, ALDH16A1 and serine/threonine-protein phosphatase PP1-beta 
catalytic subunit were not detected again. The mass spectrometry methodology was more 
sensitive and allowed the identification of more than one protein in a single spot. However, on 
one occasion we could not identify with confidence the neighbouring spots no 623, 628 and 
633 which were highly up-regulated in RPMNs. By mass spectrometry one peptide from each 
spot was identified as solute carrier family 12 member 7. 
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6.3.5 Principal component analysis and hierarchical clustering 
 All the experimental groups were combined in EDA. Principal component analysis 
(PCA) and hierarchical clustering of the spot maps of the differentially regulated proteins 
were performed (Figure 6.8). RPMNs showed a distinct protein expression profile compared 
to other groups. The previous observation was confirmed in hierarchical clustering (Figure 
6.9).  
 
Figure 6.8 Principal Component analysis (PCA) 
Significant differential regulated proteins were analysed with extended data analysis (EDA) 
and PCA on all spot maps was performed. Blue, red, purple, green and cyan represent 4h 
control, fresh, adherent, RPMNs and TPMNs respectively. RPMNs group (red circle) is 
distinct, compared to the other groups. 
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Figure 6.9 Hierarchical clustering of RPMNs and other control groups 
Sixteen differentially regulated proteins were used for hierarchical clustering in the EDA. 
Hierarchical clustering (up-regulation in red, down-regulation in green) revealed two groups 
of spot maps. Again, RPMNs (red line) were distinct from the control groups. 
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6.3.6 Western Blot analysis of ENO1, CAP1, PP1 and RNAse2 expression in fresh and 
RPMNs  
Western blots of ENO1, CAP1, PP1 and RNAse expression were performed as 
previously described. ENO1 expression was slightly higher in RPMNs, compared with the 
fresh. CAP1 was markedly increased in RPMNs, while PP1 expression was down-regulated 
(Figure 6.10). Our results confirmed the findings from BVA in 2D-DIGE.  
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Figure 6.10 Western Blot analysis of ENO1, CAP1, PP1 and RNAse2 expression in fresh 
and RPMNs 
Fresh and RPMNs (5x106/ml)were lysed in sample buffer and protein samples were analysed 
by Western blotting with anti-ENO1, anti-CAP1, anti-PP1, anti- RNAse2 or anti-β-actin as 
control.  Results are shown as relative expression. The experiment is representative of three 
experiments, except for RNAse2, where n=2. 
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6.4 Discussion 
In this chapter, we aimed to study the changes that take place inside human RPMNs at 
a proteomic level. The question we had to address was whether RPMNs showed a distinct 
protein expression profile compared with other control groups using 2D-DIGE methodology 
and mass spectrometry. We have identified 14 proteins that are regulated in reverse migration. 
All the down-regulated proteins showed a distinct expression profile, specific for the RPMNs. 
In contrast, only one up-regulated protein was found to exhibit a different profile from the 
other groups.  
 
The proteins identified could be classified in three categories: a) metabolic enzymes, b) 
regulatory proteins and c) cytoskeletal proteins. Transaldolase and alpha enolase belong to the 
first group. The heat shock 70 kDa protein 4, serine/threonine-protein kinase PAK 2 and Rab 
GDP dissociation inhibitor beta, 14-3-3, S100-A9 and S100-A8 are regulatory proteins. 
Vimentin, myosin-9 and adenylyl cyclase associated protein 1 (CAP1) are those associated 
with the cytoskeleton. 
 
Interestingly, changes in the expression pattern of metabolic enzymes take place in 
RPMNs. Alpha enolase (spots 960-961) is an enzyme of glycolysis, which catalyzes the 
dehydration of 2-phosphoglycerate to phosphoenolopyruvate. This enzyme consists of two 
subunits of 433 aminoacids. Each subunit has a molecular weight of 47k Da. It is a highly 
conserved enzyme that is abundantly expressed in cytoplasm (Pancholi, 2002). There is also 
surface expression of alpha enolase in stimulated immune cells (neutrophils, B and T-
lymphocytes, monocytes), epithelial, neuronal and endothelial cells (Terrier et al., 2007). Cell 
surface alpha enolase acts as a strong receptor and activator of plasminogen (Miles et al., 
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1991). Alpha enolase has been detected in the nucleus, as a Myc-binding protein (MBP-1), 
playing a role in the regulation of cell growth and differentiation (Pancholi, 2002). It is also 
found to be directly or indirectly associated in the site-specific tubule organization (Rattner et 
al., 1991). Interestingly, alpha enolase may be associated to a large number of autoimmune 
and inflammatory diseases (Rattner et al., 1991; Roozendaal et al., 1998; Terrier et al., 2007). 
Antibodies against alpha enolase have been found in the sera from patients with systemic 
rheumatic diseases (Pancholi, 2002). 
 
Transaldolase (spot 1235) is a 37.5 KDa enzyme of the pentose phosphate pathway 
(PPP). PPP provides the cell with ribose-5 phosphate for nuclear acid synthesis and NADPH 
for lipid biosynthesis. PPP comprises an oxidative and a non-oxidative phase. Transaldolase is 
a rate-limiting enzyme of PPP’s non-oxidative phase (Heinrich et al., 1976). It transfers a 3-
carbon ketol, from sedoheptulose 7-phospate to glyceraldhehyde 3-phosphate (GA3P) to form 
fructose 6-phosphate and erythrose 4-phosphate (Banki et al., 1994b). Transaldolase and 
transketolase link PPP with glycolysis (Huang et al., 2005). GA3P can enter glycolysis for 
ATP production or enter glyconeogenesis to enter PPP for NADPH production.  
 
In addition PPP maintains glutathione at a reduced state (GSH) via NADPH production 
and, thus, cellular integrity is protected from reactive oxygen intermediates (ROIs) (Banki et 
al., 1998). ROIs formation is associated with apoptosis. It has been suggested that 
transaldolase modulates glutathione levels and sensitivity to apoptosis (Banki et al., 1996). 
Reduction in transaldolase expression was found to be associated with increase in glucose 6-
phosphate dehydrogenase activities and GSH levels and inhibition of apoptosis (Banki et al., 
1996). In contrast, transaldolase up-regulation leads to an increased susceptibility to 
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apoptosis. Another study has demonstrated that transaldolase can regulate the production of 
ROI and subsequently, caspase activation and cell death, during HIV infection (Banki et al., 
1998). There is evidence that transaldolase is associated with multiple sclerosis. 
Autoantibodies against transaldolase have been found in the serum and CFS of multiple 
sclerosis patients (Banki et al., 1994a; Esposito et al., 1999). The change in the levels of 
abundance of the above metabolic enzymes may imply a change in the metabolism of 
RPMNs, especially glucose, as these cells prolong their survival. 
 
The majority or regulatory proteins were down-regulated in RPMNs. Serine/threonine-
protein kinase PAK-2 (spot 737) belongs to protein kinase superfamily. It phosphorylates 
ribosomal protein S6, histone H4 and myelin basic protein and is associated with apoptosis 
(Rudel and Bokoch, 1997). Full-length PAK-2 stimulates cell survival by inhibiting via 
phosphorylation the pro-apoptotic BAD, whereas proteolytically activated PAK-2p34 is 
associated with cell death response (Jakobi et al., 2003), probably via JNK pathway (Vilas et 
al., 2006). PAK-2 is also involved in the regulation of various cytoskeletal functions, such as 
cell motility (Bokoch, 2003). Protein phosphatase 1 (PP1) is a  serine/threonine phosphatase 
that regulates a large number of functions (Cohen, 2002). Another regulatory protein down 
regulated in RPMNs was the heat shock 70 kDa protein 4 (spot 234). Increased levels of 
protein from this family occur after environmental stress, infection, normal physiological 
processes, and gene transfer (Kiang and Tsokos, 1998). The Rab GDP dissociation inhibitor 
beta (spots 960-961) is a protein that inhibits the dissociation of GTP and the binding of GDP 
in Rab proteins, regulating the GTP/GDP exchange reaction in them (Sedlacek et al., 1998). 
The Rab GDP dissociation inhibitor beta may also play a role in protein transport (Bächner et 
al., 1995) . The down-regulation of the regulatory proteins probably may be attributed to the 
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fact that some cellular events that these proteins take part in are impaired after reverse 
migration. 
 
The expression levels of a number of regulatory proteins in RPMNs were increased. 
The 14-3-3 proteins (spot 1533) are a family of conserved regulatory proteins, present in all 
eukaryotic cells. These proteins bind to a plethora of regulatory proteins, enabling 14-3-3 
proteins to play an important role in mitogenic signal transduction, apoptotic cell death and 
cell cycle control (Fu et al., 2000). Recently, it has been shown that 14-3-3 proteins 
antagonize the pro-apoptotic activity of BAD. 14-3-3 protein binding to BAD ,via 
phosphorylation, prevents the latter from forming complexes with Bcl-XL/Bcl-2, thus 
inhibiting apoptosis (Zha et al., 1996). Subsequently, the up-regulation of 14-3-3 proteins in 
RPMNs may be associated with inhibition of apoptosis. 
 
Proteins S100A8 and S100A9 (spot 1701) were also up-regulated. These proteins 
belong to the group of S100 calcium-binding proteins and are mainly expressed by cells of the 
myeloid lineage, where they comprise up to the 30% of cytosolic proteins (Hessian et al., 
1993). S100A8 and S100A9 proteins exhibit antimicrobial properties and play a role in 
neutrophil activation and adhesion (Kerkhoff et al., 1998; Newton et al., 1998; Steinbakk et 
al., 1990). They form an heterodimer, calprotectin, which exist in abundance in neutrophils 
(Foell et al., 2007). Calprotectin is also present in NETs (Urban et al., 2009). Calprotectin 
levels are increased in the extracellular fluid of patients with inflammatory diseases, such as 
RA and vasculitis. This complex has been recently used as a marker of inflammation 
(Ehrchen et al., 2009).  
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Interestingly, the majority of proteins associated with the cytoskeleton were up-
regulated in RPMNs. The protein with the most significant increase in expression was 
vimentin. Vimentin is a major intermediate filament protein. Vimentin regulates secretion and 
plays an important role in the lysosomal vesicle transport (Quintanar et al., 2000; Styers et al., 
2004). It has been recently demonstrated that vimentin is degraded in apoptotic neutrophils 
(Lavastre et al., 2002a; Lavastre et al., 2002b). Interestingly, when apoptosis was suppressed 
by GM-CSF, vimentin expression was increased (Moisan et al., 2003). The marked increase 
of vimentin levels in RPMNs suggests that these cells had not undergone apoptosis. 
 
Myosin-9 (spot 298) is involved in cytokinesis and cell shape (Sellers, 2000). It is 
expressed in other leukocytes (Toothaker et al., 1991). Mutations of myosin 9 gene causes 
platelet disorders characterized by a triad of giant platelets, thrombocytopenia, and 
characteristic Döhle body-like leukocyte inclusions (Kunishima et al., 2001). Another 
cytoskeletal protein identified, CAP1 (spot 838) is a membrane protein associated with actin. 
CAP1 binds to adenylyl cyclase with the N-terminal domain and regulates filament dynamics 
by inhibiting actin polymerazation through the C-terminal domain (Moriyama and Yahara, 
2002). The up-regulation in cytoskeletal proteins may suggest that RPMNs have a high 
requirement for these proteins dynamically regulate their cytoskeleton which after activation 
has an established polarity. These findings are consistent at the molecular level with our 
visual observations under phase contrast microscopy. i.e., RPMNs on the apical surface of 
HUVEC are not spherical, but polarised with protrusions and actively migrating across the EC 
monolayer. 
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 This broad range of proteins that are differentially regulated in RPMNs is the very first 
evidence that changes in glucose metabolism, cell shape/motility and regulatory pathways 
occur within hours after the cells have reverse migrated. These changes might be associated 
with prolonged survival and immune function. Alternatively, they may have some as yet to be 
defined role in the clearance of these cells from the circulation as part of the resolution phase 
of inflammation.  
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7. GENERAL DISCUSSION 
This thesis explored neutrophil transmigration and reverse migration through the 
endothelial monolayer in human and murine in vitro models of inflammation. Neutrophils are 
believed to be terminally differentiated effector cells of the innate immune response, with a 
limited life span in the circulation. After recruitment to tissue and execution of their 
inflammatory functions, they are thought to die by apoptosis followed by clearance by tissue 
macrophages. During the last decade a number of studies have revealed that neutrophils play a 
very important role in the innate immune response and their functions are not restricted to 
killing invading microorganisms. Thus neutrophils: a) interact with other cell types 
(monocytes, dendritic cells, T cells and B cells) in a bidirectional way, b) recruit and activate 
APCs, c) play a key role in repairing inflamed tissue by controlling microbial contamination 
and attracting monocytes and/or macrophages and d) may also play a part in tumor 
destruction (reviewed by Nathan, 2006).  
 
In this thesis, we used human and murine in vitro models of inflammation to 
investigate the reverse transmigration of neutrophils. This term describes a phenomenon 
where transmigrated neutrophils have the ability to reverse transmigrate back across the same 
endothelial monolayer by which they were recruited. Reverse migration of neutrophils has 
been reported in vitro (Buckley et al., 2006) and in vivo (Mathias et al., 2006). The process of 
reverse transmigration challenges well established paradigms of neutrophil behaviour and 
inevitably leads us to the following questions: a) do reverse migrated neutrophils show 
prolonged survival and b) what is their fate after re-entering the circulation. A previous study 
has confirmed the prolonged survival of human reverse migrated neutrophils and their 
presence in the blood of healthy people and patients with chronic inflammatory diseases 
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indicates that in vivo these cells also have prolonged residence in the systemic circulation. 
RPMNs in vivo were found to share the same phenotype with the in vitro generated reverse 
migrated neutrophils (Buckley et al., 2006). However, in this study the fate of these cells in 
vivo was not demonstrated. In this thesis, after generating mRPMNs in murine in vitro models 
of inflammation, we assessed the phenotype and the prolonged survival of mRPMNs and 
finally their fate in vivo using adoptive transfer methodology.  
 
A schematic diagram illustrating the major findings in this thesis is shown in Figure 
7.1. Murine in vitro models of inflammation were developed in order to investigate the 
recruitment and reverse migration of murine neutrophils to cytokine stimulated murine EC 
monolayers. A differential response of mECs to TNF-α stimulation compared to IL-1β was 
observed, implying that mECs are far less sensitive to TNF-α than IL-1β, which is not the 
case for human EC (Luu et al., 1999). 
 
Next, mRPMNs were generated in static cultures and examined for CXCR2 and 
ICAM-1 surface expression, viability and apoptosis levels. Around 90% of mRPMNs were 
alive, as determined by Trypan Blue exclusion. Murine RPMNs showed a prolonged survival, 
as shown with human RPMNs (Buckley et al., 2006). This is also in accordance with 
previous studies showing prolonged survival of neutrophils after being in contact with the 
endothelium (Buckley et al., 2006; McGettrick et al., 2006). These findings suggest that 
under inflammatory conditions neutrophils are rescued from apoptosis in order to prosecute 
their immune functions, although how reverse migration contributes to the process of 
inflammation is still to be determined. 
 
                                                                                                                  CHAPTER 7 
 
203 
 
Murine reverse migrated neutrophils showed an altered phenotype compared to control 
populations. CXCR2 was not found to be down-regulated, but ICAM-1 expression increased 
significantly. ICAM-1 up-regulation in these cells has been suggested to facilitate their 
engagement by the macrophages in the liver and spleen and therefore their removal from 
circulation (Buckley et al., 2006). However, when adoptive transfer experiments were 
performed in order to examine the fate of RPMNs in vivo, our results did not give a clear 
indication as to the tissue localisation of RPMNs. We attributed this to the limitations of the 
particular methodology used and investigation of the fate of mRPMNs may be possible using 
more sensitive imaging platforms to track their localisation in vivo after adoptive transfer.  
 
 A chapter of this thesis was also dedicated to the role of shear stress and nitric oxide 
on the recruitment and reverse migration of human neutrophils. There is increasing evidence 
that EC phenotype can be conditioned by the physicochemical environment, including wall 
shear stress (Nash et al., 2004). A number of studies have investigated the role of wall shear 
stress on leukocyte adhesion and transmigration (Sheikh et al., 2004; Sheikh et al., 2003). We 
examined whether wall shear stress could modulate the reverse migration of neutrophils. In 
the absence of continuous flow, efficient reverse migration proceeded over a timeframe of 
several hours. Continuous flow delayed but did not inhibit reverse migration. In our hands, 
NO seemed to impair neutrophil recruitment and transmigration, which is in agreement with 
previous observations in animal models of inflammation (Kubes et al., 1991). Importantly, the 
availability of NO also appeared to delay reverse migration. It is thus tempting to speculate 
that the well documented regulation of NO synthesis by shear stress (Li et al., 2004), might be 
a possible mechanism by which neutrophils are retained in tissue and in the absence of these 
cues, neutrophils spontaneously undergo reverse migration. 
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Finally, using 2D-DIGE methodology, we examined whether reverse migrated 
neutrophils had a distinct protein expression profile. The proteins identified as characterising 
reverse migrated cells could be classified in three categories: a) metabolic enzymes, b) 
regulatory proteins and c) cytoskeletal proteins. Transaldolase and alpha enolase are 
metabolic enzymes. The heat shock 70 kDa protein 4, Serine/threonine-protein kinase PAK 2 
and Rab GDP dissociation inhibitor beta are regulatory proteins. Myosin-9, adenylyl cyclase 
associated protein 1 (CAP1), vimentin, protein S100-A9 and S100-A8 are those associated 
with the cytoskeleton. All cytoskeletal proteins were up-regulated in reverse migrated 
neutrophils. These changes in expression profiles depict changes in metabolism, motility and 
regulatory pathways in these cells and could be associated with prolonged survival and 
immune function, although the relevance of their regulation during the process of reverse 
migration remains to be described in future studies. 
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Figure 7.1 Schematic overview of the major findings of this thesis 
The major findings from experiments in murine (in red) and human (in green) in vitro models 
of inflammation are shown. MLECs were more sensitive to cytokine treatment than MHECs. 
Stimulation of mECs with IL-1β could promote neutrophil adhesion and transmigration, 
whereas treatment with TNF-α could support rolling only. Murine RPMNs showed prolonged 
life and were ICAM-1high (CD54high). In human in vitro models of inflammation, continuous 
flow retarded the process of reverse migration and there was an indication that NO could 
mediate in this process. Finally, it was demonstrated that human RPMNs have a distinct 
protein expression profile. 
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The bidirectional transmigration of neutrophils implies that these are able to return 
back to the circulation in vivo after they had been recruited to inflammatory sites. The 
physiological relevance of this process is unknown, but it has been suggested as an alternative 
route of resolution by aiding removal of the inflammatory infiltrate once it is no longer 
required. In addition, increased incidence of neutrophil reverse migration might be associated 
with chronic inflammatory diseases such as atherosclerosis and rheumatoid arthritis  (Buckley 
et al., 2006). Interestingly, the process of reverse migration has also been reported in 
monocytes in vivo  (Bradfield et al., 2007) and in lymphocytes in vitro (McGettrick et al., 
2009), although importantly, the relevance of the process to lymphocyte and monocyte 
biology is also unknown. 
 
Future work 
The work described in this thesis could be further developed in a number of ways. 
The future directions of this work are listed below. 
• Investigate the surface expression of important adhesion molecules (such as P- and E- 
selectin, VCAM-1, CD31) after stimulation with TNF-α or IL-1β in MLECs and 
MHECs. Use blocking antibodies against the adhesion molecules to further investigate 
the different mechanisms of endothelial activation by these cytokines.  
• Examine the role of important adhesion molecules (such as CD31) in the process of 
neutrophil adhesion and transmigration on mECs using cells from knock-out mice in 
our models of inflammation. 
• Further investigate the changes in expression of other molecules on the surface of 
mRPMNs. Perform functional studies to examine the mRPMNs ability for adhesion 
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and transmigration on cytokine stimulated mECs, and for ROS production. Also, 
assess their rigidity. 
• Investigate the fate of mRPMNs with a more sensitive in vivo imaging technique such 
as in vivo imaging system methodology (IVIS). 
• Further explore the effect of wall shear stress on reverse migration. Examine the 
possible role of NO in this process, by assessing eNOS induction. Also, assess the 
release of IL-8 or other chemotactic agents in the medium in the presence or absence 
of wall shear stress. 
• Verify the data obtained from 2D-DIGE electrophoresis with Western Blot. 
• Investigate whether the specific regulated proteins in human RPMNs can serve as 
biological markers of reverse migration. For example, examine their expression by 
flow cytometry, in order to obtain information on a specific RPMN phenotype. Based 
on that phenotype, human RPMNs can be identified and isolated from the whole blood 
of healthy volunteers or patients with chronic diseases. Thus, these biological markers 
could act as a powerful tool to investigate any correlation between the numbers of 
RPMNs and chronic inflammation.   
• Further examine the significance of the changes in the proteomic profile of human 
RPMNs, by extending our proteomic study to metabolomics, using analytical 
methodology, such as nuclear magnetic resonance (NMR). 
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Our results so far confirm that RPMNs have a distinct protein expression profile and 
exhibit prolonged life. In vivo they would represent a population of neutrophils that have re-
emerged from the tissues. The investigation of their fate in vivo could answer the question 
whether these are simply cleared from the inflammatory site by trafficking to the 
reticuloendothelial cell system via the circulation. Such an outcome would suggest that 
reverse migration is an alternative mechanism for resolving inflammation. Alternatively, they 
may re-enter the tissues, showing prolonged immune functions, although the significance of 
such a process is completely unknown. 
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